Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,low-density lipoprotein particle binding (GO:0030169),0.80950610760006,1.927708427065432,0.0018050541516245488,0.43169413085628827,0.305,7/16,3.55%,STAB1;MSR1;PLTP;COLEC12;LDLR;CD36;SCARF1
prerank,clathrin adaptor activity (GO:0035615),0.8100861831234732,1.9115742728671425,0.0017889087656529517,0.26381307996773173,0.357,3/15,0.32%,DAB2;AP2A2;HIP1
prerank,lipoprotein particle binding (GO:0071813),0.7674176429140943,1.9059110581733343,0.0,0.19284295641426027,0.379,7/20,3.55%,STAB1;MSR1;PLTP;COLEC12;LDLR;CD36;SCARF1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.7563291025542063,1.8922899466926495,0.0018248175182481751,0.1708177456562864,0.433,7/18,5.98%,PDLIM5;RAB10;S100A11;TMOD3;STXBP6;PDLIM1;ANXA2
prerank,protein kinase C binding (GO:0005080),0.6470211085965045,1.8575074570215373,0.003205128205128205,0.2090926674623655,0.574,11/43,7.67%,HDAC9;NELL1;PDLIM5;GRK5;HINT1;ADAM9;UGT1A10;UGT1A7;RACK1;HSPB1;PRKCB
prerank,phospholipase activity (GO:0004620),-0.49397417067114024,-1.8502461947541005,0.0,0.42166752791570244,0.295,14/67,6.27%,PLCL1;PNPLA7;ABHD12;PLCB2;MGLL;PLD4;ENPP2;PLCB4;SMPD4;PLA2G6;LYPLA2;LIPH;LPL;PITPNM3
prerank,retinoid binding (GO:0005501),0.7093499916471008,1.8073274152796084,0.0032948929159802307,0.30688460322776956,0.779,13/22,18.29%,UGT1A6;UGT1A10;UGT1A7;UGT1A4;UGT1A8;UGT1A1;CYP26C1;CYP26B1;RARA;RBP4;NR2F2;RBP1;ABCA4
prerank,retinoic acid binding (GO:0001972),0.8186118124207447,1.8029161064921797,0.007246376811594203,0.2775875768544646,0.787,10/12,17.23%,UGT1A6;UGT1A10;UGT1A7;UGT1A4;UGT1A8;UGT1A1;CYP26C1;CYP26B1;RARA;NR2F2
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.5450345273488609,-1.7890846055783531,0.0,0.43355276460940484,0.514,8/35,3.39%,PLCL1;MPPED2;PLCB2;PLD4;PLCXD3;ENPP2;PLCB4;SMPD4
prerank,glutamate receptor activity (GO:0008066),-0.631967277220449,-1.7651456915765666,0.0,0.3768825780553746,0.593,6/19,3.79%,GRID2;GRM7;GRIA2;GRIK2;GRM3;GRIA4
prerank,lysophospholipase activity (GO:0004622),-0.632434080339471,-1.7619977683150199,0.004761904761904762,0.28679592891325345,0.601,6/20,4.99%,PNPLA7;ABHD12;MGLL;ENPP2;PLA2G6;LYPLA2
prerank,mannose binding (GO:0005537),0.7703159853637616,1.7506174018394263,0.012773722627737226,0.4139515999679204,0.911,4/12,8.45%,CLEC6A;CLN5;ACR;CLEC4D
prerank,death receptor activity (GO:0005035),0.8008344724224516,1.7495211287242776,0.01289134438305709,0.3718725707729025,0.913,3/11,4.18%,TNFRSF25;TNFRSF1B;TNFRSF11A
prerank,glucuronosyltransferase activity (GO:0015020),0.713375988375061,1.7464953681718451,0.013266998341625208,0.3439848471267567,0.921,8/19,3.64%,EXT1;LARGE2;UGT1A6;UGT1A10;UGT1A7;UGT1A4;UGT1A8;UGT1A1
prerank,monocarboxylic acid binding (GO:0033293),0.7107819342993116,1.739706125618071,0.013793103448275862,0.3322024717556224,0.929,9/18,9.99%,NR1H4;UGT1A6;UGT1A10;UGT1A7;UGT1A4;UGT1A8;UGT1A1;CYP26C1;CYP26B1
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.7462093749985904,-1.713609558223552,0.006622516556291391,0.3846682693387854,0.784,7/10,16.99%,GNAS;DLG4;SHANK1;IGSF11;SHANK2;SHISA7;SQSTM1
prerank,endonuclease activity (GO:0004519),0.5731811637214127,1.7109069066530174,0.009216589861751152,0.39253820061989025,0.971,16/49,13.53%,ENDOG;ANG;RPS3;ENDOU;ERN1;NYNRIN;RNASEK;SND1;SMG6;RNASEL;CPSF3;ZRANB3;LACTB2;ZC3H12A;ZC3H12D;PIWIL2
prerank,phosphatidylinositol binding (GO:0035091),0.5148760502077323,1.7061460774398964,0.008152173913043478,0.3762734295986172,0.975,14/91,3.78%,DENND1A;SNX2;HIP1;SNX9;WDFY3;FCHO2;SNX8;SESTD1;ANKFY1;SNX24;MTM1;DENND1B;PITPNA;SNX27
prerank,acylglycerol lipase activity (GO:0047372),-0.7053771518011512,-1.6993449180320728,0.006263048016701462,0.3680978378904641,0.829,5/11,17.06%,ABHD12;MGLL;ABHD15;ABHD16A;FAAH
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.4602061870832636,1.6938491551035042,0.0,0.3871542602123855,0.981,68/254,17.73%,RBPJ;ETV1;TCF4;IRF4;MEF2A;ZBTB16;RREB1;TFEC;ESR1;TCF12;MEF2C;NR1H4;MITF;KLF6;HOXD8;RAX;ALX1;HOXA10;NR3C1;CLOCK;GRHL2;NFIC;SMAD4;NR4A1;FOSL2;KLF4;YY1;REL;SATB2;CEBPG;NR4A2;IRF2;KLF10;ATF6;FOXC2;ESRRB;MDM2;FOXJ3;MLXIP;STAT6;CREBRF;SP1;TFDP1;ELF1;MYBL2;FOXK2;HINFP;NFIA;FOXO3;FOXO1;CREB1;NR1H2;STAT3;KLF5;MYC;MTF1;SMARCD1;NR2C2;ELK1;ZFP62;HOXB3;CREB3L1;NFATC3;GLIS2;RELA;MEF2B;MECOM;GMEB1
prerank,voltage-gated chloride channel activity (GO:0005247),0.7700622822755246,1.6726881591142626,0.02099236641221374,0.4341740064379269,0.991,4/10,5.28%,CLCN5;ANO6;CLCNKB;ANO1
prerank,hyaluronic acid binding (GO:0005540),0.7718323870361824,1.67186685828971,0.02626641651031895,0.4092406521113538,0.992,2/10,2.35%,LYVE1;CD44
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.7713986072557497,1.665145548581526,0.015503875968992248,0.4066458519550631,0.994,4/10,15.09%,CYBB;NCF2;CYBA;NOX4
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.7089217228121878,1.6583767077174287,0.026785714285714284,0.40466566234588575,0.994,4/16,3.66%,CD38;BST1;RPS3;DNPH1
prerank,ribonuclease activity (GO:0004540),0.5393133970838652,1.6506936309875848,0.014992503748125937,0.40541844082923173,0.996,20/56,15.22%,ENDOG;ANG;RNASE4;ENDOU;ERN1;NYNRIN;RNASEK;SND1;SMG6;RNASEL;CPSF3;RNASE6;LACTB2;ZC3H12A;EXOSC8;DIS3L2;ZC3H12D;PIWIL2;EXOSC1;SAMHD1
prerank,phosphatidylglycerol binding (GO:1901611),0.7163296942256235,1.6493908049617225,0.039473684210526314,0.3896015058521604,0.997,3/13,4.51%,PLTP;PITPNA;GSDME
prerank,cell adhesion mediator activity (GO:0098631),-0.5403781279276924,-1.6450779461953795,0.012376237623762377,0.5291514075804893,0.947,8/24,8.30%,SIRPA;LRRC4C;PALLD;CNTN4;BSG;CNTN6;CNTN2;NTNG1
prerank,retinoid X receptor binding (GO:0046965),0.7387785949338169,1.6392503814484265,0.03308823529411765,0.40386545186684825,0.999,5/11,8.46%,RARG;ARID5A;NR4A2;NRIP1;NCOA6
prerank,solute:proton symporter activity (GO:0015295),-0.6218231838917505,-1.6385440928603756,0.015909090909090907,0.4915578871688872,0.961,7/16,12.85%,SLC2A9;SLC36A1;SLC25A3;SLC11A2;SLC2A13;SLC17A5;CTNS
prerank,MAP kinase kinase kinase activity (GO:0004709),0.749970885269765,1.638415182133497,0.026881720430107527,0.3877771954661464,0.999,4/11,9.28%,EGFR;MAP3K5;MAP3K1;MAP3K20
prerank,triglyceride lipase activity (GO:0004806),-0.5607174465479665,-1.6372525025576294,0.017369727047146403,0.4407298399075343,0.962,3/20,5.90%,DAGLB;LIPH;LPL
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.6206681264470085,-1.6235305431303786,0.017817371937639197,0.45039879574917435,0.971,7/14,24.80%,SLC1A3;SLC38A7;SLC1A1;SLC25A22;SLC17A6;SLC1A2;SLC25A13
prerank,voltage-gated calcium channel activity (GO:0005245),-0.48565897962351473,-1.6224159083229333,0.0079155672823219,0.41386930937358946,0.971,13/37,19.50%,CACNB2;CACNB4;CACNA2D3;CACNA2D1;CACNA1D;CACNA1E;CACNG7;CACNA1C;CACNG8;CACNG4;NCS1;ITGAV;CACNG2
prerank,chemokine activity (GO:0008009),0.5894962991389187,1.611320814714615,0.022617124394184167,0.4493568602564027,0.999,8/31,17.31%,PF4;CCL8;CCL19;CXCL16;CCL24;CKLF;CCL5;CCL25
prerank,voltage-gated cation channel activity (GO:0022843),-0.4042020326695279,-1.6073374986753568,0.0,0.4296771439484149,0.984,21/97,14.03%,KCNMA1;CACNB2;KCND2;KCNH7;PTK2B;CACNB4;KCNQ3;CACNA2D3;CACNA2D1;GRIN3A;CACNA1D;KCNQ5;CACNA1E;KCNA1;KCNA2;CACNG7;GRIN2A;CACNA1C;CACNG8;KCNS3;HVCN1
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.595158149146918,-1.6067689884077836,0.022271714922048998,0.3992485530152069,0.985,6/17,10.87%,PTK2B;GRIA2;GRIK2;GRIA4;GRIN3A;GRIN2A
prerank,3'-5' DNA helicase activity (GO:0043138),-0.6013243419466178,-1.604355574725141,0.03803131991051454,0.3777438270911501,0.986,4/16,8.79%,NAV2;HELQ;BLM;RECQL5
prerank,endoribonuclease activity (GO:0004521),0.5777640864828041,1.5994813856189962,0.02936378466557912,0.46885147715353687,0.999,13/32,13.53%,ENDOG;ENDOU;ERN1;NYNRIN;RNASEK;SND1;SMG6;RNASEL;CPSF3;LACTB2;ZC3H12A;ZC3H12D;PIWIL2
prerank,cation:chloride symporter activity (GO:0015377),-0.6771383851115227,-1.5978627704894515,0.029411764705882353,0.3714394841492732,0.988,7/10,25.14%,SLC12A2;SLC12A9;SLC12A6;SLC6A1;SLC12A4;SLC12A5;SLC12A1
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.6887464136250621,-1.5942850855382653,0.021505376344086023,0.35668628816643827,0.989,4/10,11.72%,CACNB2;CACNB4;CACNA1D;CACNA1C
prerank,amyloid-beta binding (GO:0001540),0.48969834023730424,1.5764721011535607,0.01813110181311018,0.5313459733079213,1.0,15/79,4.97%,MSR1;FCGR2B;APOE;ITM2B;C1QA;LDLR;ADRB2;LILRB1;LILRB3;CD36;CD74;TLR4;TLR2;TM2D1;INSR
prerank,rRNA binding (GO:0019843),0.5442110613025345,1.5723062652622644,0.03538461538461538,0.5254424638261259,1.0,14/42,9.26%,RPL23;ANG;RPS3;RPS13;ERAL1;RPL12;NOP53;RPLP0;RPL5;RPS14;RPS9;MDM2;RPS5;MRPS11
prerank,CXCR chemokine receptor binding (GO:0045236),0.7176244807125913,1.5533187498798646,0.046065259117082535,0.5755559189840915,1.0,1/11,0.26%,PF4
prerank,CCR chemokine receptor binding (GO:0048020),0.5784170531479692,1.5532795018673333,0.043973941368078175,0.5552800356649197,1.0,7/28,8.22%,CCL8;MSMP;NES;CCL19;CCRL2;CCR2;CCL24
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.5883578426568975,-1.5424153762433621,0.03991130820399113,0.5015509090692827,0.999,8/15,27.73%,SLC1A3;SLC38A7;SLC1A1;SLC25A22;SLC17A6;SLC1A2;SLC25A13;SLC1A4
prerank,lipase activity (GO:0016298),-0.4432399868101751,-1.5373661654563526,0.02710843373493976,0.4914861164159059,0.999,11/43,18.58%,ABHD12;MGLL;DAGLB;LIPH;LPL;PITPNM3;ABHD15;DDHD1;ABHD16A;FAAH;SMPD2
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.6507847076377019,1.5369121201758884,0.05805243445692884,0.5967228747577968,1.0,6/14,22.10%,CYBB;NCF2;CYBA;NOX4;AIFM1;KMO
prerank,voltage-gated anion channel activity (GO:0008308),0.647162655123466,1.531945885545291,0.056672760511883,0.5965079672096604,1.0,4/15,5.28%,CLCN5;ANO6;CLCNKB;ANO1
prerank,cytokine activity (GO:0005125),0.4438001703160717,1.5269758392421038,0.010113780025284451,0.5950122527777807,1.0,16/131,8.22%,PF4;IL16;IL15;TSLP;KITLG;BMP2;CCL8;WNT2;GDF3;CCL19;GDF10;FAM3C;TNF;WNT6;CXCL16;CCL24
prerank,SH2 domain binding (GO:0042169),-0.471994904517255,-1.5266753284347572,0.034666666666666665,0.5010837547935308,0.999,6/31,4.20%,PAG1;ARHGAP5;BLNK;JAK2;SRC;LAT2
prerank,BMP binding (GO:0036122),-0.6318676703810868,-1.522455467698036,0.033542976939203356,0.49111865016064166,0.999,4/11,32.70%,ENG;GREM1;GREM2;BMPR2
prerank,cGMP binding (GO:0030553),0.6975139300673571,1.5199013034511826,0.060218978102189784,0.6029095539290381,1.0,4/11,10.60%,CNGA3;RAPGEF2;PDE2A;PDE5A
prerank,gated channel activity (GO:0022836),-0.5867757412152784,-1.5194483318231027,0.04576659038901602,0.4782638931238091,1.0,10/14,32.37%,PIEZO1;TMC7;PACC1;PIEZO2;TMEM63A;TMC6;TMC8;TMC1;TMC4;TMC3
prerank,transmitter-gated ion channel activity (GO:0022824),-0.4754166486952406,-1.515487871510165,0.02313624678663239,0.46906754303011244,1.0,9/29,16.82%,GRID2;GRIA2;GRIK2;GABRB3;GRIA4;GABRB1;GABRA2;GABRG2;GLRA3
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.4554788266104266,1.5147108828031386,0.017379679144385027,0.6030309892240422,1.0,15/100,7.13%,IQGAP2;DENND1A;HIP1;IQGAP1;ARHGAP9;SESTD1;ANKFY1;ARAP1;SNX24;FCHSD2;DENND1B;SNX27;SNX3;KIF16B;WIPI1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.574942470467362,-1.5130433639017553,0.04888888888888889,0.43665326113819675,1.0,7/16,12.34%,TCIRG1;ATP6V1C1;ATP6V0A2;ATP6V1D;ATP6V0B;ATP6V0D2;ATP6V0C
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.574942470467362,-1.5130433639017553,0.04888888888888889,0.43665326113819675,1.0,7/16,12.34%,TCIRG1;ATP6V1C1;ATP6V0A2;ATP6V1D;ATP6V0B;ATP6V0D2;ATP6V0C
prerank,microtubule binding (GO:0008017),-0.33281880432838434,-1.511728356308566,0.0,0.4231971062032398,1.0,86/222,25.00%,NAV3;DST;MAP4K4;MAP2;KIF21B;CCDC88B;DNM3;CLASP2;EML3;NEFM;CAMSAP1;MAP1B;CCDC66;FGF13;KIF1A;MTCL1;NEFH;KIF5A;CLIP2;MACF1;KIF6;KIF5C;CRIPT;MAPT;PRNP;HAUS8;FMR1;FMN1;TUBGCP5;CENPE;MAP6;ARHGEF2;MAPRE3;IRAG2;KRIT1;CEP44;TPPP;KIF1C;MTUS1;KIF3A;EML6;TOGARAM1;HAUS7;NUMA1;CKAP5;EML1;KIF15;TUBGCP3;MAPRE1;EML2;SGIP1;MAP1LC3A;KIF3B;DLGAP5;MAP4;CLIP3;KIFC2;APC2;REEP1;NUSAP1;KIF2A;GOLGA2;EML5;SKA2;FSD1;TUBGCP6;KIFC1;GAPDH;CLIP4;ARL3;REEP2;TOGARAM2;HDAC6;KATNB1;MAP9;FNTA;CETN3;REEP4;BIRC5;GAS2L3;DCTN1;KIF14;HOOK2;S100A9;HAUS6;HDGFL3
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.6209511615636366,-1.5086469401886868,0.03624733475479744,0.4163012839235625,1.0,6/12,18.85%,TGFBR1;BMPR1B;ACVR1;TGFBR3;TGFBR2;ENG
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.6436947580550152,-1.5082089695628036,0.06736842105263158,0.4019544944301735,1.0,6/10,27.23%,ANKRD13B;DNAJB2;ANKRD13D;ANKRD13A;IDE;FAAP20
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5285881615014957,1.5065035533351239,0.04245283018867924,0.6162164520953141,1.0,4/38,5.98%,SERPINB8;APP;SERPINB2;ANXA2
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.5215258897961695,-1.504714083983251,0.05084745762711865,0.3962360742450163,1.0,8/22,12.45%,TCIRG1;ATP6V1C1;ATP6V0A2;ATP6V1D;ATP6V0B;ATP6V0D2;ATP6V0C;ATP2C1
prerank,sequence-specific DNA binding (GO:0043565),0.39048195325691093,1.5040882851152306,0.0010351966873706005,0.6076161317041052,1.0,131/590,18.57%,RBPJ;ZEB2;MAF;ETV1;KLF2;TCF7L2;TCF4;IRF4;FOXP1;FLI1;MEF2A;AHR;FOXN2;TFEC;KMT2A;ESR1;ZBTB20;RARG;TCF12;MEF2C;NR1H4;CEBPB;OSR1;KLF6;TBX15;HOXD8;NR2C1;PHOX2A;FOXA3;RAX;ALX1;HOXA10;NR1D1;NR3C1;HEY2;CLOCK;GRHL2;DMRTA2;NFIC;ARID5A;SMAD4;SMG6;ELF2;THRB;IRX2;MBNL2;CBFB;NR4A1;TCF7;BCL2;KLF3;ZNF148;KLF4;YY1;CEBPG;NR4A2;LHX5;IRF2;KLF10;IRX5;ATF6;TET3;FOXC2;ESRRB;OLIG2;HIVEP1;FOXJ3;ATF7;NFATC2;NR2F1;RFX2;ZNF296;SP1;ELF1;ETS2;CENPB;SREBF2;BCL11B;MYBL2;FOXK2;XPA;FOXO3;FOXK1;TERF2IP;SP3;NFIX;FOXO1;CREB1;KLF13;RARA;MBD1;KLF5;JUND;TERF1;USF1;PRMT1;MTF1;HDAC4;KDM2A;NR2C2;RUNX3;ELK1;E2F8;KDM1A;CREB3L1;ZGPAT;ZNF177;TBX2;NFATC3;ARNT;GLIS2;FOXP2;NR5A2;LHX1;ZBTB7A;NR2F2;XBP1;MEF2B;NR6A1;SP8;GMEB1;ZNF32;GZF1;BATF;HSF5;ZBTB12;MAFB;ATF2;RFX3;LONP1;ZBTB14
prerank,transferrin receptor binding (GO:1990459),0.6856811815843946,1.50384322393845,0.07380073800738007,0.5917983789340048,1.0,2/10,7.63%,SNX2;HFE
prerank,RNA cap binding (GO:0000339),-0.5595494271109482,-1.4965190477802304,0.053452115812917596,0.4080538535019264,1.0,12/16,37.17%,EIF4A1;CYFIP2;DCPS;NCBP1;EIF4E;LARP1;SNUPN;NCBP3;EIF4E2;EIF3D;GEMIN5;NCBP2
prerank,mechanosensitive ion channel activity (GO:0008381),-0.6056132034162972,-1.4840306667013796,0.05506607929515418,0.4298666187362855,1.0,9/12,32.37%,PIEZO1;TMC7;PIEZO2;TMEM63A;TMC6;TMC8;TMC1;TMC4;TMC3
prerank,epidermal growth factor receptor binding (GO:0005154),0.5688993169865754,1.4825313817985457,0.06543624161073826,0.65543852410576,1.0,3/25,1.92%,SNX2;HIP1;FER
prerank,kinase inhibitor activity (GO:0019210),0.5300215644880514,1.4811028062802116,0.05598755832037325,0.6433679984566059,1.0,16/33,23.00%,LRP6;SH3BP5;GMFG;DNAJC3;SMCR8;SH3BP5L;PARVA;GMFB;TRIB1;SNCA;DUS2;CDKN1C;CDKN1B;NPM1;QARS1;NCK1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5915789135570365,1.4746387474427562,0.08050089445438283,0.6524733374969018,1.0,4/18,4.77%,TNFAIP8;GAS6;RPS6KA3;BIRC3
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.42609237353458085,-1.4699130397075293,0.042735042735042736,0.45760661671180675,1.0,10/46,11.79%,HEXB;LARGE1;MGAT4C;GCNT2;MGAT5;B3GALT1;B3GALT5;MGAT4B;POMGNT1;B3GALT2
prerank,1-phosphatidylinositol binding (GO:0005545),0.6145320833816644,1.4606519362254298,0.08214285714285714,0.687431300212763,1.0,3/15,1.61%,SNX9;WDFY3;SESTD1
prerank,GDP binding (GO:0019003),0.4665304439298438,1.45841599906089,0.04061624649859944,0.6794031407359405,1.0,12/63,8.92%,RAP1B;RAB31;RAP2B;NRAS;KRAS;GNAI3;RAB8B;RAB10;RAP1A;GEM;RAB7A;RAB14
prerank,phosphatidate phosphatase activity (GO:0008195),-0.5798064582499316,-1.4583438318368023,0.07192575406032482,0.47821929272731356,1.0,6/13,22.05%,LPIN2;PLPP3;PLPPR1;PLPP4;PLPP2;PLPP5
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.5856172535401641,-1.4578481088396034,0.0625,0.4655129333733661,1.0,4/12,8.69%,ITGB3;VEGFB;ITGA5;CADM4
prerank,muscle alpha-actinin binding (GO:0051371),0.6017919533943564,1.4571968739255665,0.08775137111517367,0.6684010519758469,1.0,6/15,17.63%,PDLIM5;NRAP;PDLIM1;PKD2L1;PKD2;PDLIM2
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.41161936783813335,1.455569117905149,0.018072289156626505,0.658775761151678,1.0,42/181,15.93%,RBPJ;TCF7L2;MDFIC;MEF2A;RBBP8;NCOA3;NR1H4;NCOA2;PIAS1;BCL10;HEY2;SPI1;GSK3B;NCOA7;RB1;ACTB;TRIM32;PIAS2;DMAP1;HSPB1;KLF4;MIER1;FIZ1;NRIP1;NCOR1;MAPK14;SPEN;MIER3;SP1;JUP;CREBBP;PSMA6;BUD31;BCAS3;CREB1;STAT3;EP300;SNW1;HDAC4;ARID1A;ELK1;KDM1A
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.5203084044857662,1.4543912246718718,0.06748466257668712,0.6480528931000218,1.0,6/34,5.87%,IQGAP2;IQGAP1;ARHGAP9;ARAP1;FCHSD2;KIF16B
prerank,carboxy-lyase activity (GO:0016831),-0.49463742105174546,-1.4459472477516913,0.04455445544554455,0.48638279369803594,1.0,9/23,12.78%,PPCDC;AZIN1;BCKDHA;UMPS;GGCX;CSAD;UXS1;PCK2;DDC
prerank,PDZ domain binding (GO:0030165),-0.3872701967601241,-1.4435949463237423,0.025889967637540454,0.47927770627449345,1.0,14/61,7.73%,CADM1;F11R;GRID2;DOCK4;NLGN1;DLG4;GNG12;PLEKHA1;TBC1D10A;CIT;SYNJ2;CRIPT;SDC2;TGFBR3
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5225670602109287,-1.442316695567564,0.08185840707964602,0.46955297430482223,1.0,7/18,18.85%,TGFBR1;BMPR1B;ACVR1;TGFBR3;TGFBR2;ACVR1B;ENG
prerank,tubulin binding (GO:0015631),-0.3087752819221404,-1.4414678087463682,0.0,0.4595159314878922,1.0,109/296,25.00%,NAV3;DST;MAP4K4;MAP2;UNC5C;KIF21B;CCDC88B;DNM3;TRAPPC14;CLASP2;PAK1;TTLL11;TBCD;EML3;NEFM;CAMSAP1;MAP1B;CCDC66;IFT81;DIP2B;FGF13;KIF1A;ALDOA;MTCL1;NEFH;KIF5A;CLIP2;KIF6;KIF5C;TTLL7;CRIPT;MAPT;APPL1;NCALD;PRNP;HAUS8;FMR1;FMN1;TUBGCP5;CENPE;MAP6;ARHGEF2;BRCA1;MAPRE3;IRAG2;STMN3;VBP1;KRIT1;CEP44;BRCA2;TPPP;KIF1C;STMN4;MTUS1;KIF3A;EML6;TOGARAM1;NUMA1;TTLL1;CKAP5;EML1;KIF15;TUBGCP3;GPAA1;EML2;SGIP1;MAP1LC3A;KIF3B;GABARAPL1;DLGAP5;MAP4;CLIP3;KIFC2;APC2;REEP1;NUSAP1;KIF2A;CENPJ;GOLGA2;EML5;SKA2;FSD1;B9D2;EMD;BBS4;TUBGCP6;KIFC1;SETD2;GAPDH;PRUNE1;ARL3;REEP2;TOGARAM2;HDAC6;KATNB1;BRSK1;MAP9;FNTA;RITA1;CETN3;REEP4;BIRC5;GAS2L3;DCTN1;KIF14;HOOK2;S100A9;HAUS6;HDGFL3
prerank,mitogen-activated protein kinase binding (GO:0051019),0.5287361980113532,1.4397975772675982,0.09046052631578948,0.687534628361998,1.0,10/29,16.14%,PTPRJ;DUSP1;GCH1;MAPKAPK2;DUSP2;MAPK14;ATF7;PRMT1;DUSP7;MAPK7
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.40858563823488153,1.438901806430494,0.0316055625790139,0.6759079653089535,1.0,28/147,10.09%,ITSN1;VAV3;DENND1A;FGD4;RASGRP4;SBF2;FGD6;RGL1;DOCK2;SH3BP5;RIN2;DOCK1;DENND1B;RAPGEF2;RIC1;RAP1A;DOCK11;GAPVD1;MYCBP2;NUCB2;NGEF;FNIP1;DENND4C;DENND5A;SMCR8;DENND2C;EEF1D;CYTH1
prerank,protein kinase activator activity (GO:0030295),0.4587435388977889,1.4382816526978124,0.05873715124816446,0.6639637765990068,1.0,16/60,10.64%,IQGAP1;PRKAG2;GAS6;ABI1;RPLP1;RGCC;GHRL;GPRC5B;INCENP;PAK2;STK3;WNK1;FAM20A;PARP16;MARK2;CALM1
prerank,protein kinase binding (GO:0019901),0.37597447522850785,1.4346473981705399,0.0021231422505307855,0.6625509695417183,1.0,100/480,14.23%,BANK1;HDAC9;AP2A2;NELL1;PDLIM5;NEDD9;SPRED1;PTPRJ;TCF7L2;IQGAP1;SASH1;PRKAG2;ESR1;CLTC;GRK5;DNAJC3;HINT1;ITGB1;RPS3;IRAK3;OXSR1;CASS4;EEF1A1;MYH6;PRKAG3;CDC42;GDF3;ADAM9;MAP3K1;AXIN1;CRK;UGT1A10;UGT1A7;RHOA;UTRN;RGCC;PRKN;BCL10;DUSP1;NR3C1;GCH1;DOK7;GSK3B;PGAM1;RACK1;GPRC5B;PAK2;PTPRK;MAPKAPK2;TBC1D14;ACTB;WNK1;VRK2;FOXM1;HSPB1;CCND3;DUSP22;DUSP2;PRKCB;IFNAR2;RHOBTB1;TRIM68;MAPK8IP2;VRK1;MSN;TRIM27;RCC2;MAPK4;SMCR8;RPS7;ATF7;SH2B3;CCND2;CACUL1;ACSL3;RPS6;MAML1;CALM1;SPRED2;SHC1;IL15RA;FOXO3;KCNQ1;STK38;TRIB2;MAP3K11;CDKN2C;NOD2;EXOC2;RBBP6;RND3;CTBP2;CNTLN;RARA;FAM83B;IBTK;STAT3;CAVIN3;ITGB2;RHOC
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.6424786944825851,1.4305692601306088,0.12208258527827648,0.6646119832165764,1.0,1/11,0.54%,PADI4
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.6572639926512791,1.4274473229381728,0.09351145038167939,0.6619897345416634,1.0,3/10,15.98%,SLC10A6;SLC10A3;SLC6A11
prerank,symporter activity (GO:0015293),0.6545069585708934,1.4264214018136754,0.11262135922330097,0.6528291662746911,1.0,4/10,17.21%,SLC28A2;SLC4A4;MFSD2A;SLC5A6
prerank,ligand-gated anion channel activity (GO:0099095),-0.5212474883837375,-1.4263140670586019,0.06506024096385542,0.4927885667121138,1.0,12/17,29.48%,GABRB3;GABRB1;GLRB;GABRA2;GLRA1;GABRG2;GLRA3;CFTR;GLRA2;GABRA4;GABRG3;GABRE
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.49968406415055006,1.4255595330714088,0.060897435897435896,0.643098504199918,1.0,7/38,7.13%,DENND1A;HIP1;SESTD1;SNX27;SNX3;KIF16B;WIPI1
prerank,double-stranded DNA binding (GO:0003690),0.37083973293419803,1.4236810590240656,0.003131524008350731,0.6373735832678583,1.0,114/531,18.05%,MAF;ETV1;EGFR;KLF2;TCF4;RBMS1;IRF4;FOXP1;FLI1;AHR;FOXN2;TFEC;ESR1;ZBTB20;RBBP8;RARG;RPS3;TCF12;MEF2C;CEBPB;DDX60;OSR1;KLF6;TBX15;HOXD8;NR2C1;PHOX2A;FOXA3;RAX;ALX1;HOXA10;NR1D1;MND1;NR3C1;HEY2;CLOCK;DMRTA2;NFIC;ELF2;THRB;MBNL2;NR4A1;TCF7;KLF3;KLF4;YY1;DDX11;CEBPG;NR4A2;LHX5;IRF2;KLF10;IRX5;ATF6;FOXC2;ESRRB;OLIG2;HIVEP1;FOXJ3;ATF7;NFATC2;NR2F1;PURA;POLG2;RFX2;ZNF296;SP1;PCID2;ELF1;ETS2;SREBF2;BCL11B;MYBL2;XPA;FOXO3;FOXK1;SP3;NFIX;CREB1;KLF13;RARA;KIN;MBD1;KLF5;JUND;TERF1;USF1;RAD51B;MTF1;NR2C2;RUNX3;ELK1;FBH1;E2F8;CREB3L1;ZNF177;TBX2;NFATC3;ARNT;GLIS2;NR5A2;LHX1;ZBTB7A;XBP1;MEF2B;DMC1;NR6A1;SP8;GMEB1;ZNF32;BATF;HSF5;ZBTB12;APTX
prerank,acid-thiol ligase activity (GO:0016878),-0.5571613302084621,-1.4159564964408957,0.08405172413793104,0.5111844276956952,1.0,7/13,33.80%,AASDH;ACSS1;ACSS3;SLC27A2;ACSF3;ACSS2;AACS
prerank,hexosaminidase activity (GO:0015929),-0.5640111274989852,-1.412164106702849,0.10810810810810811,0.5108584780606169,1.0,3/12,10.80%,HEXB;HEXD;HYAL1
prerank,GTPase activator activity (GO:0005096),0.3773543127766357,1.4114597343239923,0.012318029115341545,0.6674273330757884,1.0,46/313,6.86%,ITSN1;ARHGAP15;STARD8;VAV3;IQGAP2;DENND1A;NRP1;FGD4;RASGRP4;SBF2;GNAQ;FGD6;IQGAP1;ARHGAP9;RGL1;TBC1D5;TBC1D4;DOCK2;SH3BP5;OPHN1;ARAP1;EVI5;RIN2;RASA1;USP6NL;DOCK1;ARHGAP10;DENND1B;ARHGAP18;ARHGEF10L;ARHGAP31;RAPGEF2;RIC1;NPRL3;RAP1A;DOCK11;OCRL;TBC1D14;RGS8;ARHGAP29;GAPVD1;MYCBP2;NUCB2;NGEF;STXBP5;TBC1D2B
prerank,chemokine receptor binding (GO:0042379),0.5083550142460045,1.4111161757416002,0.07852564102564102,0.6563779778127832,1.0,6/35,8.22%,PF4;CCL8;CCL19;CCRL2;CXCL16;CCL24
prerank,neuropeptide binding (GO:0042923),-0.505064827991256,-1.4101540891234057,0.09887640449438202,0.5039189114396705,1.0,10/18,47.84%,SORL1;GPR149;OPRL1;OPRD1;OPRK1;MC4R;SSTR2;OPRM1;GPR37;NMUR1
prerank,RNA methyltransferase activity (GO:0008173),-0.4986295360742445,-1.4055785175060116,0.07692307692307693,0.5041013641970752,1.0,9/19,21.65%,TRDMT1;FTSJ3;TRMT12;MEPCE;TGS1;BCDIN3D;TRMT9B;MRM2;METTL3
prerank,calcium:sodium antiporter activity (GO:0005432),-0.6067476356747561,-1.405324225503131,0.09322033898305085,0.4930270177915415,1.0,4/10,7.42%,SLC24A3;SLC24A2;SLC8A1;SLC24A4
prerank,mannosyltransferase activity (GO:0000030),-0.48345415598826363,-1.4041054216439757,0.07906976744186046,0.48503979787540424,1.0,11/21,23.29%,DPY19L4;TMTC4;ALG1;DPY19L1;TMTC2;ALG12;ALG3;DPY19L3;ALG8;TMTC1;PIGB
prerank,single-stranded DNA helicase activity (GO:0017116),-0.502546873083124,-1.4018816632431572,0.056155507559395246,0.4806688285265651,1.0,14/19,39.40%,DNA2;HELQ;RFC2;MCM6;DHX9;RAD51;CHTF18;MCM2;MCM7;POLQ;DSCC1;PIF1;MCM5;RFC5
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.5362003184403413,1.4003778650063345,0.09555189456342669,0.6808586976373676,1.0,5/23,7.13%,HIP1;SESTD1;SNX3;KIF16B;WIPI1
prerank,cadherin binding (GO:0045296),0.36944471215066643,1.393249413131933,0.010044642857142858,0.6936095220998437,1.0,87/315,16.20%,AHNAK;SNX2;PDLIM5;EGFR;PTPRJ;EHD4;CTNNA1;IQGAP1;SNX9;EPS15;ITGB1;ABI1;WASF2;EIF3E;SPTBN1;RPL23A;ARHGAP18;SWAP70;CD46;CBL;TMPO;RAB10;S100A11;EHD1;GOLGA3;RPL24;SND1;TMOD3;RACK1;PKN2;PAK2;TXNDC9;STXBP6;PDLIM1;CTNND1;STK24;ANXA2;SFN;GAPVD1;CNN2;BAG3;EPN2;FLNB;PSEN1;RPL14;VASN;DCHS1;VCL;LRRFIP1;RPL34;CDH12;RAB1A;SERBP1;EEF1D;RPL6;RTN4;AHSA1;MARK2;PACSIN2;DDX6;CHMP5;PPP1CA;JUP;PLCB3;CEMIP2;YWHAE;RPL15;NIBAN2;STK38;SNX5;CAST;VAPA;DIAPH3;GLOD4;CAPZA1;TAGLN2;ADD1;RARS1;PARVA;EIF5;BZW2;FXYD5;UBAP2;TRIM25;IDH1;HSP90AB1;HCFC1
prerank,SH3 domain binding (GO:0017124),0.4434438524696492,1.3841901535350207,0.08416547788873038,0.7129417263128989,1.0,11/62,4.82%,AFAP1L1;PTPN12;ABI1;PTPN22;WASF2;SYNJ1;ADAM9;CBL;CRK;PRKN;WIPF1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5718537588153919,1.3830958591187517,0.1415929203539823,0.7053376721227768,1.0,5/15,11.96%,CCR1;CMKLR1;CCRL2;CCR2;GPR17
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.5975290414260357,-1.381283628990797,0.12734864300626306,0.5304095800849267,1.0,3/10,6.22%,CYLD;OTUD5;STAMBP
prerank,growth factor receptor binding (GO:0070851),0.4196766673963078,1.3808950098439727,0.06125166444740346,0.7011032458536387,1.0,15/95,9.45%,SNX2;HIP1;PTPRJ;FER;TSLP;FGF23;ERN1;PIBF1;FRS2;PDGFRA;SDCBP;PSEN1;FYN;IL6R;PDGFC
prerank,phospholipase C activity (GO:0004629),-0.4650810284757092,-1.3792339075876578,0.09090909090909091,0.5257870390066938,1.0,8/25,11.24%,PLCL1;PLCB2;PLCB4;PLCG1;CHRM3;EDNRA;PLCB1;PLCH1
prerank,histone deacetylase binding (GO:0042826),0.42605606599564966,1.3791170082324664,0.06763925729442971,0.6957559472660955,1.0,28/88,17.38%,HDAC9;MEF2A;MEF2C;HOXA10;PRKN;HEY2;SPI1;PKN2;BRMS1L;MIER1;SATB2;GMNN;NCOR1;LCOR;MIER3;SP1;ZMYND15;YWHAE;BCOR;KPNA2;USF1;HDAC4;SFPQ;HSP90AB1;TOP2B;RELA;NACC1;MEF2B
prerank,retinoic acid receptor binding (GO:0042974),0.5668908191050464,1.375655885651718,0.12585034013605442,0.6966913619400401,1.0,6/17,9.48%,RARG;ARID5A;NR4A2;NRIP1;NCOA6;ASXL1
prerank,Wnt-activated receptor activity (GO:0042813),-0.5189787827841905,-1.3690131286789884,0.10609480812641084,0.5440294846735118,1.0,10/15,41.20%,LRP5;TSPAN12;FZD4;FZD6;FZD2;FZD5;PKD1;FZD8;FZD1;FZD10
prerank,actin binding (GO:0003779),0.3864916787178362,1.3587786649773057,0.0471584038694075,0.7445841971937277,1.0,31/170,14.55%,EPS8;IQGAP2;MTSS1;PDLIM5;FLII;PHACTR2;ANG;ITGB1;TMOD1;NRAP;SYNE2;UTRN;PRKN;LCP1;SSH2;PDLIM1;CXCR4;FLNB;VCL;FHDC1;SYNPO;FHL3;NOD2;PARVB;SLC6A2;CORO7;SPEF1;CAPZA1;ADD1;SPTBN5;PARVA
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.5683108394692855,1.3553485947783501,0.14608695652173914,0.7452474784524443,1.0,2/16,1.41%,ALOX5;ALOX15
prerank,ligand-gated ion channel activity (GO:0015276),-0.4298506101038377,-1.3533464638262391,0.09308510638297872,0.5806365234089321,1.0,6/30,5.51%,GRID2;GRIA2;GRIK2;GRIA4;GRIN3A;GABRB1
prerank,phosphatidic acid binding (GO:0070300),0.5593562703821447,1.3522858975775902,0.15285451197053407,0.7448512129084655,1.0,5/19,11.88%,PLTP;SESTD1;RAPGEF2;PACSIN2;GRAMD1B
prerank,ligand-gated channel activity (GO:0022834),-0.42985405040061914,-1.3496659094095735,0.09183673469387756,0.5814877889864971,1.0,6/29,5.51%,GRID2;GRIA2;GRIK2;GRIA4;GRIN3A;GABRB1
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5675040566592627,-1.34741194153045,0.14473684210526316,0.5775434710494771,1.0,6/11,28.17%,SRRM2;EHMT2;TAF9;LEF1;THAP7;MBD2
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.5474509946623588,-1.3472603245109736,0.13786008230452676,0.5669138653029551,1.0,9/12,37.17%,CYFIP2;DCPS;NCBP1;EIF4E;LARP1;NCBP3;EIF4E2;GEMIN5;NCBP2
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.5658622186475915,1.3449057639669346,0.14795008912655971,0.759639878377878,1.0,8/14,23.82%,MTM1;SYNJ1;MTMR3;PTEN;MTMR1;MTMR6;MTMR12;MTMR11
prerank,filamin binding (GO:0031005),-0.5632320120986148,-1.3430264159835852,0.14505494505494507,0.5687948631970553,1.0,3/11,6.54%,FBLIM1;TMEM67;NEBL
prerank,tRNA methyltransferase activity (GO:0008175),-0.49967491753766347,-1.3416481323396632,0.12264150943396226,0.5620702596145765,1.0,7/16,15.38%,TRDMT1;METTL2B;METTL2A;TRMT12;ALKBH8;BCDIN3D;TRMT9B
prerank,semaphorin receptor activity (GO:0017154),0.5985228602646855,1.3409474410052271,0.1634980988593156,0.7619042723760018,1.0,3/11,6.52%,NRP1;PLXNC1;PLXNA4
prerank,GTPase inhibitor activity (GO:0005095),0.583982058601777,1.3408521335380859,0.15567765567765568,0.7510452912843228,1.0,2/13,0.99%,IQGAP2;IQGAP1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.5105958982753426,1.340399213809064,0.14814814814814814,0.7419055694610273,1.0,4/25,5.87%,HIP1;SESTD1;FCHSD2;KIF16B
prerank,cytokine receptor activity (GO:0004896),0.41055075208984637,1.339760267292806,0.08390646492434663,0.733208777937352,1.0,20/83,11.96%,LIFR;CCR1;CMKLR1;IFNAR1;CD44;CD74;IL17RB;IL17RD;IL17RC;IL17RA;IL10RB;GFRA3;CCRL2;CCR2;IL20RB;IFNAR2;IL6R;IL1RL1;IL15RA;GPR17
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.34659363252101594,1.3373072589578041,0.008350730688935281,0.7313748701585234,1.0,127/597,18.00%,MAF;ETV1;KLF2;TCF7L2;TCF4;IRF4;FOXP1;FLI1;AHR;FOXN2;TFEC;ESR1;ZBTB20;RARG;TCF12;MEF2C;CEBPB;OSR1;ORC5;KLF6;ARID4B;TBX15;HOXD8;NR2C1;PHOX2A;FOXA3;RAX;ALX1;HOXA10;NR1D1;NR3C1;HEY2;CLOCK;DMRTA2;SPI1;NFIC;ARID5A;SMAD4;ELF2;THRB;MBNL2;NR4A1;ORC2;TCF7;MCM9;ZNF568;TNF;KLF3;KLF4;YY1;DDX11;TBL1XR1;CEBPG;NR4A2;LHX5;IRF2;KLF10;IRX5;NCOR1;ATF6;FOXC2;ESRRB;ASH2L;OLIG2;HIVEP1;TBL1X;FOXJ3;ATF7;NFATC2;BEND3;NR2F1;RFX2;ZNF296;SP1;ELF1;ETS2;CENPB;SREBF2;BCL11B;MYBL2;FOXK2;XPA;HINFP;FOXO3;DHX33;FOXK1;SP3;NFIX;CREB1;KLF13;PSPC1;RARA;KAT7;STAT3;KLF5;BCOR;JUND;USF1;MTF1;HDAC4;NR2C2;SFPQ;RUNX3;ELK1;E2F8;MCM8;CREB3L1;PER1;ZNF177;TBX2;NFATC3;ARNT;GLIS2;NR5A2;RELA;LHX1;ZBTB7A;XBP1;MEF2B;ARID4A;NR6A1;SP8;GMEB1;ZNF32;BATF;HSF5;ZBTB12
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.5795812384404209,-1.3369679920426243,0.14791666666666667,0.5662258297096195,1.0,3/10,1.96%,DPP10;NAALAD2;DPP6
prerank,protein kinase inhibitor activity (GO:0004860),0.4638487296675601,1.3367476623041983,0.11349693251533742,0.7232970446445748,1.0,20/42,23.00%,SPRED1;SH3BP5;GMFG;DNAJC3;RACK1;SMCR8;SPRED2;SH3BP5L;IBTK;PARVA;GMFB;SPRY2;TRIB1;SNCA;DUS2;CDKN1C;CDKN1B;NPM1;QARS1;NCK1
prerank,CoA-ligase activity (GO:0016405),-0.5132200979819311,-1.3351922761910944,0.13260869565217392,0.5614482464220719,1.0,7/14,33.80%,ACSS1;ACSS3;SLC27A2;ACSBG1;ACSF3;ACSS2;AACS
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.5627250779853733,-1.3342768780712266,0.13319672131147542,0.5543180109837829,1.0,7/11,18.41%,TRPC4;TRPC1;TRPC3;ITPR2;TRPC5;CYTH2;RPH3A
prerank,chemokine binding (GO:0019956),0.4903566252078519,1.3342088859022176,0.12315270935960591,0.7222123598191525,1.0,6/30,7.58%,ITGA4;CCR1;ITGB1;CCRL2;CXCR4;CCR2
prerank,channel activity (GO:0015267),0.4543274732509536,1.3320903179537857,0.1244309559939302,0.7195563598678617,1.0,4/41,8.44%,MCUB;SLC14A1;BCL2;TRPV3
prerank,cytokine receptor binding (GO:0005126),0.4088869081822124,1.3314570398011727,0.08425414364640885,0.7119592275116798,1.0,22/83,17.66%,LIFR;SPRED1;TSLP;KITLG;PIBF1;CCL19;TGFBRAP1;SYK;CCRL2;SDCBP;USP15;IL6R;SH2B3;PXDN;SPRED2;JAK1;CRLF2;IL13RA1;ERAP1;CCL5;CCL25;IL6
prerank,chemokine receptor activity (GO:0004950),0.5044683163524897,1.3303381890866601,0.1454248366013072,0.7062106904379829,1.0,5/24,7.58%,CCR1;CMKLR1;CCRL2;CXCR4;CCR2
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.4819710529574355,-1.3301281235327969,0.1336405529953917,0.5562183858979316,1.0,9/18,23.11%,TGFBR1;SMAD7;FERMT2;TGFBR3;TGFBR2;ENG;TGFB2;TGFB1;BAMBI
prerank,endodeoxyribonuclease activity (GO:0004520),0.5321397583532456,1.32838621542956,0.156140350877193,0.70370071635563,1.0,5/20,10.47%,ENDOG;RBBP8;RPS3;DCLRE1C;ZRANB3
prerank,DNA-binding transcription factor binding (GO:0140297),0.3731473708136806,1.3264507092174385,0.06706586826347305,0.7005272018799685,1.0,27/189,11.73%,RBPJ;HDAC9;TCF7L2;MEF2A;TLE4;RBBP8;TCF12;MEF2C;PIAS1;HEY2;SPI1;GSK3B;RB1;PIAS2;BCL2;DMAP1;HSPB1;KLF4;MIER1;FIZ1;NCOR1;PURA;SPEN;MIER3;SP1;CREBBP;CRTC3
prerank,Tat protein binding (GO:0030957),0.6025734784967376,1.3243013170139304,0.15019011406844107,0.698611185673456,1.0,3/10,5.88%,MDFIC;ACTB;TRIM32
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.47204743067259536,1.323388909392195,0.14728682170542637,0.6927418232510744,1.0,10/35,11.03%,PEAK1;LYN;FER;FRK;SYK;ZAP70;FYN;DYRK1A;STYK1;SLA
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.6100042836169521,1.318208465981694,0.178,0.7010965990136293,1.0,1/10,0.19%,GDA
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.589520734897724,1.3165066005357997,0.17679558011049723,0.6977395763588391,1.0,4/12,10.33%,SLC25A17;SLC25A24;SLC35B3;SLC25A5
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5431012627612282,-1.31607986101443,0.13983050847457626,0.5858361915758039,1.0,5/11,19.41%,CASP7;CFLAR;CASP6;PYCARD;CASP12
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.42635095685888036,-1.3158766468398406,0.10123456790123457,0.5766234544324368,1.0,16/28,31.86%,SGK1;MAPK10;RPS6KA1;MAP2K7;RPS6KA2;MAP2K2;MAP3K9;PAK3;MAP2K4;MAP2K5;RPS6KB1;AURKB;AKT1;TTK;MAP2K3;AURKA
prerank,chemorepellent activity (GO:0045499),-0.44079836400637246,-1.3140031277142419,0.1037037037037037,0.5721009086760497,1.0,5/25,5.58%,NRG3;SEMA4D;EPHA7;SEMA4C;SEMA4G
prerank,double-stranded RNA binding (GO:0003725),0.416432882395202,1.3134023458973136,0.11030478955007257,0.6989451486745953,1.0,17/70,13.29%,TLR8;OAS2;MBNL1;CLTC;DDX60;PRKRA;RFTN1;VIM;RC3H1;DROSHA;STAU2;MSN;LRRFIP1;ILF3;EIF4B;DHX33;MRPL44
prerank,transaminase activity (GO:0008483),-0.5458392243139033,-1.3119622785364953,0.12526997840172785,0.5687577503353798,1.0,5/11,34.61%,ABAT;AGXT;BCAT1;GOT1;PSAT1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.615501333027382,1.3093583632363128,0.18181818181818182,0.7036413891886051,1.0,2/10,7.27%,DSE;FUOM
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.4760520977348563,1.306768158115344,0.13908450704225353,0.7033902208966126,1.0,7/30,12.48%,TNFAIP8;GAS6;RPS6KA3;BIRC3;BIRC6;CARD16;CAST
prerank,microtubule minus-end binding (GO:0051011),-0.5190506268689056,-1.3064108447079275,0.1447661469933185,0.5749862610272866,1.0,6/13,12.95%,CAMSAP1;MACF1;TUBGCP5;HAUS7;NUMA1;TUBGCP3
prerank,glutathione transferase activity (GO:0004364),0.5124360096542915,1.3062623350122171,0.15472312703583063,0.6969072629807285,1.0,4/23,8.98%,LTC4S;ALOX5AP;MGST3;MGST1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.33614554115826656,1.3051397673297775,0.011224489795918367,0.6929136930310631,1.0,159/731,18.37%,RBPJ;ZEB2;MAF;ETV1;KLF2;TCF7L2;TCF4;IRF4;FOXP1;MEF2A;AHR;ZBTB16;RREB1;FOXN2;TFEC;HIVEP2;ESR1;ZBTB20;RARG;TCF12;MEF2C;NR1H4;CEBPB;MITF;KLF6;TBX15;NR2C1;FOXA3;RAX;HOXA10;NR1D1;NR3C1;HEY2;CLOCK;GRHL2;PBX3;DMRTA2;SPI1;RBPJL;KLF9;NFIC;BATF2;SMAD4;ZFP2;THRB;IRX2;NR4A1;FOSL2;TCF7;ZBTB25;KDM6A;ZNF235;ZNF568;KLF3;ZNF148;LYL1;KLF4;ZSCAN25;YY1;REL;THAP11;SATB2;STAT4;CEBPG;E2F5;NR4A2;NRIP1;IRF2;KLF10;IRX5;ZBTB5;ATF6;ZNF628;FOXC2;ESRRB;BACH1;OLIG2;HIVEP1;ESR2;LRRFIP1;FOXJ3;ATF7;NFATC2;MLXIP;STAT6;NR2F1;H3-3A;ZNF205;RFX2;ZNF296;SP1;ELF1;ETS2;SREBF2;BCL11B;MYBL2;FOXK2;HINFP;NFIA;FOXO3;FOXK1;CHD2;SP3;NFIX;FOXO1;CREB1;KLF13;ZBTB7C;NR1H2;RARA;HIF3A;STAT3;KLF5;PROX2;JUND;USF1;MYC;MTF1;MYT1;HDAC4;NR2C2;RUNX3;ELK1;E2F8;ZFP62;HOXB3;POU5F2;ZGPAT;ZNF569;PER1;TBX2;NFATC3;ARNT;GLIS2;FOXP2;NR5A2;RELA;NACC1;CARF;ZBTB7A;NR2F2;XBP1;MEF2B;MECOM;ZFP28;NR6A1;SP8;GMEB1;ZNF32;ZBTB41;GZF1;BATF;HSF5;ZBTB12;ZBTB40;ZBTB1;MAFB;ATF2;RFX3
prerank,frizzled binding (GO:0005109),0.4655292050605024,1.300603379803882,0.13099041533546327,0.6995674138172828,1.0,6/34,10.04%,LRP6;WNT2;ZNRF3;SDCBP;WNT6;SFRP1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.33365707834164077,1.297603920659582,0.012219959266802444,0.7012541135061879,1.0,160/730,18.37%,RBPJ;ZEB2;MAF;ETV1;KLF2;TCF7L2;TCF4;IRF4;FOXP1;MEF2A;AHR;ZBTB16;RREB1;TFEC;HIVEP2;ESR1;ZBTB20;RARG;TCF12;MEF2C;NR1H4;CEBPB;MITF;KLF6;TBX15;NR2C1;FOXA3;RAX;HOXA10;NR1D1;NR3C1;HEY2;CLOCK;GRHL2;PBX3;DMRTA2;SPI1;RBPJL;KLF9;NFIC;BATF2;SMAD4;ZFP2;THRB;IRX2;NR4A1;FOSL2;TCF7;ZBTB25;KDM6A;TRIM24;ZNF235;ZNF568;KLF3;ZNF148;LYL1;KLF4;ZSCAN25;YY1;REL;THAP11;SATB2;STAT4;CEBPG;E2F5;NR4A2;NRIP1;IRF2;KLF10;IRX5;ZBTB5;ATF6;ZNF628;FOXC2;ESRRB;BACH1;OLIG2;HIVEP1;ESR2;LRRFIP1;FOXJ3;ATF7;NFATC2;MLXIP;STAT6;NR2F1;H3-3A;ZNF205;RFX2;ZNF296;SP1;ELF1;ETS2;SREBF2;BCL11B;MYBL2;FOXK2;HINFP;NFIA;FOXO3;FOXK1;CHD2;SP3;NFIX;FOXO1;CREB1;KLF13;ZBTB7C;NR1H2;RARA;HIF3A;STAT3;KLF5;PROX2;JUND;USF1;MYC;MTF1;MYT1;HDAC4;NR2C2;RUNX3;ELK1;E2F8;ZFP62;HOXB3;POU5F2;CREB3L1;ZGPAT;ZNF569;PER1;TBX2;NFATC3;ARNT;GLIS2;FOXP2;NR5A2;RELA;NACC1;CARF;ZBTB7A;NR2F2;XBP1;MEF2B;MECOM;ZFP28;NR6A1;SP8;GMEB1;ZNF32;ZBTB41;GZF1;BATF;HSF5;ZBTB12;ZBTB40;ZBTB1;MAFB;ATF2;RFX3
prerank,death domain binding (GO:0070513),0.5838530567240352,1.2951285583091872,0.1756007393715342,0.7015111201269344,1.0,4/11,6.34%,RIPK1;MCL1;RACK1;BCL2
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3321588319965276,1.2913509519783388,0.012207527975584944,0.7052370292028173,1.0,180/830,18.37%,RBPJ;ZEB2;MAF;TRPS1;ETV1;KLF2;TCF7L2;TCF4;IRF4;FOXP1;MEF2A;ZBTB16;RREB1;TFEC;HIVEP2;NFXL1;ESR1;ZBTB20;RARG;RPS3;TCF12;MEF2C;NR1H4;CEBPB;MITF;OSR1;KLF6;TBX15;HOXD8;NR2C1;PHOX2A;FOXA3;RAX;ALX1;HOXA10;NR1D1;NR3C1;HEY2;CLOCK;GRHL2;PBX3;DMRTA2;SPI1;RBPJL;RB1;KLF9;NFIC;BATF2;SMAD4;ZFP2;THRB;IRX2;NR4A1;FOSL2;TCF7;ZBTB25;KDM6A;FOXM1;ZNF235;ZNF568;KLF3;ZNF148;LYL1;KLF4;ZSCAN25;YY1;REL;THAP11;SATB2;STAT4;CEBPG;E2F5;NR4A2;LHX5;NRIP1;IRF2;KLF10;IRX5;ZBTB5;ATF6;ZNF628;FOXC2;ESRRB;BACH1;OLIG2;HIVEP1;ESR2;LRRFIP1;FOXJ3;ATF7;NFATC2;MLXIP;STAT6;NR2F1;PURA;H3-3A;ZNF205;RFX2;ZNF296;CREBRF;SP1;TFDP1;ELF1;ETS2;SREBF2;BCL11B;MYBL2;FOXK2;HINFP;NFIA;FOXO3;FOXK1;ZBTB8B;ZFP3;CHD2;SP3;NFIX;FOXO1;GTF2A1;CREB1;PEG3;KLF13;ZBTB7C;NR1H2;ZBTB10;RARA;HIF3A;STAT3;KLF5;PROX2;JUND;USF1;MYC;MTF1;MYT1;HDAC4;NR2C2;RUNX3;ELK1;E2F8;ZFP62;HOXB3;POU5F2;ZGPAT;ZNF569;PER1;GTF2B;ZNF177;TBX2;NFATC3;ARNT;GLIS2;FOXP2;NR5A2;RELA;LHX1;NACC1;CARF;ZBTB7A;NR2F2;ZNF22;XBP1;MEF2B;MECOM;ZFP28;NR6A1;SP8;GMEB1;ZNF32;ZBTB41;GZF1;BATF;HSF5;ZBTB12;ZBTB40;ZBTB1;MAFB;ZBTB8A;ATF2;RFX3
prerank,5'-3' exonuclease activity (GO:0008409),0.5514103176665218,1.291078412344877,0.19156414762741653,0.6984758261870514,1.0,6/14,21.07%,DCLRE1C;CPSF3;DCP2;DXO;MRE11;TRIR
prerank,metal ion:proton antiporter activity (GO:0051139),0.5616521040953493,1.2900962914863907,0.1884328358208955,0.6939230797754776,1.0,4/13,14.19%,SLC9A9;SLC9A4;SLC9A7;SLC9A6
prerank,potassium:proton antiporter activity (GO:0015386),0.5974854165111089,1.2889938987049199,0.18095238095238095,0.6901857532839138,1.0,4/10,14.19%,SLC9A9;SLC9A4;SLC9A7;SLC9A6
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.4055797127259619,1.2886197626462543,0.1278409090909091,0.6840747096142086,1.0,17/75,14.64%,KCNAB2;SORD;DHRS3;HMGCR;EHHADH;HIBADH;HSD3B7;ABCC4;IMPDH2;HSD17B7;DHDH;CRYL1;HADH;HADHA;HADHB;KCNAB3;CBR3
prerank,transcription coactivator binding (GO:0001223),0.5053675419276888,1.28725801201882,0.18624161073825504,0.6813539735406553,1.0,5/20,5.57%,AHR;ESR1;RPL23;SMAD4;THRB
prerank,protein tyrosine kinase binding (GO:1990782),0.4041440881868437,1.286983526361983,0.12309820193637622,0.6751269528053587,1.0,10/71,7.84%,BANK1;NEDD9;GAS6;ITGB1;CASS4;CBL;CRK;RACK1;DUSP22;FIZ1
prerank,phosphatase binding (GO:0019902),0.3843488017189271,1.2848635870268905,0.11096433289299867,0.6746307072030834,1.0,22/105,12.59%,EGFR;MAP3K5;SPRED1;IQGAP1;CTSC;RCAN3;MTMR3;AP3B1;RACK1;SNX3;WNK1;CDC27;CD33;MAPK14;NFATC2;PPP1R3C;STAT6;CHCHD3;PXN;JUP;JAK1;TERF2IP
prerank,transcription cis-regulatory region binding (GO:0000976),0.336601449941034,1.2792858390603257,0.03854389721627409,0.6845564045773507,1.0,87/406,17.48%,TRPS1;TCF7L2;FOXP1;FLI1;MEF2A;AHR;RREB1;FOXN2;NFXL1;ZBTB20;RPS3;TCF12;MEF2C;NR1H4;CEBPB;OSR1;ARID4B;HOXD8;PHOX2A;FOXA3;ALX1;NR1D1;NR3C1;GRHL2;SPI1;RB1;ARID5A;SMAD4;FOSL2;TCF7;FOXM1;ZNF568;TNF;KLF4;YY1;SATB2;TBL1XR1;LHX5;IRF2;KLF10;NCOR1;ZBTB5;ATF6;FOXC2;ESRRB;ASH2L;TBL1X;MLXIP;STAT6;PURA;CREBRF;SP1;TFDP1;FOXK2;HINFP;FOXO3;FOXK1;ZBTB8B;ZFP3;SP3;PEG3;PSPC1;ZBTB10;RARA;HIF3A;STAT3;BCOR;JUND;MYC;MTF1;HDAC4;NR2C2;SFPQ;RUNX3;ELK1;E2F8;CREB3L1;PER1;ZNF177;ARNT;GLIS2;NR5A2;RELA;LHX1;ZNF22;XBP1;ARID4A
prerank,nuclease activity (GO:0004518),0.42590772518259734,1.2785666422293702,0.14871016691957512,0.6799035726248154,1.0,17/52,20.21%,ENDOG;ANG;RNASE4;SND1;DNASE1L1;RNASEL;RNASE6;ZC3H12A;DIS3L2;SAMHD1;RNASE3;RNASE12;ENPP1;APEX1;MRE11;ERN2;REXO5
prerank,E-box binding (GO:0070888),0.4521915778345933,1.277795349966285,0.14790996784565916,0.6755754854450219,1.0,4/34,4.61%,TCF4;AHR;MITF;CLOCK
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.5680695802605775,1.2765795892687866,0.18679245283018867,0.6723303550590933,1.0,4/12,14.19%,SLC9A9;SLC9A4;SLC9A7;SLC9A6
prerank,protein heterodimerization activity (GO:0046982),0.3556655973757191,1.2757579410833644,0.09202453987730061,0.6679697574599512,1.0,39/178,17.28%,SNX2;HIP1;EXT1;CYBB;TCF4;MEF2A;AHR;ITGB1;IRAK3;MEF2C;TLR4;KRT10;MCL1;BCL2L2;NR4A1;BCL2;SDCBP;NR4A2;ATF6;GTF2A2;ADRA1A;PPP2CA;YWHAE;KCNB1;RALGAPA2;VAPA;GTF2A1;PAFAH1B1;ATP1A1;ADD1;USF1;CYBA;HEXA;ZHX1;PAFAH1B2;TOP2B;ARNT;RALGAPB;XBP1
prerank,histone acetyltransferase activity (GO:0004402),0.47121904688279764,1.2749521838063067,0.16108452950558214,0.6638059673057054,1.0,13/30,18.44%,NCOA3;CLOCK;EPC1;EPC2;ARRB1;CREBBP;HAT1;KAT7;EP300;KAT6A;USP22;ATF2;SRCAP
prerank,tau-protein kinase activity (GO:0050321),0.4993908259565728,1.273274342503732,0.20134228187919462,0.6622013630217506,1.0,6/20,11.99%,GSK3B;ROCK1;FYN;DYRK1A;MARK2;ROCK2
prerank,anion transmembrane transporter activity (GO:0008509),-0.522928234144876,-1.2685194626315035,0.16192560175054704,0.6807204722640364,1.0,3/12,11.99%,SLCO2B1;SLC4A2;ABCG2
prerank,vinculin binding (GO:0017166),0.5632758551385434,1.2658006684437413,0.20475319926873858,0.6770189626322114,1.0,3/11,10.66%,CTNNA1;UTRN;PXN
prerank,calcium channel activity (GO:0005262),-0.3215586794567053,-1.2657337145467253,0.08013937282229965,0.6798355388797771,1.0,25/84,19.50%,CACNB2;CACNB4;SLC24A3;SLC24A2;TRPC4;CACNA2D3;CACNA2D1;ORAI2;CACNA1D;TRPC1;SLC24A4;CACNA1E;TRPC3;CACNG7;CACNA1C;TRPC5;CACNG8;ANXA9;SEC61A1;CACNG4;SLC24A5;NCS1;ITGAV;ORAI3;CACNG2
prerank,pyridoxal phosphate binding (GO:0030170),-0.4399816954018038,-1.265712859448389,0.15270935960591134,0.6696132957787904,1.0,13/20,37.02%,ABAT;ACCS;PYGL;PLPBP;PYGB;AGXT;CBS;SHMT2;PYGM;THNSL2;PSAT1;CTH;GLDC
prerank,guanyl ribonucleotide binding (GO:0032561),0.3524664936478002,1.2654398409961296,0.06516587677725119,0.6718169581728161,1.0,31/196,10.60%,RAP1B;RAB31;RAP2B;ATL1;GBP3;MFHAS1;NRAS;KRAS;GNAI3;EEF1A1;CNGA3;CDC42;RAB8B;RAB10;ARL8A;RHOA;RAPGEF2;PDE2A;GCH1;RAP1A;INSR;GBP7;GTPBP10;GEM;RHOBTB1;ADSS2;RAB7A;RAB14;TUBB6;ARL4A;PDE5A
prerank,sodium:proton antiporter activity (GO:0015385),0.5774115015060849,1.2650836783744128,0.19694072657743786,0.666575329038237,1.0,4/11,14.19%,SLC9A9;SLC9A4;SLC9A7;SLC9A6
prerank,I-SMAD binding (GO:0070411),-0.5096141924462821,-1.2626360633465115,0.17209302325581396,0.6691673627637945,1.0,3/13,2.01%,TGFBR1;CTNNB1;SMAD7
prerank,O-methyltransferase activity (GO:0008171),-0.5443634630801262,-1.2598851544498413,0.17786561264822134,0.6677010465827797,1.0,5/10,21.94%,COMT;FTSJ3;MEPCE;BCDIN3D;ASMT
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.44112935536472886,-1.259698276792568,0.181360201511335,0.6586982408052304,1.0,5/20,5.08%,SENP2;OTULINL;OTUD5;SENP5;USP50
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.3953652868812542,-1.2574257431449396,0.14285714285714285,0.65618317964585,1.0,16/31,28.68%,SLC12A2;TMEM38B;SLC12A9;KCNA1;KCNA2;SLC12A6;KCNK9;ABCC9;SLC12A4;TMEM175;SLC12A5;ABCC8;KCNC4;SLC12A1;KCNK10;KCNK3
prerank,P-type ion transporter activity (GO:0015662),0.5697490219146042,1.2571800823488093,0.21723518850987433,0.6828399081638274,1.0,4/12,14.25%,ATP2B1;ATP7A;ATP2B4;ATP2A2
prerank,protein homodimerization activity (GO:0042803),0.3264556347127894,1.2548973473151408,0.03619441571871768,0.6833955696758978,1.0,132/590,17.95%,SNX2;HIP1;NLRC4;LRP6;EXT1;APOE;FGFR1;MAP3K5;SNX9;AHR;ZBTB16;CPQ;KIF20B;KMT2A;GBP3;DPYD;ANG;ST6GAL1;IRAK3;CEBPB;ADRB2;GYG1;S100A1;XDH;RIPK1;LILRB1;PRKRA;ERN1;SNX6;AXIN1;STARD3NL;UGT1A6;UGT1A10;UGT1A7;UGT1A4;UGT1A8;UGT1A1;CLN6;S100A11;HMOX1;S100A10;B2M;PDE2A;AOC1;MGAT2;XPNPEP3;NPR3;GCH1;MCL1;NQO2;GNPTG;RACK1;SMAD4;BCL2L2;ANO1;PDGFRA;GUCY2D;DROSHA;BCL2;PEX7;CR2;HSPB1;CACYBP;BST2;VPS4B;AOX1;IL6R;TRIM68;GTF2A2;RABEP1;ZDHHC3;TKT;TRIM27;PLN;MAPK4;LRRFIP1;PDGFC;LHPP;RIPK2;KYAT1;ATG7;CRYL1;SP1;ACHE;JUP;STK10;CRYAB;XPA;SLC8B1;PANK1;RBM11;MAP3K11;BANF1;RBPMS2;SHMT1;MID2;STAT3;ADD1;TERF1;USF1;CNOT9;PKD2;ACP3;ABCB7;BMPR1A;SPPL2B;CLCN1;SFPQ;ZDHHC2;IDH1;HSP90AB1;MKLN1;PAFAH1B2;MTMR1;SPPL2A;ARNT;FOXP2;BNIP3;CCL5;RELA;MFSD1;ABCB10;DGCR8;NR2F2;RDH5;FAP;NR6A1;MID1;S100A6;PRPS1L1;PRPS1;PIP4K2A
prerank,nuclear receptor binding (GO:0016922),0.37286070391222603,1.253999090643972,0.12242268041237113,0.6797786969554129,1.0,41/111,19.93%,TCF7L2;FOXP1;ESR1;NCOA3;NR1H4;NCOA2;NCOA7;ARID5A;NR4A1;WIPI1;MED16;PRKCB;NR4A2;NRIP1;NCOR1;TRIM68;NCOA6;ASXL1;LCOR;RNF14;JMJD1C;JUP;GAS2L1;BUD31;STRN;BCAS3;EP300;MMS19;SNW1;ARID1A;KDM1A;PPARGC1B;GTF2B;MED17;ZBTB7A;GTF2H1;KDM4C;THRAP3;RNF6;CNOT1;MED14
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.47330235616845673,-1.2532555132906473,0.19298245614035087,0.6497406267396607,1.0,7/16,15.95%,PTPRM;PTPRE;PTPRD;PTPRT;PTPRN2;PTPRG;PTPRB
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.47330235616845673,-1.2532555132906473,0.19298245614035087,0.6497406267396607,1.0,7/16,15.95%,PTPRM;PTPRE;PTPRD;PTPRT;PTPRN2;PTPRG;PTPRB
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.46536295498799674,-1.253109561941848,0.175704989154013,0.641194008168888,1.0,8/17,25.43%,ACOT9;PLA2G6;PPT1;ACOT7;THEM4;ACOT11;ACOT8;ACOT1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.5539022142159565,1.2526922336866588,0.2084130019120459,0.6774762545566787,1.0,5/12,6.13%,PDE7B;PDE2A;PDE8A;PDE4D;PDE7A
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.4873424628120303,-1.251882779678166,0.17817371937639198,0.636328030832513,1.0,2/13,1.13%,LPCAT2;LPCAT1
prerank,GTPase regulator activity (GO:0030695),0.3465863980055008,1.251257054452094,0.11084624553039332,0.675431133761442,1.0,32/212,7.72%,ARHGAP15;STARD8;VAV3;IQGAP2;NRP1;GNAQ;IQGAP1;ARHGAP9;TBC1D5;TBC1D4;OPHN1;ARAP1;EVI5;RIN2;RASA1;USP6NL;DOCK1;ARHGAP10;ARHGAP18;ARHGEF10L;ARHGAP31;RAPGEF2;ITGB1BP1;NPRL3;OCRL;TBC1D14;RGS8;ARHGAP29;STXBP5;TBC1D2B;RABGAP1L;SGSM1
prerank,GTPase binding (GO:0051020),0.3467437723026054,1.2500657696256072,0.09761904761904762,0.6730698323793473,1.0,27/195,8.80%,EPS8;IQGAP2;FGD4;MYO5A;FGD6;IQGAP1;ANKFY1;STK19;EVI5;RASA1;USP6NL;SPTBN1;RILP;EXPH5;LCP1;EHD1;RIC1;PAK2;OCRL;AP3M1;MYCBP2;EXOC4;RABGAP1L;SGSM1;GNB1;RANBP9;RCC2
prerank,manganese ion binding (GO:0030145),-0.3578455864255502,-1.2498963408002446,0.10057471264367816,0.6337966104233601,1.0,16/48,17.32%,LARGE1;MPPED2;MGAT5;GALNT3;PPM1M;FAM20C;PRIMPOL;DYRK2;POMGNT1;PCK2;XPNPEP1;ADPRM;ATP13A2;XXYLT1;B4GALT7;MGAT1
prerank,alanine transmembrane transporter activity (GO:0022858),-0.5065811989566473,-1.2498794809999139,0.21428571428571427,0.6255115760147859,1.0,4/12,11.34%,SLC36A1;SLC38A7;SLC36A4;SLC7A8
prerank,endopeptidase inhibitor activity (GO:0004866),0.38828830030003064,1.24878881797146,0.1495956873315364,0.6707921579019805,1.0,12/82,12.48%,SERPINB8;APP;SERPINB2;RARRES1;ROCK1;ANXA2;BST2;BIRC6;CARD16;PROS1;USP14;CAST
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.5232871501503726,-1.2482668365545708,0.20518358531317496,0.6220052386895047,1.0,5/11,23.49%,NAA40;NAA60;NAA25;NAA80;NAA30
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.5528157460023914,1.244083694516566,0.23539823008849559,0.6790093997007101,1.0,4/13,9.45%,PTPRJ;ERN1;PDGFRA;PDGFC
prerank,small GTPase binding (GO:0031267),0.3494701399847301,1.2428116005148448,0.11192214111922141,0.6768202941182518,1.0,27/170,11.18%,EPS8;IQGAP2;FGD4;MYO5A;FGD6;IQGAP1;ANKFY1;STK19;EVI5;USP6NL;RILP;EXPH5;EHD1;RIC1;PAK2;OCRL;AP3M1;MYCBP2;EXOC4;RABGAP1L;SGSM1;RANBP9;RCC2;DOCK7;MYO1C;PDE6D;CHM
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.5331538182168796,-1.2425544326443614,0.20950323974082075,0.6311630433718102,1.0,3/10,15.26%,SLCO2B1;SLCO4C1;SLCO4A1
prerank,WW domain binding (GO:0050699),0.4717746245051614,1.2416136763518224,0.1930379746835443,0.6744194195822989,1.0,8/26,14.65%,KIF20B;RAPGEF2;NDFIP1;TCEAL6;PMEPA1;TCEAL8;NDFIP2;DAZAP2
prerank,G protein-coupled receptor binding (GO:0001664),0.3548124525599407,1.239733646274258,0.1388888888888889,0.6741647610344539,1.0,19/132,11.26%,LRP6;GNAQ;GNAI3;WNT2;CCL19;ADM;PRKN;ZNRF3;GHRL;GPRC5B;S1PR2;CCRL2;SDCBP;WNT6;ARHGEF12;HOMER1;SFRP1;ARRB1;S1PR1
prerank,sodium channel regulator activity (GO:0017080),-0.37876120782167266,-1.2385783358845834,0.1396011396011396,0.6345552072955803,1.0,7/37,4.14%,FGF14;FGF12;YWHAH;SCN1B;SNTA1;SGK1;FGF13
prerank,titin binding (GO:0031432),-0.5028676106551196,-1.237193395641905,0.2079646017699115,0.6307831000471814,1.0,5/13,21.06%,CAPN3;CALM2;ACTN2;CAMK2D;CALM3
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.5387495821568316,-1.2350103357068074,0.24726477024070023,0.6289542217706559,1.0,3/10,14.58%,SIRPA;CD200;CXADR
prerank,pre-mRNA binding (GO:0036002),-0.40397901173647394,-1.2323836940634387,0.15721649484536082,0.6287580094790366,1.0,14/28,32.01%,DDX5;HNRNPU;CELF4;U2AF1;HNRNPA1;TARBP2;U2AF2;CELF5;SLBP;SRSF6;TRA2B;SNRPC;U2AF1L4;PTBP1
prerank,calcium-activated potassium channel activity (GO:0015269),-0.5201225298734606,-1.2295368836313596,0.21713147410358566,0.6290272415461121,1.0,1/11,0.07%,KCNMA1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.48008409380697264,1.2291009083140432,0.21972318339100347,0.6991291343708869,1.0,6/21,6.13%,PDE7B;PDE2A;PDE8A;PDE6A;PDE4D;PDE7A
prerank,alpha-actinin binding (GO:0051393),0.45978918816325964,1.226882444488771,0.21237458193979933,0.6996048303828497,1.0,6/24,14.70%,PDLIM5;NRAP;PDLIM1;RARA;PKD2L1;PKD2
prerank,MHC protein binding (GO:0042287),0.48719142927163817,1.2262748018738385,0.21516754850088182,0.6956195434107637,1.0,3/20,4.52%,LILRB1;CD74;KIR3DL2
prerank,antiporter activity (GO:0015297),0.4824813271621359,1.2256699850728627,0.2171628721541156,0.6916513067184236,1.0,5/20,16.00%,SLC25A16;SLC35E3;TMEM241;ATP1A3;SLC25A30
prerank,ephrin receptor binding (GO:0046875),0.500344134117941,1.2248669162794563,0.2387312186978297,0.6885917683064626,1.0,6/21,11.24%,LYN;ANKS1A;CBL;CRK;FYN;SHC1
prerank,aspartic-type peptidase activity (GO:0070001),-0.5368191487783871,-1.2246793678946886,0.22371364653243847,0.635712520421231,1.0,2/10,5.48%,CTSD;CTSE
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.45711912939894356,-1.2216018436744984,0.20092378752886836,0.6369270986832802,1.0,2/15,1.13%,LPCAT2;LPCAT1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.5473764311712233,1.21947840441903,0.24901960784313726,0.6984164964405843,1.0,3/11,12.36%,SASH1;STK38;MAP3K11
prerank,MAP-kinase scaffold activity (GO:0005078),0.5798312478975136,1.2194493943947662,0.25,0.6929356606438122,1.0,3/11,8.50%,IQGAP1;SH3RF1;MAPK8IP2
prerank,phosphate ion binding (GO:0042301),0.5621908133603521,1.2177108621067607,0.2532347504621072,0.6925512464055833,1.0,4/10,16.92%,PDE2A;ADSS2;ADSS1;RELA
prerank,histone demethylase activity (GO:0032452),0.45381133714376953,1.2162281550772336,0.2231543624161074,0.6913010073806569,1.0,11/27,20.68%,PHF8;JARID2;KDM7A;KDM6A;KDM4D;JMJD1C;KDM5C;KDM2A;KDM1A;KDM4C;JMJD6
prerank,metal ion binding (GO:0046872),0.31370370544825016,1.2149906378601811,0.07991587802313355,0.6892961393320644,1.0,65/477,12.39%,ITSN1;AOAH;MCTP1;NLRC4;APOE;PADI4;MAP3K5;CHP2;IQGAP1;PPP3CA;CLEC6A;CDC42BPG;TPT1;S100A4;IRAK3;CALML4;OXSR1;RCN3;S100A1;STIM2;THBS4;ERN1;MOV10L1;S100A11;RAPGEF2;S100A10;LCP1;PDE2A;AOC1;CAMKK2;ACER3;SLC25A24;STK3;ANXA2;PAM;NUCB2;NUDT22;PLA2G2D;STIM1;CANX;MCTP2;GEM;CLYBL;TKT;TRIM27;DCHS1;CDH12;MAP3K20;MAST1;TESMIN;MARK2;CALM1;TRPM2;CETN2;SLIT3;SLIT1;CEMIP2;FOXK2;PLSCR4;GJB2;STK38;MICU3;PRKACB;NUCB1;LOXL2
prerank,"DNA binding, bending (GO:0008301)",-0.4679813342064276,-1.2137059328598532,0.21888412017167383,0.6514167241848656,1.0,9/14,34.71%,TOP2A;SAP30L;TFAM;FOXC1;HMGB1;LEF1;HMGB3;FOXD1;HMGA2
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.5283263710954612,-1.2126747162476916,0.25,0.6465782588720916,1.0,5/10,29.26%,ASH1L;SETD3;SETD2;PRDM9;SMYD2
prerank,solute:sodium symporter activity (GO:0015370),0.4532859494361652,1.21181400061947,0.2176759410801964,0.6927662957074722,1.0,6/27,17.95%,SLC28A2;SLC4A4;SLC4A5;SLC5A6;SLC5A11;SLC5A3
prerank,G protein-coupled receptor activity (GO:0004930),0.3329894800292173,1.211493509732408,0.1452894438138479,0.6884120665951156,1.0,23/239,8.64%,ADGRE5;HRH1;ADGRG6;ADGRE1;CMKLR1;C5AR1;C3AR1;CYSLTR1;CALCRL;ADRB2;GPR65;DRD1;P2RY6;NPR3;TM2D1;S1PR2;P2RY10;ADCYAP1R1;RRH;GPR52;CXCR4;ADRA1D;ADRA1A
prerank,heme binding (GO:0020037),0.39263675439152657,1.2075959411283623,0.19054441260744986,0.6938460501473244,1.0,11/65,10.66%,CYBB;NR1D1;HMOX1;THAP4;CYP27A1;RSAD1;HMOX2;BACH1;CYCS;CYP26B1;PXDN
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.5093299675122424,-1.2061405259645013,0.23109243697478993,0.6576810818649549,1.0,4/10,19.41%,CASP7;CFLAR;CASP6;CASP12
prerank,mRNA 5'-UTR binding (GO:0048027),0.4595084225564745,1.2043168082516682,0.23875432525951557,0.6976821313850831,1.0,7/24,9.26%,RPL26;RPS13;RPL41;RPL5;RPS14;RPS7;MRPS11
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3301082994946175,1.2042494579434186,0.12427409988385599,0.6926800942192652,1.0,53/232,15.31%,WWP1;RNF150;SMURF2;ARIH1;PIAS1;SH3RF1;SIAH2;CDC42;CBL;PELI1;PRKN;TRIM56;ZNRF3;BIRC3;RC3H1;TRIM32;ANKIB1;MYCBP2;PIAS2;TRIM24;NSMCE2;DTX2;TRIM68;SHPRH;TRIM27;RNF121;MDM2;RNF19B;UBE2D3;UHRF2;COP1;CUL3;MKRN1;RNF38;RNF14;ZNRF2;RNF111;AMFR;RNF185;UBE3B;TRIM71;CBLB;MKRN3;RNF115;RBBP6;RNF187;RNF19A;ASB12;BFAR;NEDD4L;MKRN2;RNF122;RNF41
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.4517174664651369,1.2040595670867258,0.23205342237061768,0.6881944782974632,1.0,8/27,14.66%,SLC9A9;SLC9A4;SLC8B1;SLC9A7;SLC9A6;SLC23A1;PKD2L1;CNNM4
prerank,TBP-class protein binding (GO:0017025),0.47429161302843437,1.203601926375796,0.22758620689655173,0.684429825413392,1.0,7/21,18.86%,AHR;ESR1;GTF2A2;GTF2A1;GTF2B;TAF12;THRA
prerank,calcium ion binding (GO:0005509),0.31886295257243846,1.2024367003576264,0.12211221122112212,0.6824635701950886,1.0,44/323,12.39%,ITSN1;AOAH;MCTP1;PADI4;CHP2;IQGAP1;PPP3CA;CLEC6A;TPT1;S100A4;CALML4;RCN3;S100A1;STIM2;THBS4;S100A11;RAPGEF2;S100A10;LCP1;AOC1;CAMKK2;ACER3;SLC25A24;ANXA2;PAM;NUCB2;PLA2G2D;STIM1;CANX;MCTP2;TKT;DCHS1;CDH12;CALM1;TRPM2;CETN2;SLIT3;SLIT1;CEMIP2;PLSCR4;GJB2;MICU3;NUCB1;LOXL2
prerank,calcium channel regulator activity (GO:0005246),0.4198590576554534,1.201738021634784,0.22899505766062603,0.6794192307921086,1.0,7/37,11.84%,MCUB;SGK3;STIM2;STIM1;GEM;CALM1;YWHAE
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.38342215686615794,1.2003800556092257,0.20260492040520983,0.6783060670106383,1.0,10/72,6.90%,HIP1;FLII;FCHO2;ALOX15;SESTD1;GSDME;STXBP6;ANXA2;PLCD1;SDCBP
prerank,flavin adenine dinucleotide binding (GO:0050660),0.40224903156842157,1.1988162285585184,0.19970845481049562,0.6778520815656441,1.0,10/53,10.17%,CYBB;DPYD;XDH;DAO;NQO2;AGPS;AOX1;ETFDH;ETFA;SDHA
prerank,neuropeptide receptor activity (GO:0008188),-0.38468270940486243,-1.1977216791651393,0.19638242894056848,0.6745728234234157,1.0,4/29,10.66%,SORCS1;HCRTR2;SORCS3;TACR3
prerank,telomeric DNA binding (GO:0042162),-0.37399443266238036,-1.197392488597372,0.20533333333333334,0.6679503021860747,1.0,9/32,13.41%,XRCC5;CTC1;NCL;HNRNPA2B1;STN1;BLM;UPF1;TERF2;XRCC6
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.5463001592719121,1.1935810978464163,0.2640449438202247,0.6873045988427604,1.0,3/11,10.21%,SLC25A17;SLC25A24;SLC35B3
prerank,phospholipase A2 activity (GO:0004623),0.4443137464131584,1.192830268295517,0.23208191126279865,0.6842705618301241,1.0,5/26,14.62%,PLA2G7;PNPLA8;PLA2G2D;PLAAT1;PLAAT3
prerank,deoxyribonuclease activity (GO:0004536),0.513385367673566,1.190456754246445,0.28205128205128205,0.686009159564754,1.0,5/14,19.71%,RPS3;DNASE1L1;ZRANB3;APEX1;MRE11
prerank,GTP binding (GO:0005525),0.33493422886665564,1.1884370207602162,0.15356265356265356,0.6865747642388417,1.0,25/172,10.26%,RAP1B;RAB31;RAP2B;ATL1;GBP3;MFHAS1;NRAS;KRAS;EEF1A1;CDC42;RAB10;ARL8A;RHOA;GCH1;RAP1A;INSR;GBP7;GTPBP10;GEM;RHOBTB1;ADSS2;RAB7A;RAB14;TUBB6;ARL4A
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.4563136275444231,1.1837541093833301,0.25517241379310346,0.694612700348792,1.0,6/23,6.13%,PDE7B;PDE2A;PDE8A;PDE6A;PDE4D;PDE7A
prerank,endopeptidase activator activity (GO:0061133),0.5467597372922677,1.1826133025645316,0.2886405959031657,0.6930063269236474,1.0,1/10,0.36%,NLRC4
prerank,kinase binding (GO:0019900),0.3097721484411044,1.1816235837271327,0.13227513227513227,0.6909956219234827,1.0,86/435,14.50%,AP2A2;EGFR;SPRED1;PTPRJ;TCF7L2;IQGAP1;SASH1;PRKAG2;ESR1;CLTC;DNAJC3;RPS3;IRAK3;PTPN22;OXSR1;EEF1A1;MYH6;MYOM2;PRKAG3;CDC42;GDF3;MAP3K1;AXIN1;CRK;RHOA;UTRN;RGCC;PRKN;BCL10;PDE8A;NR3C1;DOK7;GSK3B;PGAM1;RB1;GPRC5B;PAK2;PTPRK;TBC1D14;ACTB;WNK1;VRK2;FOXM1;HSPB1;CCND3;MOB1B;IFNAR2;RHOBTB1;TRIM68;MAPK8IP2;VRK1;MSN;TRIM27;RCC2;MAPK4;SMCR8;RPS7;CARD16;CCND2;CACUL1;ACSL3;PIP5K1A;PARP16;RPS6;SP100;MAML1;CALM1;SPRED2;SHC1;IL15RA;FOXO3;CDKN2C;NOD2;EXOC2;RBBP6;RND3;CTBP2;CNTLN;FAM83B;IBTK;STAT3;ATP1A4;ITGB2;RHOC;USF1;CNOT9
prerank,C-C chemokine receptor activity (GO:0016493),0.45887545340597946,1.1805056197653803,0.27712854757929883,0.6895346086274884,1.0,4/21,7.58%,CCR1;CCRL2;CXCR4;CCR2
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.4645780510941137,-1.1782489902842606,0.2791762013729977,0.7157490558151098,1.0,9/13,29.48%,GLRB;GABRA2;GLRA1;GABRG2;GLRA3;GLRA2;GABRA4;GABRG3;GABRE
prerank,cyclic nucleotide binding (GO:0030551),0.4681299957594316,1.1780353359384539,0.2665589660743134,0.6915949026938565,1.0,6/21,14.08%,CNGA3;RAPGEF2;PDE2A;PDE4D;PDE5A;POPDC3
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.47286965515053847,1.1771396832069365,0.265625,0.6892683659396873,1.0,3/16,4.05%,MTM1;SYNJ1;MTMR3
prerank,FMN binding (GO:0010181),-0.49485995209280614,-1.1744344654872199,0.2662337662337662,0.7194050641443304,1.0,1/11,0.55%,PPCDC
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.5040496677515958,-1.173374746121183,0.2727272727272727,0.7144922000793847,1.0,4/11,21.33%,AKR1B1;RDH14;DHRS13;AKR1B10
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.5433098116295242,1.1715018436440905,0.2701688555347092,0.6999317012853349,1.0,7/10,28.34%,CDKN2C;HEXIM2;INCA1;CDKN1B;HEXIM1;KAT2B;CDKN1A
prerank,phospholipid transfer activity (GO:0120014),0.4629094435203902,1.1710068922081924,0.2571428571428571,0.6968145552052682,1.0,3/21,9.15%,PLTP;PITPNA;GLTP
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.4704144111708791,1.1704315168903814,0.28028933092224234,0.6937957383831318,1.0,2/22,1.61%,APOE;CLTC
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.38130240733436005,-1.1684715843813962,0.22105263157894736,0.7212722456801708,1.0,12/29,20.20%,HEXD;NEU1;GAA;HPSE2;GBA2;ABHD10;HPSE;ACER2;IDUA;OVGP1;ADPRS;PARG
prerank,lipoprotein particle receptor binding (GO:0070325),0.449399174091601,1.168274804744135,0.27413793103448275,0.6951385348575085,1.0,2/27,1.61%,APOE;CLTC
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.5032315464992274,-1.1661576770023783,0.29375,0.7206750615783207,1.0,4/10,4.67%,PRKAG1;PRKAR1A;PKIG;PRKAR1B
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.5345820441923437,1.1645690294902231,0.3290441176470588,0.7001711873529846,1.0,3/10,15.70%,DPYSL2;CRMP1;DPYSL5
prerank,ferrous iron binding (GO:0008198),-0.4032610228863909,-1.1635030763281302,0.25183374083129584,0.72099463029949,1.0,7/21,11.25%,CDO1;PHYH;FECH;ALKBH2;ISCU;EGLN2;FXN
prerank,C-C chemokine binding (GO:0019957),0.4506682335004682,1.163347016567993,0.2727272727272727,0.6988517798650458,1.0,4/22,7.58%,CCR1;CCRL2;CXCR4;CCR2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.4343501576801176,-1.1630302543484046,0.2649164677804296,0.7149254882540841,1.0,7/16,27.73%,SLC38A7;SLC1A1;SLC25A14;SLC25A22;SLC25A10;SLC25A13;SLC1A4
prerank,cholesterol transfer activity (GO:0120020),0.4867786676832265,1.1627491963770515,0.2718808193668529,0.6958096093298266,1.0,1/16,0.21%,PLTP
prerank,disordered domain specific binding (GO:0097718),0.4462672364619114,1.1607042982059805,0.28426395939086296,0.6967649092161069,1.0,9/23,16.01%,CLTC;NCOA3;RB1;BCL2L2;FYN;MDM2;CALM1;FN1;HSP90AB1
prerank,receptor ligand activity (GO:0048018),0.3165171122466406,1.1588497090743455,0.17330210772833723,0.6969878713934939,1.0,27/245,10.69%,IL16;SEMA4A;IL15;GAS6;JAG1;TSLP;METRNL;KITLG;BMP2;FGF23;WNT2;C1QTNF12;ENDOU;GRN;GDF3;THPO;GDF10;FAM3C;TNF;EDA;WNT6;CCL24;TNFSF12;IGF1;CCK;METRN;DAND5
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.3556861529642755,1.1570923738829537,0.2175732217573222,0.6972325190000613,1.0,13/91,7.13%,HIP1;FLII;FCHO2;ALOX15;SESTD1;GSDME;SNX3;STXBP6;KIF16B;ANXA2;PLCD1;SDCBP;WIPI1
prerank,inward rectifier potassium channel activity (GO:0005242),-0.390966746754648,-1.1566218226727663,0.2677165354330709,0.7266129620196052,1.0,14/24,32.60%,KCNJ2;KCNN2;ABCC9;KCNK6;KCNJ3;KCNJ10;KCNJ13;KCNJ9;ABCC8;KCNH2;KCNJ12;KCNJ16;KCNN1;KCNJ6
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.49291790608665154,-1.1563146733917764,0.30879345603271985,0.7202025421711328,1.0,2/10,2.33%,EHMT2;ASH1L
prerank,sterol transfer activity (GO:0120015),0.4764338173466834,1.1540164974386216,0.29014598540145986,0.7006905074896302,1.0,1/17,0.21%,PLTP
prerank,5'-3' RNA polymerase activity (GO:0034062),0.42733548801958954,1.1524852359526532,0.27483443708609273,0.7006494479584606,1.0,9/27,18.53%,TENT2;POLR1A;POLR1B;MED20;POLR2B;POLR1D;POLR2D;CRCP;POLR2F
prerank,ubiquitin protein ligase activity (GO:0061630),0.31691676851650175,1.1522845382610762,0.20352941176470588,0.6968794700355256,1.0,53/228,16.08%,WWP1;RNF150;SMURF2;ARIH1;SH3RF1;SIAH2;CDC42;CBL;PELI1;PRKN;TRIM56;ZNRF3;BIRC3;RC3H1;TRIM32;ANKIB1;MYCBP2;TRIM24;DTX2;TRIM68;SHPRH;TRIM27;RNF121;MDM2;RNF19B;UBE2K;UBE2D3;UHRF2;COP1;CUL3;MKRN1;RNF38;RNF14;ZNRF2;RNF111;AMFR;RNF185;UBE3B;TRIM71;CBLB;MKRN3;RNF115;RBBP6;RNF187;RNF19A;ASB12;BFAR;NEDD4L;MKRN2;RNF122;RNF41;TRIM25;FANCL
prerank,actin monomer binding (GO:0003785),0.4543070704399888,1.1519134607573676,0.28642384105960267,0.6936210410138521,1.0,1/22,0.25%,MTSS1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.47458105642770887,-1.1516677536236395,0.3,0.7259089172976252,1.0,4/12,14.98%,B3GALT1;B3GALT5;B3GALT2;B3GNT2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.3205785546210821,1.151095112129331,0.22085889570552147,0.6913988045075495,1.0,47/188,18.86%,TCF7L2;FLI1;AHR;ZBTB20;TCF12;MEF2C;CEBPB;ARID4B;FOXA3;NR1D1;SPI1;ARID5A;SMAD4;TCF7;ZNF568;TNF;KLF4;YY1;TBL1XR1;NCOR1;ATF6;FOXC2;ASH2L;LIN54;TBL1X;SP1;FOXK2;HINFP;FOXO3;FOXK1;PSPC1;STAT3;BCOR;JUND;HDAC4;SFPQ;ELK1;CREB3L1;PER1;GLIS2;NR5A2;RELA;ARID4A;RFX3;ZBTB14;GABPB1;THRA
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.325911795423498,1.147698299656462,0.21133412042502953,0.6960674236813178,1.0,40/173,18.57%,ZEB2;TRPS1;FOXP1;ZBTB16;TFEC;ZBTB20;CEBPB;MITF;NR1D1;NR3C1;HEY2;IRX2;ZBTB25;ZNF148;YY1;THAP11;ZBTB5;BACH1;LRRFIP1;NR2F1;ETS2;SREBF2;FOXK2;FOXO3;FOXK1;PEG3;MYC;E2F8;CREB3L1;ZGPAT;ZNF177;TBX2;NFATC3;FOXP2;RELA;NACC1;GZF1;ZBTB12;ZBTB1;ZBTB14
prerank,poly(U) RNA binding (GO:0008266),0.44739472984638795,1.1458717350283665,0.3030821917808219,0.6964597315820164,1.0,5/20,12.67%,RBMS1;HNRNPC;ATXN1;RBM11;DIS3L2
prerank,tropomyosin binding (GO:0005523),0.48546141856150904,1.1458308637853643,0.29401408450704225,0.6924481537743015,1.0,3/16,4.86%,TMOD1;TNNT1;TMOD3
prerank,ion channel inhibitor activity (GO:0008200),0.40301169863967967,1.1446206960623166,0.2939244663382594,0.6913570297568041,1.0,8/35,14.32%,MCUB;RASA1;RACK1;WNK1;STX7;CALM1;SCN3B;NEDD4L
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.46332901097549384,-1.1430283853772123,0.29646017699115046,0.7436382318049369,1.0,2/14,1.05%,CAPN15;CAPN3
prerank,DNA binding (GO:0003677),0.294797956617919,1.1425487960761858,0.13641025641025642,0.6923459452799343,1.0,142/694,18.46%,RBPJ;ZEB2;EGFR;APP;KLF2;TCF7L2;TCF4;RBMS1;IRF4;FLI1;TLR8;MEF2A;AHR;ZBTB16;HIVEP2;NUPR1;RBBP8;ANG;RARG;RPS3;LIG4;NR1H4;CEBPB;DDX60;RYBP;TSHZ3;NR2C1;RPS15;MND1;HEY2;FAM111A;CLOCK;GRHL2;ARID5A;SMAD4;DCLRE1C;THRB;IRX2;CBFB;DNASE1L1;NR4A1;MCM9;ACR;BCL2;WDR76;CR2;ZNF148;TSHZ1;LYL1;YY1;THAP11;PDS5B;DDX11;CEBPG;TIPIN;RPA1;NR4A2;IRF2;ATF6;FOXC2;ARID3A;ESRRB;BRIP1;GTF3C3;GTF3C6;ESR2;LRRFIP1;FOXJ3;NFATC2;RAD52;NHEJ1;NR2F1;PURA;ILF3;RPL6;POLG2;RFX2;TRIM16;SP1;PCID2;ETS2;CENPB;CREBBP;FOXK2;XPA;HINFP;FOXO3;ZC3H12A;RPA3;CHD2;FOXO1;BANF1;GTF2A1;XRCC4;XPC;NR1H2;KIN;STAT3;MBD1;EP300;TERF1;CRLF3;KAT6A;POLR2D;SMARCAD1;USF1;RAD51B;MYC;SAMHD1;MTF1;HDAC4;NR2C2;SFPQ;ARID1A;FBH1;MCM8;ZGPAT;TBX2;ARNT;FOXP2;NR5A2;RELA;RBM6;CARF;ZBTB7A;TAF12;NR2F2;ZNF22;XBP1;RFC3;MECOM;ARID4A;DMC1;NR6A1;MPG;GZF1;BATF;APTX;MAFB;RFX3;RPL7;LONP1
prerank,ubiquitin protein ligase binding (GO:0031625),0.3103134600917618,1.1387765804805892,0.2158438576349024,0.6977769953764662,1.0,71/254,20.10%,EGFR;SNX9;FBXW7;TXNIP;RPL23;MFHAS1;ARIH1;PTPN22;RPS27A;CCDC50;TNFRSF1B;SLC22A18;RIPK1;AXIN1;PRKN;BCL10;GSK3B;RB1;SPOP;CD40;BCL2;CXCR4;RPL5;UBXN7;SPOPL;SHPRH;VCL;MDM2;UBE2K;CUL3;RTN4;ARRB1;SLC25A5;CASP8;WFS1;JAK1;YWHAE;PRKACB;TRIB2;FOXO1;UBE2N;RALB;PSMA3;PSMD1;RPL11;ASB4;AMBRA1;GPI;NLK;USP25;GABARAP;HSP90AB1;UBE2W;FANCL;PER1;RELA;CUL5;PA2G4;GLMN;MID1;UBE2A;TNK2;TRAF6;ATXN3;SUMO1;TRIB1;SMC6;TMBIM6;DTX1;USP7;SMAD5
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.33442697352272155,-1.1331699399057096,0.25271739130434784,0.7656706574876464,1.0,18/40,34.65%,DNMT3A;METTL2B;METTL2A;COMT;AS3MT;SETD3;MEPCE;DNMT1;LCMT1;ASMT;PCMT1;PEMT;RRP8;METTL18;PRMT8;FBL;THUMPD3;LRTOMT
prerank,RNA binding (GO:0003723),0.2859365624463112,1.131305827830644,0.08542713567839195,0.7128883461353513,1.0,274/1321,15.05%,AHNAK;DHX34;DHX8;MYO5A;RBMS1;CTNNA1;TLR8;OAS2;MBNL1;FNDC3A;DIAPH1;RPS23;TPT1;ZCCHC24;MRPL23;RPL17;RPL23;ZFP36L2;CLTC;MRPS12;RPS12;S100A4;ANG;RPS16;RPS3;RBM47;RPS27A;NOL6;EIF3E;DDX60;RCAN3;NCOA5;RPL39;RPS18;RPS21;SPTBN1;EEF1A1;RPL23A;PRKRA;ENDOU;ADK;RPS15;MOV10L1;HNRNPC;GRN;PPHLN1;RPL37;ANKRD17;KCTD12;SAMD4A;AGFG1;RPL26;TUT7;ZFP36L1;RPS10;FNDC3B;NYNRIN;RPS20;RPS13;ERAL1;RFTN1;SNU13;RPSA;VIM;LARP7;RPL41;RPS28;NKAP;TRIM56;MRPL13;RPL13;PTBP3;RPS24;RSL24D1;RPL24;RPL12;SND1;RPL36A;GTPBP10;RACK1;RPUSD3;RPS8;RPL18A;PKN2;TENT5A;SMG6;RC3H1;PUM2;NUFIP2;DROSHA;RPL37A;MANF;MBNL2;TBCA;RPS11;RPL28;RNASEL;TRIM32;WDR36;ANXA2;NMD3;DARS1;FARS2;NOP53;RPL30;HNRNPF;RPL8;RPL35A;RPS4X;RPS15A;RPL38;GLRX3;HSPB1;ZGRF1;RPS17;RPLP0;CPSF3;BST2;SF3B5;YY1;IBA57;SRSF4;RPL5;DDX11;RPL36;CANX;FLNB;CELF3;PTBP2;RPL14;LARP4B;STAU2;RBM4;PNO1;DCP1A;RPS14;RPL9;TUT4;RO60;EIF1;TDRD7;SNRPG;ACO1;RPS9;MSN;GRSF1;KMT2C;RCC2;SCAF8;RPS5;SELENOH;CCT6A;RPS7;ASCC3;LRRFIP1;RPL34;RPL27;ZCCHC7;MRPS11;COL14A1;MAP3K20;APOBEC1;MTREX;SERBP1;ZNF106;PURA;POLR2B;ILF3;RPL6;MKRN1;RTN4;HEATR1;RPL22L1;SRP68;HELZ;SLC25A5;RPS6;SEC63;NSRP1;SPEN;RBM15;RARS2;MARK2;MRPL1;FAU;NSUN2;PCID2;DDX6;RPP38;RPL4;EIF3I;EIF4B;SEPSECS;RBM27;DNAJC21;ASS1;GTF2E2;DCP2;RPL22;DUSP14;ZC3H18;SCAF4;PSMA6;LACTB2;CDK13;NANOS3;YWHAE;DHX40;RPL15;RPL10;MRPL16;LBR;ROCK2;ZC3H14;DHX33;RBM11;DDX10;RPL32;DEK;ZC3H12A;PDIA4;POLR1G;CAST;NUP98;MKRN3;ETF1;ELP5;CHD2;ESF1;GTPBP1;ZC3H12D;LSM4;GPATCH1;VIRMA;UBE2N;RBPMS2;RBBP6;PRPF38B;LARP4;AQR;R3HDM1;MRPL44;MAGOHB;LSM2;PSPC1;RPP30;DDX42;HADHB;ZNF326;RPL19;KIN;CTU1;STAT3;ANKHD1;RAMAC;MRPS14;ADD1;KPNA2;POLR2D;EXOSC1;RPL31;HMGN5;TPD52L2;EIF3H;RPL11;RTRAF;SNW1;PRMT1;PPIA;RPL7L1;RALY;NOVA1;MKRN2;SRBD1
prerank,adenylyltransferase activity (GO:0070566),0.4398896654771436,1.1307797525232568,0.31158238172920066,0.71019351384838,1.0,6/21,16.36%,OAS2;TENT2;NMNAT3;NMNAT2;PAPOLA;TUT1
prerank,cysteine-type peptidase activity (GO:0008234),-0.29850348100948615,-1.130584460262106,0.20640569395017794,0.7653309781135135,1.0,20/73,16.37%,USP35;CAPN3;OTULINL;LGMN;USP12;USP50;OTULIN;CTSS;USP46;CASP7;UCHL1;CTSF;USP40;CASP6;USP49;USP34;USP29;USP5;CTSO;USP33
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.4073408967784606,-1.1305389680684088,0.2870159453302961,0.7580912762673755,1.0,4/19,13.85%,GRID2;GRIK2;GABRA2;GABRG2
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.4820316443079846,1.127717501811269,0.3145869947275923,0.7141512845026727,1.0,8/14,24.43%,USP9X;MINDY3;USP15;MINDY2;ATXN3;USP7;USP13;MINDY1
prerank,carbohydrate kinase activity (GO:0019200),0.5033292206805983,1.1271458636036344,0.3228346456692913,0.7115975012990199,1.0,3/11,12.24%,POMK;FGGY;GALK2
prerank,kinase activator activity (GO:0019209),0.4092084477800524,1.1250380682366785,0.3241042345276873,0.7129271502416903,1.0,8/30,10.58%,PRKAG2;RPLP1;RGCC;BCL10;GPRC5B;WNK1;MOB1B;MARK2
prerank,thyroid hormone receptor binding (GO:0046966),0.4170618602704238,1.1246844111388026,0.29489291598023065,0.709883741989206,1.0,12/28,20.83%,NCOA3;ARID5A;MED16;NCOR1;NCOA6;JMJD1C;GAS2L1;GTF2B;MED17;GTF2H1;THRAP3;TRIP12
prerank,iron ion binding (GO:0005506),0.37812531964278473,1.123156156631952,0.30505952380952384,0.7098992149572578,1.0,10/48,11.34%,ALOX5;ALOX15;AGMO;PHF8;FTL;KDM7A;FBXL5;AOX1;FTH1;ETHE1
prerank,actinin binding (GO:0042805),0.432695768185753,1.122732888878437,0.30976430976430974,0.7069723515699151,1.0,5/21,16.92%,PDLIM5;RARA;PKD2L1;PKD2;RELA
prerank,phosphatidylcholine transporter activity (GO:0008525),0.4701631290185909,1.121392039196473,0.3463687150837989,0.7067645407669845,1.0,2/17,3.71%,PLTP;PITPNA
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.36141523627949834,1.115476183294421,0.31314623338257014,0.7181165155689456,1.0,6/60,5.33%,NRP1;EGFR;FGFR1;CRIM1;INSR;PDGFRA
prerank,secondary active transmembrane transporter activity (GO:0015291),0.3681999269402829,1.1142600644747407,0.27934621099554235,0.7172473578041739,1.0,12/51,17.56%,SLC25A16;SLC28A2;SLC16A10;MCU;SLC4A4;SLC35E3;SLCO5A1;TMEM241;MFSD2A;SLC25A30;SLC5A6;SLCO2A1
prerank,MAP kinase kinase activity (GO:0004708),-0.42994829687837127,-1.1141957206353863,0.31447963800904977,0.7981760778183974,1.0,7/15,24.77%,MAPK10;MAP2K7;MAP2K2;MAP3K9;PAK3;MAP2K4;MAP2K5
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.3948390799702182,1.1113506878995667,0.33278145695364236,0.7205493539116836,1.0,9/33,13.63%,RPS3;ARIH1;SIAH2;PRKN;ANKIB1;RNF19B;RNF14;RNF185;RNF19A
prerank,GTPase activity (GO:0003924),0.3117422346366574,1.1099673398468546,0.2824519230769231,0.7202775927779154,1.0,45/192,18.29%,GNAQ;RAP1B;RAB31;RAP2B;ATL1;GBP3;NRAS;KRAS;GNAI3;EEF1A1;CDC42;RAB8B;ARL8A;RHOA;GCH1;RAP1A;GBP7;GTPBP10;GEM;RHOBTB1;GNB1;RAB7A;RAB14;RAB1A;RAB23;GNG5;GTPBP1;AGAP3;RND3;RALB;RAB11A;RHOC;GNA11;ARHGDIB;RAB3B;LSG1;GNA13;HBS1L;RAB32;RHOF;EFL1;RAB22A;RHEB;RRAGC;ABCA4
prerank,miRNA binding (GO:0035198),0.41221634406941243,1.109002766903135,0.31329113924050633,0.718802343643715,1.0,7/30,12.28%,TUT7;RC3H1;PUM2;RBM4;TUT4;TRIM71;ZC3H12A
prerank,protein phosphatase binding (GO:0019903),0.32625702586275224,1.107227777458016,0.2933832709113608,0.7192954910214016,1.0,24/117,12.87%,EGFR;MAP3K5;IQGAP1;MFHAS1;LILRB1;MTMR3;AP3B1;RACK1;SNX3;CDC27;CD33;MAPK14;PPP1R3C;IGBP1;STAT6;PPP1R3D;PXN;JUP;ARPP19;JAK1;KCNQ1;STRN;ATP2B4;FOXO1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.4213133535181726,-1.1071920005453368,0.3211009174311927,0.812076590827295,1.0,4/15,18.65%,ALDH1L2;ALDH1A1;ALDH1A2;ALDH4A1
prerank,histone deacetylase activity (GO:0004407),0.44651731567732544,1.1028014767729084,0.3431542461005199,0.7262744541347727,1.0,1/19,0.10%,HDAC9
prerank,DNA secondary structure binding (GO:0000217),0.4002392755468398,1.101485434682731,0.32114467408585057,0.72579057388983,1.0,7/31,14.89%,KMT2A;RBBP8;MEF2C;YY1;LIN54;XPC;RAD51B
prerank,peptidase activator activity (GO:0016504),0.4299199353105113,1.10055505485565,0.3587521663778163,0.72418271449516,1.0,4/22,11.58%,NLRC4;PCOLCE;CLPX;EBAG9
prerank,pentosyltransferase activity (GO:0016763),-0.33614447958236543,-1.0972995141635367,0.30434782608695654,0.8362068114754907,1.0,13/36,18.38%,LARGE1;QTRT1;UPP2;UMPS;PARP1;SIRT2;PARP10;PARP3;PARP4;QTRT2;SIRT5;SIRT4;PARP9
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.3654317667454302,1.0968589619112903,0.33433734939759036,0.7295780222257701,1.0,10/54,12.84%,HDAC9;HINT1;ACER3;HINT3;ACR;DARS1;MIER1;MIER3;NGLY1;GLS2
prerank,adenylate cyclase binding (GO:0008179),-0.47997018416179726,-1.0961473215387554,0.35129740518962077,0.8320144157278221,1.0,5/10,24.93%,CALM2;AKAP6;CALM3;ADCY5;AKAP5
prerank,protein tyrosine kinase activator activity (GO:0030296),0.4312200914417808,1.0945389281481679,0.3479020979020979,0.7316367566619112,1.0,4/19,5.21%,GAS6;ABI1;GHRL;PAK2
prerank,potassium channel activity (GO:0005267),-0.2787911945042487,-1.0939190923056612,0.24528301886792453,0.8309709962792806,1.0,17/89,18.03%,KCNMA1;KCND2;KCNH7;GRIK2;TMEM38B;KCNQ3;KCNQ5;KCNK2;KCNA1;KCNA2;KCNK12;KCNS3;KCNK9;KCNN2;ABCC9;KCNK6;KCNT1
prerank,GABA-A receptor activity (GO:0004890),-0.3914973049006464,-1.0937068020403287,0.3333333333333333,0.8240086274686018,1.0,8/18,29.48%,GABRB3;GABRB1;GABRA2;GABRG2;GABRA4;GABRR2;GABRG3;GABRE
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.352420422451511,1.0902345011318224,0.3303030303030303,0.73873678536496,1.0,16/60,16.43%,PPP3CA;MTMR3;DUSP1;CTDSP1;PPM1B;CTDSP2;PPP1R3C;PPP2CA;PPP2CB;PPP1R3D;PPEF1;PPP1CA;LRRK1;CTDSPL2;PTEN;PPM1A
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.44346685531055124,1.0840989182230363,0.3607705779334501,0.7503331211725103,1.0,2/17,1.73%,BLVRB;DPYD
prerank,ubiquitin-specific protease binding (GO:1990381),0.4462474116901931,1.0834937328485712,0.36348684210526316,0.7481103774109337,1.0,8/19,18.84%,CLTC;PRKN;RHBDD2;LCOR;AMFR;DERL2;PTEN;SUMO1
prerank,diacylglycerol kinase activity (GO:0004143),-0.4529674483107373,-1.0834839247071564,0.3739495798319328,0.8475249160054481,1.0,7/11,30.66%,DGKI;DGKB;DGKZ;AGK;DGKG;DGKA;DGKQ
prerank,calcium channel inhibitor activity (GO:0019855),0.49596126097860005,1.0834650182657715,0.3902439024390244,0.7443592537849826,1.0,1/11,0.56%,MCUB
prerank,N-acyltransferase activity (GO:0016410),-0.339368081157302,-1.0821849013078122,0.32180851063829785,0.8441101799636028,1.0,10/32,20.07%,SAT1;TGM2;SMARCE1;SIRT7;CERS4;CERS5;CERS1;TLCD3B;NAA80;CERS2
prerank,general transcription initiation factor binding (GO:0140296),0.4109844725075218,1.0816993693890244,0.3557377049180328,0.7451063872497432,1.0,8/25,18.86%,AHR;ESR1;GTF2A2;GTF2A1;GTF2B;RELA;TAF12;THRA
prerank,RNA polymerase II complex binding (GO:0000993),0.3922475648196242,1.0812487093356187,0.3745980707395498,0.7424520903809199,1.0,12/32,16.61%,NCOA3;WAC;CDC73;ESRRB;SCAF8;RPRD2;ELOF1;ELP4;ZNF326;RTRAF;GTF2B;BRD4
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.4946053479129924,1.0800710388245474,0.3664259927797834,0.7416588028387644,1.0,1/11,3.05%,CNGA3
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.43467615539366866,-1.0778536235694098,0.36980306345733044,0.8501671234036986,1.0,7/12,29.48%,GABRB3;GABRB1;GABRA2;GABRG2;GABRA4;GABRG3;GABRE
prerank,voltage-gated potassium channel activity (GO:0005249),-0.28032899127202604,-1.0777991005257452,0.3229571984435798,0.8428817668652072,1.0,9/80,9.32%,KCNMA1;KCND2;KCNH7;KCNJ2;KCNQ3;KCNQ5;KCNK2;KCNA1;KCNA2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.5001196825574634,1.07768818520754,0.3817829457364341,0.7438987263642922,1.0,4/10,18.88%,PHF8;KDM7A;KDM2A;KDM4C
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.4303181446025226,-1.076464945962438,0.35634743875278396,0.839533577478712,1.0,4/13,18.65%,ALDH1L2;ALDH1A1;ALDH1A2;ALDH4A1
prerank,damaged DNA binding (GO:0003684),0.37443195642653565,1.0754584144485235,0.37367624810892586,0.7455435951748571,1.0,14/44,20.20%,RBBP8;RPS3;DCLRE1C;RPA1;CREBBP;XPA;RPA3;XPC;EP300;MPG;APTX;APEX1;SMC6;PCNA
prerank,purinergic nucleotide receptor activity (GO:0001614),0.4613442410093237,1.075432328320713,0.37222222222222223,0.7419220855899393,1.0,1/15,0.51%,P2RX7
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.4622098113975602,-1.0753140992132226,0.37447698744769875,0.8359312839479965,1.0,3/10,9.66%,PIK3CB;ATM;PIK3C2B
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.32657104813458265,-1.0745868820883635,0.2966751918158568,0.8308005698645794,1.0,10/35,15.46%,AARS1;QTRT1;TRDMT1;TARS2;DUS1L;TRMT12;BCDIN3D;QTRT2;TRMT9B;MTFMT
prerank,cation channel activity (GO:0005261),-0.27086518999367487,-1.0738386249163232,0.3057553956834532,0.8260108125151606,1.0,24/94,17.50%,CACNB2;SLC24A3;SLC24A2;TRPM3;TMEM38B;PIEZO1;CACNA1D;TRPC1;NALCN;SLC24A4;CACNA1E;TRPC3;KCNA1;KCNA2;PIEZO2;TRPC5;ANXA9;TMEM63C;SEC61A1;HVCN1;KCNK9;ABCC9;TMEM63A;SLC24A5
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.4634269434529522,1.0725249564666266,0.35855855855855856,0.7455570186806437,1.0,6/13,17.41%,ITGB1BP1;ARHGDIA;ARHGDIB;EIF5;RGS14;GDI2
prerank,potassium channel regulator activity (GO:0015459),0.35864509970518466,1.0722964241370163,0.34393939393939393,0.7424870938693535,1.0,14/49,19.14%,SGK3;RASA1;ADRB2;KCNAB2;KCNMB1;WNK1;ARPP19;YWHAE;KCNAB3;NEDD4L;KCNE3;SLC5A3;SUMO1;KCNIP1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.35059004859509135,-1.0720487031908867,0.36597938144329895,0.8244889004603166,1.0,9/26,16.45%,SLC16A6;SLC16A3;MPC2;SLC16A1;ABCG2;SLC16A4;MPC1;SLC6A1;SLC16A9
prerank,androgen receptor binding (GO:0050681),0.41012744234467685,1.0719855676572392,0.3904923599320883,0.7395048486104825,1.0,12/25,19.28%,FOXP1;ARID5A;WIPI1;PRKCB;TRIM68;RNF14;EP300;SNW1;KDM1A;ZBTB7A;KDM4C;RNF6
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2798873369143869,1.0718679894199312,0.2955032119914347,0.736255641393813,1.0,67/431,14.23%,NLRC4;P2RX7;MAP3K5;RAP1B;STK17B;OAS2;PEAK1;CDC42BPG;PRKAG2;RAB31;RAP2B;ATL1;GBP3;MFHAS1;DAPK1;IRAK3;LIG4;NRAS;KRAS;OXSR1;EEF1A1;ERN1;MOV10L1;CDC42;RAB10;ARL8A;RHOA;GCH1;CDK6;RAP1A;PNPLA8;INSR;GBP7;GTPBP10;ATP7A;STK3;WNK1;NOL9;ZAP70;GEM;RHOBTB1;ADSS2;RAB7A;RAB14;MAP3K20;MAST1;PMVK;MTREX;TUBB6;ARL4A;CLPX;MARK2;PSMA6;HSPA13;STK36;STK38;PRKACB;MKNK1;GLUD1;RND3;LATS2;UHMK1;RALB;ATP1A3;ATP1A1;ADSS1;RHOC
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.38065543726180284,-1.0708652913308567,0.3544600938967136,0.8210287058048185,1.0,5/18,21.33%,AKR1B1;ALDH18A1;ALDH1A1;ALDH1A2;AKR1B10
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.4492512635475248,1.0701268210553059,0.3580705009276438,0.7369963403014461,1.0,4/15,8.91%,KMT2A;ASH2L;KMT2C;WDR82
prerank,protein serine/threonine kinase activity (GO:0004674),0.28425849477175685,1.0693824147231643,0.32339955849889623,0.7353181043862322,1.0,60/335,12.36%,EGFR;MAP3K5;STK17B;SGK3;CDC42BPG;CASK;GRK5;STK19;DAPK1;IRAK3;ALPK1;OXSR1;RIPK1;ERN1;MAP3K1;CAMK1D;CDK12;RPS6KA3;CDK6;TRIO;GSK3B;PKN2;PAK2;MAPKAPK2;ROCK1;STK24;STK3;RIOK3;WNK1;PIKFYVE;VRK2;ACVR2A;RPS6KC1;SYK;CHEK1;MAP3K8;FAM20A;NRK;HTATIP2;PRKCB;ULK2;CDK14;CDK20;VRK1;MAPK4;SBK3;MAPK14;DYRK1A;MAP3K20;MAST1;RPS6KA6;RIPK2;MARK2;STK10;CDK13;STK36;ROCK2;STK38;MKNK1;MAP3K11
prerank,cell-cell adhesion mediator activity (GO:0098632),0.3676317783108969,1.069292274614206,0.3677621283255086,0.73203235199766,1.0,7/42,5.98%,PDLIM5;RAB10;S100A11;TMOD3;STXBP6;PDLIM1;ANXA2
prerank,microtubule plus-end binding (GO:0051010),-0.3842613617565772,-1.0691671390618722,0.3567961165048544,0.8194450040654793,1.0,7/20,16.02%,DST;CLASP2;CLIP2;MAPRE3;NUMA1;MAPRE1;CLIP3
prerank,water transmembrane transporter activity (GO:0005372),-0.4505253678308964,-1.0674255658816405,0.392,0.8179126785557093,1.0,5/11,49.88%,PDPN;AQP4;AQP1;SLC5A1;SLC4A11
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.46127391325816136,-1.0666681418547161,0.3769063180827887,0.8133719918160336,1.0,4/10,23.49%,NAA60;NAA25;NAA80;NAA30
prerank,protein kinase C activity (GO:0004697),-0.41374880469633074,-1.0657241479473183,0.37557603686635943,0.80947129938925,1.0,3/14,8.69%,PRKCD;PRKCE;CCL3
prerank,adrenergic receptor binding (GO:0031690),-0.40636488121719616,-1.0634079922487665,0.3761467889908257,0.8098993012649127,1.0,6/16,7.67%,GNAS;MAGI2;DLG4;GRK2;UCHL1;APLP1
prerank,protease binding (GO:0002020),0.3225106404442555,1.0628762257923008,0.35789473684210527,0.7443935770731115,1.0,17/99,11.25%,NLRC4;LDLR;CLTC;ITGB1;PRKN;BCL10;GSK3B;RIOK3;ANXA2;BCL2;TNF;STIM1;CARD16;RHBDD2;LCOR;RIPK2;AMFR
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.2954119520999367,-1.0626806797830999,0.34615384615384615,0.805628752807975,1.0,19/60,15.94%,MERTK;EPHA7;BMPR1B;ACVR1;FGFR2;FLT1;NTRK3;AXL;EPHB1;EPHA10;ALK;FLT3;CSF1R;ERBB4;EPHA3;TGFBR2;TYRO3;EPHB2;ACVR1B
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.39211713491005307,1.060749445489793,0.38578680203045684,0.7461582034369607,1.0,7/27,13.63%,ARIH1;SIAH2;PRKN;ANKIB1;RNF19B;RNF14;RNF19A
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.27708259860468154,-1.0606439830696601,0.31868131868131866,0.8049247051335101,1.0,27/78,23.54%,USP35;CAPN15;CAPN3;LGMN;USP12;CTSS;USP46;CASP7;UCHL1;CTSF;USP40;CFLAR;CASP6;USP49;USP34;GPAA1;USP29;USP5;CTSO;USP33;PIGK;PYCARD;CASP12;CTSK;ESPL1;CAPN11;USP10
prerank,transcription coregulator binding (GO:0001221),0.356247387437398,1.0605954003331897,0.3656387665198238,0.7429513009380632,1.0,7/50,5.57%,AHR;ZBTB16;ESR1;RPL23;NR1D1;SMAD4;THRB
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.28758145192985757,1.0595238223522878,0.34545454545454546,0.7420279652027595,1.0,72/269,20.10%,EGFR;SNX9;FBXW7;TXNIP;RPL23;MFHAS1;ARIH1;PTPN22;RPS27A;CCDC50;TNFRSF1B;SLC22A18;RIPK1;AXIN1;PRKN;BCL10;GSK3B;RB1;SPOP;CD40;BCL2;CXCR4;RPL5;UBXN7;SPOPL;SHPRH;VCL;MDM2;UBE2K;CUL3;RTN4;ARRB1;SLC25A5;CASP8;WFS1;JAK1;YWHAE;PRKACB;TRIB2;FOXO1;UBE2N;RALB;PSMA3;PSMD1;RPL11;ASB4;AMBRA1;GPI;NLK;USP25;GABARAP;HSP90AB1;UBE2W;FANCL;STAM;PER1;RELA;CUL5;PA2G4;GLMN;MID1;UBE2A;TNK2;TRAF6;ATXN3;SUMO1;TRIB1;SMC6;TMBIM6;DTX1;USP7;SMAD5
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.4371340961859419,-1.0581256536090704,0.3948497854077253,0.8053701217731245,1.0,5/11,15.74%,CTC1;HNRNPA2B1;STN1;TERF2;HNRNPA1
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.45626572982968294,-1.0577617341633414,0.39330543933054396,0.8002485691858158,1.0,6/10,27.23%,ANKRD13B;DNAJB2;ANKRD13D;ANKRD13A;IDE;FAAP20
prerank,tau protein binding (GO:0048156),0.36593542935807494,1.05628098323928,0.38412698412698415,0.7467063470679863,1.0,14/40,17.84%,APOE;GSK3B;ROCK1;ACTB;FYN;DYRK1A;PPP2CA;PPP2CB;MARK2;ROCK2;EP300;HSP90AB1;MARK3;PICALM
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.47565865604317764,1.0552265731718564,0.4090909090909091,0.7457649451122567,1.0,2/12,7.25%,RRH;GPR52
prerank,AMP binding (GO:0016208),-0.44381385368759485,-1.0548398128477878,0.38716814159292035,0.802249501829362,1.0,5/11,9.29%,MPPED2;PFKL;PRKAG1;PYGL;PFKP
prerank,chloride channel regulator activity (GO:0017081),0.43848284128018844,1.0530268161260241,0.4084249084249084,0.7477462300760331,1.0,3/14,8.48%,SGK3;WNK1;STX7
prerank,SUMO transferase activity (GO:0019789),0.43719671805301863,1.0506783368201433,0.423728813559322,0.75005812890915,1.0,4/16,8.74%,PIAS1;PIAS2;NSMCE2;MDM2
prerank,metalloexopeptidase activity (GO:0008235),0.35562022294301987,1.0494812801081845,0.38719068413391555,0.7494300693586725,1.0,7/51,10.23%,PEPD;CPQ;XPNPEP3;LNPEP;ZMPSTE24;RNPEP;ENPEP
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.3964656012673873,1.0493581147876196,0.40298507462686567,0.7462752093621756,1.0,4/28,7.31%,BABAM2;RIPK1;TNF;EDA
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.4213181024065998,1.04747920141689,0.4222972972972973,0.7474938599809182,1.0,2/21,7.43%,P2RX7;CHRNA4
prerank,motor activity (GO:0003774),-0.2847109334679473,-1.0471404633636672,0.36065573770491804,0.8179314964860868,1.0,17/60,17.38%,KIF21B;KIF1A;DYNLRB1;KIF5A;KIF6;KIF5C;MYO6;CENPE;DYNC2H1;KIF1C;KIF3A;KIF11;KIF15;KIF3B;DNAH8;KIFC2;KIF2A
prerank,protein kinase regulator activity (GO:0019887),0.3182468843523916,1.0467532192617397,0.3895582329317269,0.7458181316402647,1.0,20/95,14.55%,PRKAG2;SH3BP5;GMFG;DNAJC3;PRKAG3;RPLP1;RGCC;GPRC5B;WNK1;CCND3;CCNYL1;SMCR8;CCND2;CCNJ;MARK2;SH3BP5L;ELP4;CCNQ;CCNY;PARVA
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.31844786461747643,-1.0449978489825438,0.36235955056179775,0.8181474363033149,1.0,20/37,29.05%,FARSA;AARS1;CARS1;TARS2;TARS1;NARS1;YARS1;IARS2;SARS1;DARS2;AARS2;SARS2;PARS2;HARS2;FARSB;WARS1;VARS2;VARS1;NARS2;KARS1
prerank,transcription corepressor binding (GO:0001222),0.40179891459413786,1.0439818488206705,0.3956228956228956,0.749043200733774,1.0,8/27,17.18%,ZBTB16;ESR1;NR1D1;LCOR;CTBP2;EHMT1;PER1;ZBTB7A
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.35848611454503376,-1.0420022291426572,0.37623762376237624,0.8202717132312685,1.0,7/23,11.24%,PLCB2;PLCB4;PLCG1;CHRM3;EDNRA;PLCB1;PLCH1
prerank,magnesium ion binding (GO:0000287),0.29770843792634555,1.0418182526590225,0.38071065989847713,0.7509604741858378,1.0,24/135,15.99%,NLRC4;MAP3K5;CDC42BPG;IRAK3;OXSR1;ERN1;MOV10L1;PDE2A;STK3;GEM;CLYBL;TKT;MAP3K20;MAST1;MARK2;FOXK2;STK38;PRKACB;DIS3L2;XYLT2;NUDT18;PAPOLA;NLK;IDH1
prerank,anion channel activity (GO:0005253),0.33327121051645475,1.0415674759407854,0.4005602240896359,0.7483962495519619,1.0,9/61,10.28%,CLCN5;ANO6;LRRC8D;CLIC4;ANO1;CLCC1;TTYH3;BEST1;GABRA3
prerank,leucine zipper domain binding (GO:0043522),-0.45379855271360797,-1.0405032030867833,0.4410569105691057,0.8187084751935129,1.0,4/10,29.04%,DDIT3;PAWR;ATF4;PMF1
prerank,insulin-like growth factor I binding (GO:0031994),0.4448215416067603,1.0382714538129876,0.4272030651340996,0.7529431919732364,1.0,2/13,4.97%,IGFBP4;INSR
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.35865034526249295,-1.0377387808157572,0.3969849246231156,0.8204526258942219,1.0,6/21,12.12%,AKAP8L;AKAP6;AKAP7;ARFGEF1;AKAP8;WASF1
prerank,translation elongation factor activity (GO:0003746),0.44174273496684263,1.036402891570829,0.40939597315436244,0.7540736058103836,1.0,2/14,3.68%,EEF1A1;EEFSEC
prerank,ephrin receptor activity (GO:0005003),-0.3957615051690663,-1.0355641727155545,0.3926940639269406,0.8143593692934735,1.0,6/17,18.93%,EPHA7;EPHB1;EPHA10;EPHA3;EPHB2;EPHA6
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.3957615051690663,-1.0355641727155545,0.3926940639269406,0.8143593692934735,1.0,6/17,18.93%,EPHA7;EPHB1;EPHA10;EPHA3;EPHB2;EPHA6
prerank,sequence-specific mRNA binding (GO:1990825),-0.44935123188821957,-1.0338440680555656,0.41935483870967744,0.8133486111423158,1.0,4/10,18.91%,FMR1;SHFL;TYMS;DHX9
prerank,DNA replication origin binding (GO:0003688),0.39584592239206295,1.030177732597579,0.4288135593220339,0.7656976808993331,1.0,6/23,15.90%,ORC5;ORC2;MCM9;DDX11;KAT7;MCM8
prerank,GABA receptor activity (GO:0016917),-0.3562861181855723,-1.029415521502942,0.4154929577464789,0.8197281578004352,1.0,8/21,29.48%,GABRB3;GABRB1;GABRA2;GABRG2;GABRA4;GABRR2;GABRG3;GABRE
prerank,nucleoside-triphosphatase activity (GO:0017111),0.28229389034604474,1.0288355217666076,0.41391509433962265,0.7655458717198855,1.0,52/248,18.29%,GNAQ;RAP1B;ATP2B1;KIF20B;RAB31;RAP2B;ATL1;GBP3;NRAS;KRAS;GNAI3;EEF1A1;CDC42;RAB8B;ARL8A;RHOA;GCH1;RAP1A;GBP7;GTPBP10;VPS4B;GEM;RHOBTB1;GNB1;RAB7A;RAB14;RAB1A;RAB23;GNG5;CLPX;MYO1E;GTPBP1;AGAP3;RND3;RALB;RAB11A;RHOC;GNA11;ARHGDIB;RAB3B;LSG1;GNA13;HBS1L;RAB32;ABCB10;TOR1B;RHOF;EFL1;RAB22A;RHEB;RRAGC;ABCA4
prerank,hormone activity (GO:0005179),0.34007833159530115,1.028403790884342,0.4008941877794337,0.7632830348055749,1.0,8/54,14.27%,METRNL;C1QTNF12;GHRL;IGF1;CCK;METRN;NPPC;TRH
prerank,microtubule motor activity (GO:0003777),-0.2883805086902749,-1.027060380272817,0.422360248447205,0.8202658852302743,1.0,28/51,34.97%,KIF21B;KIF1A;DYNLRB1;KIF5A;KIF6;KIF5C;CENPE;KIF1C;KIF3A;KIF11;KIF15;KIF3B;DNAH8;KIFC2;KIF2A;KIFC1;KIF14;KIF5B;KIFC3;KIF2C;KIF20A;DNAH3;KIF18B;KIF19;KIF9;KIF27;KIF24;KIF7
prerank,ubiquitin-protein transferase activity (GO:0004842),0.2727815695775033,1.027050905799283,0.42248908296943233,0.76320721574967,1.0,72/346,16.08%,WWP1;RNF150;SMURF2;ARIH1;SH3RF1;UBE2E3;SIAH2;SEL1L2;CDC42;CBL;PELI1;RMND5A;PRKN;TRIM56;ZNRF3;BIRC3;RNF141;RC3H1;KLHL13;UBE2Q2;TRIM32;FBXL5;ANKIB1;MYCBP2;TRIM24;TRIM47;DTX2;BIRC6;TRIM68;SHPRH;TRIM27;RNF121;MDM2;RNF19B;UBE2K;UBE2D3;UHRF2;COP1;CUL3;MKRN1;RNF38;FBXO11;RNF14;ZNRF2;RNF111;AMFR;RNF185;UBE3B;TRIM71;CBLB;MIB1;FBXO10;MKRN3;UBE2R2;RNF115;UBE2N;RBBP6;RNF187;RNF19A;ASB12;BFAR;BCOR;ANKRD39;NEDD4L;MKRN2;RNF122;ASB4;RNF41;FBXW2;TRIM25;UBE2W;FANCL
prerank,voltage-gated ion channel activity (GO:0005244),-0.3960703334238968,-1.0235057581861073,0.4551569506726457,0.824336268591148,1.0,5/14,14.03%,KCND2;CACNA1E;VDAC1;VDAC3;HVCN1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.460451170882702,1.021208183035518,0.4435946462715105,0.7739041928842865,1.0,6/12,18.88%,PHF8;KDM7A;KDM4D;JMJD1C;KDM1A;KDM4C
prerank,dynactin binding (GO:0034452),0.4467781387089433,1.0197651152427751,0.44507575757575757,0.7739737456965595,1.0,5/12,14.51%,SNX6;GSK3B;SNX5;PAFAH1B1;SPTBN5
prerank,nucleotide diphosphatase activity (GO:0004551),-0.3958543450264066,-1.0183402767555783,0.4366812227074236,0.8324542053371704,1.0,6/14,26.22%,ENPP5;NUDT6;FHIT;NUDT13;NUDT12;NUDT11
prerank,amino acid:sodium symporter activity (GO:0005283),-0.41858449667613085,-1.0179452014814563,0.43710021321961623,0.8276518915715484,1.0,4/11,18.89%,SLC1A3;SLC1A1;SLC6A1;SLC1A2
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.39643916992849654,1.0162520976327223,0.4226086956521739,0.7787051237982976,1.0,6/22,16.03%,MTMR3;DUSP12;DUSP1;DUSP2;DUSP23;DUSP7
prerank,LRR domain binding (GO:0030275),-0.41033641443941854,-1.0155891338154872,0.4451754385964912,0.8283564996842087,1.0,4/14,19.69%,ROBO1;DDIT3;PAWR;ATF4
prerank,chemoattractant activity (GO:0042056),-0.3326181294673488,-1.015337481980917,0.41379310344827586,0.8234633677342281,1.0,13/26,39.68%,FGF2;VEGFB;CCL3;MIF;HMGB1;DEFB130A;CX3CL1;FGF7;BMP4;VEGFD;CXCL10;VEGFA;CCL15
prerank,myosin II binding (GO:0045159),-0.42972624245163443,-1.01507708935622,0.41501103752759383,0.8184886110458806,1.0,4/10,15.88%,LLGL1;SHROOM1;SHROOM4;LLGL2
prerank,protein phosphatase activator activity (GO:0072542),-0.40961491008040296,-1.0125832179777838,0.45695364238410596,0.8194239703565265,1.0,6/13,21.06%,CALM2;PPP2R5C;PPP2R5A;PTPA;IGFBP3;CALM3
prerank,transition metal ion binding (GO:0046914),0.2665466994608486,1.0112325091800813,0.4386536373507057,0.787072009272215,1.0,70/397,15.49%,GDA;ALOX5;RPS29;CRIP1;ALOX15;KMT2A;ANG;AGMO;ARIH1;GYG1;SORD;PHF8;LARGE2;ENDOU;SMPDL3A;PRKN;PDE2A;DUSP12;AOC1;AFM;MGAT2;XPNPEP3;GCH1;NQO2;MOXD1;FTL;KDM7A;GLO1;LNPEP;RC3H1;CRIP2;ACER3;ATP7A;FBXL5;ACR;MYCBP2;PAM;TRIM24;PITRM1;KLF4;THAP11;ESCO1;AOX1;RNPEP;TET3;MDM2;USP16;ZNF205;ENPEP;FTH1;ETHE1;RASSF1;LACTB2;CBLB;KDM5C;LOXL2;SEC24D;SHMT1;TET2;MBD1;XYLT2;KAT6A;ARG2;PAPOLA;ZDHHC20;SAMHD1;MELTF;MYT1;HDAC4;KDM2A
prerank,chloride channel activity (GO:0005254),0.32672509127722277,1.0082753022008724,0.4202279202279202,0.7906695079412831,1.0,9/59,10.28%,CLCN5;ANO6;CLCNKB;CLIC4;ANO1;CLCC1;TTYH3;BEST1;GABRA3
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.4304264402404044,1.007390453941389,0.4587628865979381,0.7893835535657843,1.0,1/14,1.39%,BLVRB
prerank,omega peptidase activity (GO:0008242),-0.2570667112597111,-1.0054043321715247,0.4291497975708502,0.8334190534195026,1.0,22/89,14.81%,USP35;CYLD;USP12;OTUD5;USP50;OTULIN;GGT5;USP46;STAMBP;UCHL1;USP19;USP40;MYSM1;GGT7;USP49;PAN2;UFD1;OTUB1;USP34;JOSD2;USP29;USP5
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.31824118418710273,-1.0039751757844284,0.4166666666666667,0.8314602234884704,1.0,15/29,43.32%,SLC38A7;SLC1A1;SLC25A14;SLC25A22;SLC25A10;SLC25A13;SLC1A4;SLC25A21;SLC13A5;SLC46A1;ABCC2;SLC1A5;SLC26A3;SLC26A4;SLC25A18
prerank,outward rectifier potassium channel activity (GO:0015271),-0.4186845155518688,-1.003675350695131,0.4811529933481153,0.8267852943599422,1.0,4/11,23.89%,KCND2;KCNK2;KCNT1;KCND1
prerank,mRNA binding (GO:0003729),-0.22266930063545723,-1.0029220200313016,0.45925925925925926,0.8234316476509923,1.0,57/249,16.94%,DDX5;SNRNP70;SRRM2;LUC7L3;CPSF6;EIF4G1;ELAVL2;RBM25;NCL;RBFOX1;SRRM4;SRSF5;HNRNPA2B1;EIF4A1;FXR2;TARDBP;TP53;PKM;ZC3H12B;HNRNPU;ELAVL4;HNRNPLL;FUBP1;CPEB2;SECISBP2;RIDA;FMR1;PPIE;CELF4;RBMS3;KHDRBS3;CSTF2;RNPS1;CLUH;SHFL;UNK;TYMS;CIRBP;ADARB1;MYH10;UPF3B;NOVA2;C1QBP;UTP23;CARHSP1;QKI;SF3B1;NCBP1;N4BP1;PCBP1;SLC4A1AP;PCBP2;RBM5;SNIP1;PARK7;ANGEL2;PABPC4
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3123653984098825,1.0019112762802278,0.4595744680851064,0.7994653760268636,1.0,10/71,7.38%,PTPRJ;PTPN18;PTPN20;PTPN12;PTPN22;MTMR3;DUSP1;PTPRK;PTPRA;DUSP22
prerank,nucleotidyltransferase activity (GO:0016779),0.3878022658998094,1.001136509184066,0.4381443298969072,0.7980003364412246,1.0,4/19,8.58%,TUT7;TENT2;TUT4;PAPSS2
prerank,mRNA methyltransferase activity (GO:0008174),0.4446901217303327,0.9986861271639673,0.45634920634920634,0.8003315845640242,1.0,6/12,23.11%,NSUN2;TRMT61B;CMTR2;TRMT61A;METTL16;PCIF1
prerank,ATPase binding (GO:0051117),0.31701841421938126,0.9975353234723455,0.46740638002773927,0.7997353002268169,1.0,19/71,15.71%,EGFR;PPP3CA;ESR1;S100A1;SNU13;ATP6V0A1;PDE4D;PEX26;VCPKMT;PSEN1;PLN;SNX10;WFS1;NR1H2;RALB;PKD2;USP25;NCSTN;NOP58
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3224123263239463,0.9964313748608958,0.4511173184357542,0.7989482052745711,1.0,6/73,5.83%,EDNRB;CYSLTR1;CALCRL;NPR3;S1PR2;ADCYAP1R1
prerank,protein tyrosine kinase activity (GO:0004713),0.29681507325448175,0.9945183793785984,0.44818304172274565,0.8001782423828228,1.0,18/108,11.81%,EGFR;FGFR1;PEAK1;LYN;FER;FRK;INSR;CAMKK2;PDGFRA;SYK;ZAP70;FYN;DDR2;DYRK1A;EPHB4;STYK1;SLA;JAK1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.3667368896000903,0.9936937798926944,0.45171849427168576,0.7987283913790205,1.0,9/27,18.53%,POLR1A;POLR1B;MED20;POLR2B;POLR1D;POLR2D;PRIM1;CRCP;POLR2F
prerank,Toll-like receptor binding (GO:0035325),0.4449430046777949,0.9929816381929282,0.4839319470699433,0.7969641738866541,1.0,2/11,4.23%,CD36;TLR2
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3338175578471611,0.9909762250462464,0.45871559633027525,0.7983356583536427,1.0,6/49,7.81%,MCTP1;CPNE2;CPNE7;ANXA2;CPNE8;MCTP2
prerank,metalloendopeptidase activity (GO:0004222),0.30665147265785264,0.9891194928822215,0.4604519774011299,0.799452221340858,1.0,13/76,13.48%,ADAM19;ADAMTSL5;ADAM9;ADAMTS19;ZMPSTE24;PITRM1;ADAMTS18;ADAMTS10;ADAMTS9;MMP24;MMP28;MMP25;ADAMTS17
prerank,RNA polymerase core enzyme binding (GO:0043175),0.3596873969215892,0.9886708701118482,0.4921135646687697,0.7972847746102348,1.0,11/33,16.47%,NCOA3;WAC;CDC73;ESRRB;SCAF8;RPRD2;ELOF1;ELP4;ZNF326;RTRAF;GTF2B
prerank,store-operated calcium channel activity (GO:0015279),-0.43410531346653936,-0.9860130005065755,0.49789915966386555,0.8638690460001585,1.0,5/10,12.30%,TRPC4;ORAI2;TRPC1;TRPC3;TRPC5
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.3689412152028239,0.9853829030761515,0.46511627906976744,0.8015353666519021,1.0,6/29,12.43%,SPRED1;PRKAG2;SFN;HSPB1;SPRED2;CDKN2C
prerank,poly-pyrimidine tract binding (GO:0008187),0.3779080050747223,0.9851421183627448,0.44804088586030666,0.7989191277860554,1.0,5/23,12.67%,RBMS1;HNRNPC;ATXN1;RBM11;DIS3L2
prerank,phosphoric ester hydrolase activity (GO:0042578),0.32882902973344813,0.9784493104067281,0.4772727272727273,0.8112039426404936,1.0,11/49,15.22%,PTPRJ;PTPN22;DUSP28;SMPDL3A;DUSP12;HDHD2;LHPP;PPP1CA;ACP3;DUSP23;SAMHD1
prerank,growth factor activity (GO:0008083),-0.25827620232474563,-0.9769915835503826,0.4861111111111111,0.8841278631023732,1.0,8/74,6.81%,TGFA;NRG3;CSF1;FGF2;VEGFB;CSPG5;OSGIN2;BDNF
prerank,regulatory RNA binding (GO:0061980),0.3456519041464621,0.9764844609716217,0.49617151607963245,0.8124346496959518,1.0,8/38,13.53%,TUT7;RC3H1;PUM2;RBM4;TUT4;TRIM71;ZC3H12A;PIWIL2
prerank,ion channel activity (GO:0005216),-0.25009074928185493,-0.9706304221700989,0.5274725274725275,0.8957146562799351,1.0,14/80,12.24%,GRID2;GRIA2;GRIK2;GRIA4;TRPM3;PIEZO1;GRIN3A;TMC7;GABRB1;TRPC1;NALCN;GRIN2A;PIEZO2;TMEM120B
prerank,adenyl ribonucleotide binding (GO:0032559),0.2592561982912686,0.9694343493868519,0.5346756152125279,0.8255505291275633,1.0,26/291,6.39%,NLRC4;P2RX7;MAP3K5;STK17B;OAS2;PEAK1;CDC42BPG;PRKAG2;DAPK1;IRAK3;LIG4;OXSR1;PRKAG3;ERN1;MOV10L1;HMGCR;RAPGEF2;PDE2A;CDK6;PNPLA8;INSR;ATP7A;PDE4D;STK3;WNK1;NOL9
prerank,zinc ion binding (GO:0008270),0.25924491510098086,0.9677411499100345,0.5410573678290214,0.8263998918999792,1.0,55/293,16.87%,GDA;RPS29;CRIP1;KMT2A;ARIH1;SORD;PHF8;SMPDL3A;PRKN;PDE2A;DUSP12;AOC1;AFM;GCH1;NQO2;KDM7A;GLO1;LNPEP;RC3H1;CRIP2;ACER3;ACR;MYCBP2;PAM;TRIM24;PITRM1;KLF4;THAP11;ESCO1;RNPEP;TET3;MDM2;USP16;ZNF205;ENPEP;RASSF1;LACTB2;CBLB;KDM5C;SEC24D;SHMT1;TET2;MBD1;KAT6A;ZDHHC20;SAMHD1;MYT1;HDAC4;KDM2A;CHORDC1;ERAP1;RABIF;GTF2B;TAB3;MSRB3
prerank,MHC class I protein binding (GO:0042288),0.4275142219940374,0.9662537918737375,0.5018115942028986,0.8266621658821526,1.0,1/13,2.74%,LILRB1
prerank,protein phosphorylated amino acid binding (GO:0045309),0.33091578568104124,0.9658831916887141,0.5039619651347068,0.8242708707775923,1.0,7/42,11.84%,FBXW7;RASA1;CRK;SYK;ZAP70;SHC1;YWHAE
prerank,cAMP binding (GO:0030552),0.43107687495447966,0.963287707813674,0.5043782837127846,0.8270423452931437,1.0,3/11,5.72%,RAPGEF2;PDE2A;PDE4D
prerank,intracellular chloride channel activity (GO:0061778),0.40272862069000004,0.9598921197785041,0.5122377622377622,0.8282088675818984,1.0,3/16,6.15%,ANO6;ANO1;TTYH3
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.40272862069000004,0.9598921197785041,0.5122377622377622,0.8282088675818984,1.0,3/16,6.15%,ANO6;ANO1;TTYH3
prerank,glycine binding (GO:0016594),-0.3993180096194762,-0.9590128795216741,0.5236051502145923,0.9213408814020215,1.0,5/11,22.79%,GRIN3A;GLRB;GLRA1;GLRA3;GLRA2
prerank,ATP hydrolysis activity (GO:0140603),0.3274085491263655,0.9571365536625885,0.521669341894061,0.8314147128654714,1.0,5/41,10.51%,ATP2B1;KIF20B;VPS4B;CLPX;MYO1E
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.24565325257491705,-0.9564979733884745,0.5416666666666666,0.9223182174046045,1.0,22/83,17.18%,USP35;CYLD;USP12;OTUD5;USP50;OTULIN;USP46;STAMBP;UCHL1;USP19;USP40;MYSM1;USP49;PAN2;UFD1;OTUB1;USP34;JOSD2;USP29;USP5;USP33;OTUD1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.37406864074794466,0.9559928574564637,0.5084459459459459,0.8306272961441308,1.0,4/21,17.25%,DRD1;CHRNA4;GRM1;CHRNB2
prerank,hormone receptor binding (GO:0051427),-0.3676620134335393,-0.9552846334543597,0.5408388520971302,0.9199719572925422,1.0,3/14,9.79%,JAK2;SOCS2;ADCYAP1
prerank,hexosyltransferase activity (GO:0016758),0.28913828261266294,0.9552722783246798,0.5339673913043478,0.8290101079636775,1.0,18/101,11.37%,EXT1;GBE1;GYG1;FUT4;LARGE2;UGT1A6;UGT1A10;UGT1A7;UGT1A4;UGT1A8;UGT1A1;B4GALT6;ALG9;POGLUT3;ALG5;POGLUT1;B4GALT5;B4GALNT3
prerank,ubiquitin binding (GO:0043130),-0.2476091709593538,-0.9548517293463005,0.5481727574750831,0.9152548012619265,1.0,21/73,16.99%,MVB12B;OTULINL;BIRC2;FBXO7;AUP1;UCHL1;TOM1L1;RNF168;DNAJB2;SIRT2;NSFL1C;UBXN1;OTUB1;TOP2A;NPLOC4;USP5;N4BP1;ASCC2;USP33;GGA3;SQSTM1
prerank,RNA polymerase binding (GO:0070063),-0.34978678387712764,-0.9543070299599549,0.5413533834586466,0.9110519800178919,1.0,7/18,13.00%,BIN1;PABPN1;CCNT2;TCERG1L;BRCA1;TCERG1;PHRF1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.3131715560733082,0.9527804818643496,0.5007256894049347,0.8314971817508819,1.0,8/49,10.47%,RNF169;EPS15;BABAM2;BRCC3;MINDY2;ZFAND2B;UBQLN4;ZRANB3
prerank,snRNA binding (GO:0017069),-0.28783253198127823,-0.9521167189500925,0.547752808988764,0.9108031521714709,1.0,7/42,8.31%,SNRNP70;CDK9;DDX39B;HNRNPU;CCNT2;SNRPA1;PRPF4
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.392938039402456,-0.9519089891659409,0.5187637969094923,0.9056852065232393,1.0,3/12,8.05%,GNS;SULF1;ARSG
prerank,peptidoglycan binding (GO:0042834),0.4333518314155704,0.9510507505577518,0.5161904761904762,0.8322428576619456,1.0,4/10,25.21%,TLR2;NOD2;RNASE7;NLRP3
prerank,R-SMAD binding (GO:0070412),-0.35200641333872285,-0.950041195576359,0.5273972602739726,0.9051663569776011,1.0,2/18,0.37%,DDX5;LDLRAD4
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.3266785846969744,-0.9492626711619964,0.4975124378109453,0.9018957632750088,1.0,2/20,1.13%,LPCAT2;LPCAT1
prerank,metallocarboxypeptidase activity (GO:0004181),0.35961356729333016,0.9490838645189784,0.5056910569105691,0.8332880708549957,1.0,1/26,0.62%,PEPD
prerank,insulin-like growth factor binding (GO:0005520),0.3976640069017894,0.9485833287770883,0.5142314990512334,0.8311921497577807,1.0,3/15,10.76%,IGFBP4;INSR;IGFALS
prerank,sialyltransferase activity (GO:0008373),0.3830399646141732,0.9480994902768494,0.5201401050788091,0.8291342106670938,1.0,3/20,3.59%,ST8SIA4;ST6GAL1;ST3GAL1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.40530923505945565,0.9475944384254631,0.5336976320582878,0.8272205472047457,1.0,1/14,3.24%,DHRS3
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3408367485487311,0.9473187860294282,0.5229793977812995,0.8247199474613323,1.0,11/33,16.47%,NCOA3;WAC;CDC73;ESRRB;SCAF8;RPRD2;ELOF1;ELP4;ZNF326;RTRAF;GTF2B
prerank,chloride transmembrane transporter activity (GO:0015108),-0.3572840902641595,-0.945163961367895,0.5295508274231678,0.9078026970703102,1.0,4/16,23.81%,CLCN7;SLC1A1;CFTR;SLC12A5
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.26326335168895176,-0.9448896640376422,0.5470588235294118,0.9030650253234449,1.0,24/48,37.67%,SLC12A2;TRPM3;PIEZO1;TRPC1;NALCN;SLC12A6;PIEZO2;ABCC9;UNC80;SLC12A4;MMGT1;PKD1L3;SLC39A1;TRPM7;CALHM6;TRPV2;TRPM6;CALHM5;TRPC6;ATP6V1F;GRIN3B;TRPM1;ASIC3;SLC46A1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.3902186293811546,-0.9436165202417177,0.5264270613107822,0.901055343619417,1.0,4/11,8.68%,GNPTAB;PTDSS1;SAMD8;PTDSS2
prerank,cholesterol binding (GO:0015485),-0.27288436470294913,-0.9391993662014771,0.5701492537313433,0.9072201370025008,1.0,9/47,14.78%,ABCG1;GRAMD1A;SCARB2;OSBPL6;STARD3;APOD;VDAC1;GRAMD1C;OSBPL2
prerank,O-acyltransferase activity (GO:0008374),-0.2997697927130177,-0.9388349958632474,0.5667506297229219,0.9028904266552832,1.0,5/30,16.50%,LPCAT2;LPCAT1;LPCAT3;MBOAT7;AWAT2
prerank,NADP binding (GO:0050661),0.33465007872922337,0.9387790829709951,0.5377358490566038,0.8410891055471653,1.0,8/32,20.58%,DPYD;HMGCR;GMDS;LBR;CBR3;DHCR7;DUS2;ME1
prerank,fibroblast growth factor receptor binding (GO:0005104),0.3729802660297095,0.9360163449309398,0.5366269165247018,0.844254257885162,1.0,2/21,4.00%,FGF23;FRS2
prerank,poly-purine tract binding (GO:0070717),-0.31437138283412547,-0.9351990728137318,0.5382653061224489,0.9072590996488842,1.0,10/27,16.94%,TIA1;HNRNPU;ELAVL4;FMR1;PPIE;HNRNPDL;RBMS3;MCRS1;DDX1;PABPC4
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.3571695615288062,-0.9345062628709948,0.5185995623632386,0.9038737704073071,1.0,3/15,4.10%,HS3ST5;HS3ST4;HS6ST1
prerank,fibroblast growth factor binding (GO:0017134),0.36976928941993464,0.9344708521054099,0.5383304940374787,0.8444773976280348,1.0,1/21,0.59%,FGFR1
prerank,proton transmembrane transporter activity (GO:0015078),0.32970222844455455,0.9326650687105473,0.5530903328050714,0.845374366501422,1.0,10/39,21.39%,CLCN5;ATP6V1B1;COX7A2L;COX10;SLC33A1;MFSD3;UQCRFS1;NDUFA4;CYB5A;COX5A
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.3091972611481306,-0.9319907236813346,0.5847255369928401,0.9053752056716566,1.0,6/26,14.98%,CHPF2;B3GALNT2;B3GALT1;B3GALT5;B3GALT2;B3GNT2
prerank,mRNA 3'-UTR binding (GO:0003730),0.2910681799830026,0.931673666697321,0.5751724137931035,0.8443789213165604,1.0,16/79,13.22%,RBMS1;ZFP36L2;HNRNPC;ZFP36L1;RPL41;RC3H1;PUM2;RPL5;LARP4B;RBM4;RPS7;SERBP1;ILF3;ZC3H12A;EXOSC8;LARP4
prerank,Hsp90 protein binding (GO:0051879),0.3327363097896664,0.9293782044544848,0.5491143317230274,0.8464135205276766,1.0,4/33,4.37%,AHR;RPS3;ERN1;NR3C1
prerank,snoRNA binding (GO:0030515),-0.29921169304758044,-0.9258728707720675,0.5593667546174143,0.9158181752632208,1.0,12/30,28.22%,XRCC5;NOP56;UTP6;NOP14;BMS1;GAR1;TSR1;NUDT1;BYSL;DHX37;NUDT16;NUDT5
prerank,poly(A) binding (GO:0008143),-0.3271993056383315,-0.9257192617199143,0.5591647331786543,0.910948581289723,1.0,8/21,16.94%,TIA1;HNRNPU;ELAVL4;PPIE;HNRNPDL;RBMS3;DDX1;PABPC4
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.35791571475299694,0.9256109009585994,0.5437710437710438,0.8517236529332118,1.0,8/24,18.83%,SESTD1;SNX3;GOLPH3L;OSBPL8;OSBPL5;GOLPH3;CERT1;ARFIP2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.3630597852321362,0.9254649201851846,0.5497553017944535,0.848985998645625,1.0,5/22,12.43%,ZFP36L2;ZFP36L1;ILF3;ZC3H12A;EXOSC8
prerank,ATP binding (GO:0005524),0.24835001110634405,0.9244385769704102,0.6311010215664018,0.8482472593412738,1.0,33/266,12.23%,NLRC4;P2RX7;MAP3K5;STK17B;OAS2;PEAK1;CDC42BPG;PRKAG2;DAPK1;IRAK3;LIG4;OXSR1;ERN1;MOV10L1;CDK6;PNPLA8;INSR;ATP7A;STK3;WNK1;NOL9;ZAP70;MAP3K20;MAST1;PMVK;MTREX;CLPX;MARK2;HSPA13;STK36;STK38;PRKACB;MKNK1
prerank,alkali metal ion binding (GO:0031420),-0.3656861077206534,-0.9231737153914806,0.5648148148148148,0.9126329351444612,1.0,1/13,1.05%,CAPN3
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.39348577776558646,-0.9231386894267309,0.5659574468085107,0.907500569708213,1.0,5/11,18.52%,UBE4A;RBX1;ANAPC11;PRPF19;STUB1
prerank,glucose transmembrane transporter activity (GO:0005355),0.3779569133743067,0.9225709368284937,0.5516074450084603,0.8493020218278942,1.0,5/17,20.08%,SLC2A4;SLC2A2;SLC5A11;SLC5A3;SLC2A6
prerank,sulfotransferase activity (GO:0008146),-0.2844623721532502,-0.919932413587598,0.6109589041095891,0.9107591110275961,1.0,6/33,10.82%,CHST11;CHST1;HS6ST1;TPST1;CHST2;GAL3ST4
prerank,calcium-release channel activity (GO:0015278),0.3779939486767706,0.9197416231045351,0.5464285714285714,0.8522647380060314,1.0,5/17,14.90%,TPCN1;TRPM2;MCOLN2;PKD2;ITPR3
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.317527770891081,-0.9161764320430298,0.573170731707317,0.9150493653730669,1.0,9/21,23.22%,PRIMPOL;POLM;POLG;POLI;REV3L;POLE;POLL;POLN;POLD4
prerank,receptor tyrosine kinase binding (GO:0030971),-0.2562727718614631,-0.9161515702607999,0.6183431952662722,0.9099783126806067,1.0,8/56,7.68%,BLNK;NRG3;DOCK4;PITPNM1;TP53;ITGAX;PITPNM3;SHC3
prerank,metallopeptidase activity (GO:0008237),0.26737959906695913,0.9123576233326094,0.6207792207792208,0.8652267659638196,1.0,20/113,15.95%,ADAM19;ADAMTSL5;ADAM9;LNPEP;ADAMTS19;ZMPSTE24;BRCC3;PITRM1;ADAMTS18;ADAMTS10;ADAM12;RNPEP;ADAMTS9;MMP24;MMP28;MMP25;ADAMTS17;EIF3H;MMP11;ERAP1
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.37318954413632144,-0.9101107555690583,0.5914221218961625,0.9200506934069326,1.0,3/12,4.96%,GNAS;YWHAH;SOCS2
prerank,single-stranded RNA binding (GO:0003727),0.3131347945781189,0.9094499455738444,0.5812883435582822,0.8682967372529251,1.0,10/43,14.37%,TLR8;DDX60;HNRNPF;DDX11;ILF3;EIF4B;LACTB2;RBM11;AQR;POLR2D
prerank,DNA polymerase activity (GO:0034061),-0.3085948830559324,-0.9082100810210314,0.5879518072289157,0.9196072704396864,1.0,9/22,23.22%,PRIMPOL;POLM;POLG;POLI;REV3L;POLE;POLL;POLN;POLD4
prerank,kinesin binding (GO:0019894),-0.2925343622225893,-0.9069999260105193,0.5947242206235012,0.9174728954811919,1.0,6/27,14.51%,PLEKHM2;NEFH;IFT88;CROCC;NEK6;AP1AR
prerank,protein phosphatase 2A binding (GO:0051721),-0.30317380987845777,-0.9064702143926576,0.563855421686747,0.9137095127568965,1.0,7/23,14.64%,ADCY8;TP53;GRIN3A;MAPT;CTTNBP2NL;ANKLE2;STRN4
prerank,semaphorin receptor binding (GO:0030215),-0.3070135344455258,-0.9055089985814526,0.6122931442080378,0.9110546439493357,1.0,10/23,27.82%,SEMA4D;SEMA4C;SEMA4G;SH3BP1;PLXNB1;SEMA4F;SEMA3B;SEMA3F;SEMA3A;SEMA3D
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.32239145189673074,0.904853074594921,0.5791925465838509,0.8747901620385312,1.0,6/34,10.64%,IQGAP1;INCENP;STK3;FAM20A;PARP16;CALM1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.41602170619509027,0.903582888259796,0.5768500948766604,0.8744234303492352,1.0,4/10,19.05%,EHHADH;HADHA;HADHB;ECHDC1
prerank,telomerase RNA binding (GO:0070034),0.3504907442130428,0.9031916920062654,0.5930434782608696,0.8721499199536364,1.0,5/22,16.18%,HNRNPC;SMG6;DCP2;PINX1;NOP10
prerank,death receptor binding (GO:0005123),0.37596589027748983,0.9026429280650086,0.5859649122807018,0.8702198685548777,1.0,2/15,7.31%,RIPK1;EDA
prerank,anion:anion antiporter activity (GO:0015301),0.365452514629981,0.8971550046426969,0.5833333333333334,0.8789750697312411,1.0,7/17,26.84%,SLC26A11;SLC25A5;SLC26A7;SLC25A4;SLC26A8;SLC25A11;SLC26A2
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.39266657483342204,0.894941653339392,0.5823529411764706,0.8804950221427793,1.0,4/12,16.36%,TENT5A;TENT2;PAPOLA;TUT1
prerank,UDP-glycosyltransferase activity (GO:0008194),0.2867385170877904,0.8933045366311242,0.6184798807749627,0.8810084303189557,1.0,8/70,3.64%,EXT1;LARGE2;UGT1A6;UGT1A10;UGT1A7;UGT1A4;UGT1A8;UGT1A1
prerank,nuclear receptor coactivator activity (GO:0030374),0.29935548777564636,0.892916778118718,0.5955223880597015,0.878788914481771,1.0,22/52,22.62%,NCOA3;NCOA2;NCOA7;PRKCB;NCOA6;BUD31;DCAF6;SFR1;CNOT9;ENY2;USP22;ELK1;KDM1A;PPARGC1B;MED17;SS18;WDR77;THRAP3;MED14;ZMIZ1;ATXN7L3;MED24
prerank,deubiquitinase activity (GO:0101005),-0.23046682450151668,-0.8918109199808069,0.7172131147540983,0.9393886629670404,1.0,22/88,17.18%,USP35;CYLD;USP12;OTUD5;USP50;OTULIN;USP46;STAMBP;UCHL1;USP19;USP40;MYSM1;USP49;PAN2;UFD1;OTUB1;USP34;JOSD2;USP29;USP5;USP33;OTUD1
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.3444543936903918,-0.8911925672899198,0.6187214611872146,0.9358136495928854,1.0,4/15,9.66%,PIK3CB;PI4KA;ATM;PIK3C2B
prerank,protein phosphatase 1 binding (GO:0008157),0.3543473641551809,0.8904014923658939,0.6073825503355704,0.8809169761566389,1.0,6/21,15.54%,LILRB1;PPP1R3C;PPP1R3D;KCNQ1;AKAP11;PPP1R3B
prerank,RNA stem-loop binding (GO:0035613),0.38669334420959006,0.8901922742880611,0.5988909426987061,0.8783890336065897,1.0,8/12,25.32%,RC3H1;ZC3H12A;CSDE1;METTL16;EPRS1;CPEB3;LARP6;RC3H2
prerank,vitamin D receptor binding (GO:0042809),0.3874823150600036,0.8899239790763144,0.5889679715302492,0.8759558351973862,1.0,10/14,27.88%,MED16;SNW1;MED17;THRAP3;MED14;MED24;MED13;TAF11;MED12;RXRA
prerank,endopeptidase activity (GO:0004175),0.240027999353336,0.8878112998573195,0.7005649717514124,0.8773912001198912,1.0,42/257,15.93%,CTSC;ADAM19;PSMA7;ADAMTSL5;ADAM9;RHBDD1;USP9X;CTSB;PARL;RHBDF1;ACR;HTRA3;ADAMTS19;ZMPSTE24;PITRM1;PREP;ADAMTS18;USP15;PSMB2;PSEN1;ADAMTS10;TPP2;ADAMTS9;USP16;SFRP1;F10;CASP8;USP24;PSMA6;USP14;KLK9;MMP24;MMP28;MMP25;ADAMTS17;USP9Y;PSMA3;USP28;SENP1;USP25;USP47;MMP11
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.3733411676594905,-0.8872975385417209,0.592436974789916,0.9402116812426724,1.0,8/12,40.25%,ENTPD6;CANT1;ENTPD3;NUDT5;ENTPD2;ENTPD5;NUDT15;SLC25A42
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.28734521322490525,-0.8862752746355163,0.6481012658227848,0.9373945040016541,1.0,2/28,1.92%,GRID2;GRIK2
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.39263799304942204,0.8861748823178186,0.5787476280834914,0.8778478919227413,1.0,2/11,14.90%,TRPM2;ITPR3
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.3691725032786848,-0.882111922283622,0.5945945945945946,0.9424739820729539,1.0,5/11,28.22%,DCPS;NUDT1;NUDT11;NUDT16;NUDT5
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.2897109375090314,-0.8809678311230285,0.6432038834951457,0.9401777251874983,1.0,6/26,20.22%,MGAT5;PPP1R11;PPP1R14A;SAG;PABIR1;CABIN1
prerank,copper ion binding (GO:0005507),0.3097175191588898,0.8809249696146741,0.6200317965023847,0.8856199067966267,1.0,6/42,6.21%,ANG;AOC1;MOXD1;ATP7A;ACR;PAM
prerank,histone methyltransferase binding (GO:1990226),-0.37314670174808684,-0.8804566369623743,0.6128318584070797,0.9363934674359179,1.0,2/11,2.48%,CTNNB1;NOP56
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.32389692637010087,-0.8799361361288253,0.6082949308755761,0.9327841101376168,1.0,4/18,11.89%,SOCS2;SOCS7;AGAP2;PIK3R5
prerank,neurexin family protein binding (GO:0042043),-0.37349487897715167,-0.8789301103597967,0.6103896103896104,0.9302781459929452,1.0,3/10,17.31%,NLGN1;SYTL2;CPE
prerank,pyrophosphatase activity (GO:0016462),0.28628078831508597,0.8768355302708345,0.6496124031007752,0.8910396487176534,1.0,8/50,11.37%,BNIPL;PRUNE2;NUDT22;RNGTT;DOLPP1;LHPP;TRPM2;DCP2
prerank,GABA receptor binding (GO:0050811),0.4055721335139981,0.8755489680123338,0.610586011342155,0.8905394599592681,1.0,6/11,23.31%,PLCL2;TRAK2;GABARAP;JAKMIP1;TRAK1;ARFGEF2
prerank,bHLH transcription factor binding (GO:0043425),0.35170254240983556,0.8750953669706794,0.6288659793814433,0.8884869493178099,1.0,5/19,15.93%,TCF12;SP1;CREBBP;USF1;KDM1A
prerank,phospholipase activator activity (GO:0016004),-0.37251353625059297,-0.8750840364699185,0.6336842105263157,0.9343150835070091,1.0,4/10,11.81%,SRC;BTK;CCL3;PDPK1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.26850336670952857,0.8734497808270194,0.6638772663877266,0.8888560408336164,1.0,14/85,17.50%,AOAH;PGAP1;PLA2G7;NOTUM;PLA2G2D;PLAAT1;ACHE;LYPLAL1;PLAAT3;NDST3;PAFAH1B2;LYPLA1;ESD;CEL
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.34202986990317524,-0.871112782496864,0.6572769953051644,0.9387632247665421,1.0,3/16,11.34%,SLC44A2;SLC25A26;SLC7A8
prerank,estrogen receptor binding (GO:0030331),0.3168433209825722,0.870648962610053,0.6401799100449775,0.8914882072994499,1.0,9/32,16.40%,ESR1;ARID5A;WIPI1;NRIP1;NCOA6;LCOR;STRN;MMS19;PPARGC1B
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.3997149689600701,0.8670045233059968,0.6115107913669064,0.8959072617739051,1.0,2/11,17.25%,CHRNA4;CHRNB2
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.3332585608356874,0.866315484815549,0.6471600688468159,0.8942577043873184,1.0,6/24,19.35%,IP6K3;PMVK;CMPK1;AK8;AK3;AK4
prerank,phospholipase binding (GO:0043274),-0.3456395367839127,-0.8654295778528283,0.6335540838852097,0.9464305404092862,1.0,4/13,11.81%,BLNK;SRC;BTK;PDPK1
prerank,ATPase activator activity (GO:0001671),0.344208245734727,0.863732357778013,0.641156462585034,0.8965087331658477,1.0,5/20,17.10%,FXYD2;DNAJC1;AHSA1;MYBPC3;DNAJC15
prerank,metalloaminopeptidase activity (GO:0070006),0.36520640853166497,0.8624006927745447,0.6212389380530974,0.896134508319518,1.0,4/16,10.23%,XPNPEP3;LNPEP;RNPEP;ENPEP
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.26806098725134175,-0.8617359771354249,0.6957746478873239,0.9450061602780845,1.0,9/34,22.09%,NDUFS7;NDUFV3;NDUFB8;NDUFB7;NDUFV1;NDUFB10;NDUFA8;NDUFA10;NDUFS1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.26806098725134175,-0.8617359771354249,0.6957746478873239,0.9450061602780845,1.0,9/34,22.09%,NDUFS7;NDUFV3;NDUFB8;NDUFB7;NDUFV1;NDUFB10;NDUFA8;NDUFA10;NDUFS1
prerank,glycerophospholipid flippase activity (GO:0140333),-0.35518143985553546,-0.860325535517984,0.6789838337182448,0.9434278528619,1.0,2/11,5.58%,ATP8A2;ATP8B1
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.3950158791199111,0.8600702423347516,0.6338028169014085,0.8948221289859604,1.0,3/10,16.03%,DUSP1;DUSP2;DUSP7
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.3950158791199111,0.8600702423347516,0.6338028169014085,0.8948221289859604,1.0,3/10,16.03%,DUSP1;DUSP2;DUSP7
prerank,G protein-coupled amine receptor activity (GO:0008227),0.33736361630206213,0.8592839671863718,0.6441821247892074,0.8876445977161633,1.0,3/22,12.60%,HRH1;HTR1D;HTR6
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.33736361630206213,0.8592839671863718,0.6441821247892074,0.8876445977161633,1.0,3/22,12.60%,HRH1;HTR1D;HTR6
prerank,serotonin receptor activity (GO:0099589),0.33736361630206213,0.8592839671863718,0.6441821247892074,0.8876445977161633,1.0,3/22,12.60%,HRH1;HTR1D;HTR6
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.24191530233096656,-0.859150027726101,0.7275641025641025,0.9410604212958567,1.0,14/57,22.09%,CYB561A3;COX5B;NDUFS7;NDUFV3;UQCRC1;NDUFB8;NDUFB7;COX15;NDUFV1;NDUFB10;NDUFA8;NDUFA10;UQCR10;NDUFS1
prerank,MAP kinase activity (GO:0004707),-0.3380667797385544,-0.8567938769605735,0.6666666666666666,0.9411815587858636,1.0,3/14,6.30%,MAPK10;MAPK6;MAPK3
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.3629870363631674,0.8558542830458796,0.6451612903225806,0.8916812724683428,1.0,2/15,5.18%,SESTD1;SNX3
prerank,lipase activator activity (GO:0060229),-0.3614478305813733,-0.8555426403029724,0.6775510204081633,0.9397332464148064,1.0,4/10,11.81%,SRC;BTK;CCL3;PDPK1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.3328611589882486,0.8542882474606768,0.6467576791808873,0.8917605224524182,1.0,3/24,5.27%,DAPK1;CAMK1D;MAPKAPK2
prerank,translation initiation factor activity (GO:0003743),-0.26111391465346234,-0.8532194426173929,0.7214854111405835,0.9401411528962103,1.0,6/36,7.05%,EIF4G1;EIF4A1;EIF2B3;EIF4A2;EIF2D;EIF3B
prerank,ribosomal large subunit binding (GO:0043023),0.3869416770698939,0.8510194280451998,0.6266924564796905,0.895326784550899,1.0,4/11,12.04%,NMD3;MRRF;MALSU1;DHX33
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.3207020256091222,0.8493907703728554,0.6297520661157024,0.8956762166855552,1.0,4/25,11.44%,FMO1;CYP27A1;CYP26B1;FMO5
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.31143838316722655,0.8487220559683566,0.6610738255033557,0.894109404101725,1.0,6/27,16.38%,ANO1;SLC26A11;SLC26A7;XPR1;SLC25A30;GET3
prerank,tumor necrosis factor receptor binding (GO:0005164),0.3849211636758071,0.848690709935577,0.64376130198915,0.8913273896408089,1.0,4/12,18.57%,BABAM2;TNF;TRAP1;TRAF6
prerank,acetyltransferase activity (GO:0016407),0.3089096157897743,0.8486354193517582,0.6775244299674267,0.8886282986474993,1.0,9/31,16.47%,ESCO2;ESCO1;CREBBP;SAT2;EP300;KAT6A;ACAT1;PAFAH1B2;GTF2B
prerank,methyl-CpG binding (GO:0008327),-0.2930395120262289,-0.8473200082022516,0.7094430992736077,0.9481410025337212,1.0,4/22,12.99%,CXXC5;ZCWPW1;LRWD1;ZBTB33
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.34956806257936857,-0.84682751672607,0.6916299559471366,0.9445926115846146,1.0,3/12,9.66%,PIK3CB;ATM;PIK3C2B
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.3924485291943621,0.8458442324364253,0.6297640653357531,0.8912527864338108,1.0,3/10,19.43%,DCLRE1C;MGME1;APEX1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.33976066163510577,0.8443524764776751,0.6406779661016949,0.8913131100664998,1.0,5/17,19.35%,NOL9;CMPK1;AK8;AK3;AK4
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.33659064499277147,0.8441191492208303,0.6523972602739726,0.8861422760309852,1.0,6/21,13.42%,CDK12;CDK6;CDK14;CDK20;CDK13;CDKL4
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.33659064499277147,0.8441191492208303,0.6523972602739726,0.8861422760309852,1.0,6/21,13.42%,CDK12;CDK6;CDK14;CDK20;CDK13;CDKL4
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.2820922433211416,0.8391743285909798,0.6754250386398764,0.8926726148495326,1.0,10/44,15.25%,KMT2A;SETDB2;ASH2L;KMT2C;WDR82;KMT5B;SMYD3;KMT2E;EHMT1;NSD3
prerank,transforming growth factor beta binding (GO:0050431),0.319595562212284,0.8384655569560167,0.6932409012131716,0.8911908018967853,1.0,3/23,8.26%,NRROS;CD36;VASN
prerank,sulfate transmembrane transporter activity (GO:0015116),0.35401827157231125,0.8383779329491535,0.6485507246376812,0.8886268123975593,1.0,6/14,26.84%,SLC26A11;SLC26A7;SLC25A30;SLC26A8;SLC25A11;SLC26A2
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.3359893550228081,-0.8352347011377941,0.6781115879828327,0.9646779029070033,1.0,5/12,28.76%,CNOT7;PAN2;TOE1;PNLDC1;NOCT
prerank,MAP kinase phosphatase activity (GO:0033549),0.3711215056617536,0.834328940033438,0.6885245901639344,0.8933886141436991,1.0,3/12,16.03%,DUSP1;DUSP2;DUSP7
prerank,lipid phosphatase activity (GO:0042577),0.3662258776533115,0.8341075397187183,0.6809269162210339,0.8910391161511194,1.0,1/14,1.59%,SGPP1
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.33376440278612235,0.830451020849257,0.6976744186046512,0.8949238455260449,1.0,2/20,1.34%,CASK;MPP1
prerank,protein phosphatase regulator activity (GO:0019888),-0.23127635935888757,-0.8294436658230324,0.7749287749287749,0.9718952881134327,1.0,14/53,21.06%,MGAT5;CALM2;PPP1R16B;PPP2R2B;PPP1R7;PPP2R5C;ANKLE2;SAG;PPP6R1;PPP1R16A;PPP2R5A;PTPA;CABIN1;CALM3
prerank,sodium channel activity (GO:0005272),-0.2550180618440773,-0.829357791843984,0.7507002801120448,0.9673599097311155,1.0,5/37,14.30%,GRIK2;SCN1B;SHROOM2;SCN8A;SCN1A
prerank,calcium activated cation channel activity (GO:0005227),0.34119123957686737,0.8285144338585899,0.6704980842911877,0.8955537774098384,1.0,3/17,5.28%,ANO6;KCNMB1;ANO1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.32039839314665475,0.8281292968228819,0.6946826758147513,0.8935544932869025,1.0,3/25,3.97%,PARP14;PARP8;PARP11
prerank,neuropeptide receptor binding (GO:0071855),-0.324865677622478,-0.8279021986274262,0.6986607142857143,0.9655612002412649,1.0,6/14,50.03%,SHANK1;NPY;APLN;GAL;NPPA;GHRH
prerank,syntaxin binding (GO:0019905),-0.22761305412430854,-0.826508015526288,0.7987616099071208,0.9636610239894496,1.0,21/61,27.26%,UNC13C;SNAP25;SNAP47;VPS18;STX16;CPLX1;NAPA;SYT6;VAMP2;SYT8;SYT1;GOLGA2;CPLX2;BAIAP3;ABCA1;NAPG;VAMP1;VPS11;SYT5;STXBP1;SYT17
prerank,potassium ion antiporter activity (GO:0022821),0.3519669817859663,0.8244836980470327,0.6623376623376623,0.8971751737709809,1.0,4/15,14.19%,SLC9A9;SLC9A4;SLC9A7;SLC9A6
prerank,ATPase regulator activity (GO:0060590),0.2913851464150291,0.8224575302254601,0.703875968992248,0.8982388248477536,1.0,6/38,10.15%,FXYD2;BAG3;FNIP1;DNAJC1;PLN;AHSA1
prerank,amino acid binding (GO:0016597),-0.25941424892621023,-0.8220347655425112,0.7246753246753247,0.9681915589035497,1.0,14/31,26.94%,GRM7;AARS1;GRIN3A;GLRB;CASTOR2;GLRA1;GLRA3;DDAH1;AARS2;GLRA2;AGXT;CAD;CASTOR1;GCLC
prerank,metal ion transmembrane transporter activity (GO:0046873),0.30790685385929667,0.8206357621659911,0.696763202725724,0.898729455109277,1.0,5/27,14.66%,ATP2B1;TMEM165;ATP2B4;SLC23A1;CNNM4
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.30010836186301487,0.8179307472801721,0.7008,0.9007963705917457,1.0,10/31,18.09%,UBE2E3;UBE2Q2;BIRC6;UBE2K;UBE2D3;UBE2R2;UBE2N;UBE2W;UBE2U;UBE2A
prerank,hydro-lyase activity (GO:0016836),0.2861221907556376,0.8173334351169987,0.75,0.8991209965420124,1.0,12/41,21.63%,HACD4;EHHADH;GMDS;ACO1;HADHA;HADHB;UROS;FAHD2A;ECHDC1;CDYL;IREB2;PCBD2
prerank,endopeptidase regulator activity (GO:0061135),0.28923509152575516,0.8159318385802914,0.7438423645320197,0.898831433699082,1.0,7/40,18.51%,NLRC4;PROS1;USP14;CAST;SERPIND1;TFPI;RENBP
prerank,5'-nucleotidase activity (GO:0008253),0.3482421697854008,0.8149669427547211,0.6766355140186916,0.8978812364844455,1.0,3/13,14.75%,NT5DC1;NT5C2;ACP3
prerank,glutamate receptor binding (GO:0035254),0.3396146771582592,0.8146362083294499,0.6751361161524501,0.8957591120975629,1.0,1/17,0.32%,HIP1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.2925002299451352,0.8141158185103424,0.7156398104265402,0.8940662338397545,1.0,10/34,18.09%,UBE2E3;UBE2Q2;BIRC6;UBE2K;UBE2D3;UBE2R2;UBE2N;UBE2W;UBE2U;UBE2A
prerank,platelet-derived growth factor binding (GO:0048407),-0.3420670470977408,-0.8126977563813318,0.7408207343412527,0.9811773517449318,1.0,7/11,30.09%,COL1A2;PDGFA;COL3A1;COL6A1;PDGFRB;COL4A1;COL5A1
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.34398397385580926,-0.8121285673966017,0.7355555555555555,0.9777532803414362,1.0,2/11,12.35%,SLC2A9;SLC17A5
prerank,CARD domain binding (GO:0050700),0.3422152457461284,0.8118416219700721,0.673721340388007,0.895296859164122,1.0,4/14,12.73%,BCL10;CARD16;RIPK2;NOD2
prerank,hexose transmembrane transporter activity (GO:0015149),0.3622804626184599,0.8113518519420636,0.6802841918294849,0.893548754129873,1.0,4/12,20.08%,SLC2A4;SLC2A2;SLC5A3;SLC2A6
prerank,nuclear import signal receptor activity (GO:0061608),0.34387441550214554,0.8111793400223771,0.6810810810810811,0.891198790039033,1.0,7/15,24.22%,KPNA4;KPNA2;KPNB1;TNPO1;IPO4;KPNA3;RANBP6
prerank,carboxylic acid binding (GO:0031406),-0.24366015655374773,-0.8097924270699961,0.7901907356948229,0.977752982806558,1.0,11/38,16.82%,GRM7;UBR1;PHYH;GRIN3A;SESN3;GLRB;CASTOR2;MAG;GLRA1;PSAP;GLRA3
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.3132292669566451,-0.8087443480417962,0.7235955056179775,0.9752607001881168,1.0,7/15,34.86%,SOCS2;SOCS7;PIK3R5;PIK3R2;PIK3R3;SOCS3;SOCS1
prerank,NADPH binding (GO:0070402),0.35244634046355905,0.8086496817655204,0.7217235188509874,0.8928530992154662,1.0,4/13,20.39%,HMGCR;LBR;CBR3;DUS2
prerank,myosin binding (GO:0017022),0.2607809918169554,0.8044973250892925,0.7488921713441654,0.8972449362879489,1.0,12/55,16.07%,SPATA6;RAB10;RHOA;TRIM32;STXBP5;CXCR4;RAB14;KIRREL1;TRAK2;RAB11A;MYBPC3;RAB3B
prerank,ankyrin binding (GO:0030506),-0.2885870837333039,-0.8038006748731515,0.7452380952380953,0.9796655706423628,1.0,4/19,15.65%,SLC8A1;CACNA1D;SPTB;KCTD6
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.22693445626162856,-0.8036411300437972,0.8136645962732919,0.9753980260338524,1.0,8/53,12.85%,SLC1A3;SLC36A1;SLC38A7;SLC36A4;SLC1A1;SLC25A22;SLC7A8;CTNS
prerank,gamma-tubulin binding (GO:0043015),0.3127702989440825,0.8029322583679097,0.6889692585895117,0.897426443172463,1.0,1/22,0.52%,RAB11FIP5
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.26788945936579284,0.8028107384118409,0.7492492492492493,0.8949955450484446,1.0,15/55,17.39%,ATP2B1;MCU;ANXA2;PSEN1;PKD1L2;TRPV3;TMEM165;TRPM2;ATP2B4;ATP2A2;PKD2L1;PKD2;PANX1;PKD2L2;CUL5
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.25141561535808604,0.802035116867562,0.782051282051282,0.8936231279016557,1.0,12/74,12.24%,POMK;ADK;PGM2L1;NOL9;FAM20A;CHKB;PIK3C2A;PAPSS2;FGGY;DGKH;PANK1;GALK2
prerank,N-acetyltransferase activity (GO:0008080),-0.28374848913910444,-0.7998840122873604,0.7704545454545455,0.9776660920749937,1.0,2/19,4.52%,SAT1;SMARCE1
prerank,ligand-gated cation channel activity (GO:0099094),-0.20914577569467885,-0.7992825822858933,0.8888888888888888,0.9742385881754458,1.0,31/75,37.27%,PTK2B;KCNJ2;GRIA2;GRIK2;GRIA4;GRIN3A;SHROOM2;GRIN2A;KCNN2;KCNK6;KCNJ3;ASIC1;KCNJ10;KCNJ13;GRIA3;KCNJ9;KCNH2;GRIA1;KCNJ12;KCNJ16;KCNN1;KCNJ6;P2RX3;P2RX5;GRIN3B;CHRNA7;ASIC3;SCNN1A;CHRNA5;ASIC4;KCNJ15
prerank,ribosomal small subunit binding (GO:0043024),0.3283399167608139,0.799187310506983,0.7282608695652174,0.895921732443775,1.0,7/17,22.30%,ERAL1;EIF1;EIF4B;MTIF3;PIM1;DHX29;NPM1
prerank,FAD binding (GO:0071949),0.31208782952296465,0.7988874392204642,0.735593220338983,0.8937991789171317,1.0,3/24,6.59%,DAO;NQO2;AGPS
prerank,phosphatase activator activity (GO:0019211),0.3434190778855245,0.7982647608926831,0.6994535519125683,0.8922699918105769,1.0,6/14,21.26%,BMP2;FRS2;CALM1;PPP2R5B;PHACTR4;PPP2R5E
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.31236488561398756,-0.7959543146519017,0.75,0.9755379626161494,1.0,5/13,30.55%,SLC38A7;SLC3A1;SLC7A6;SLC25A29;SLC7A3
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.32683620312671713,-0.7930088373726414,0.7387580299785867,0.9764027295807385,1.0,3/11,15.55%,PPP1R11;PPP1R14A;PABIR1
prerank,3'-5' exonuclease activity (GO:0008408),-0.23246561786999273,-0.7923398143502273,0.8255813953488372,0.9731397046242821,1.0,16/45,32.85%,CNOT7;EXOSC9;DIS3;POLG;PAN2;REV3L;ANGEL2;TOE1;RAD50;ERI3;PNLDC1;RAD9A;ANGEL1;NOCT;RAD1;PNPT1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.35224746715994326,0.7910629780593147,0.7156308851224106,0.9013880793536326,1.0,2/13,11.27%,EHHADH;SREBF2
prerank,methylated histone binding (GO:0035064),-0.2168468405690129,-0.7909385822982181,0.8594771241830066,0.9712887301464892,1.0,26/62,33.03%,BPTF;ING4;ZCWPW1;WDR5;FMR1;DPF2;LRWD1;KDM4A;CBX5;PHF2;PHF1;PHF13;MTF2;TAF1;CXXC1;TTLL12;UHRF1;CBX8;MPHOSPH8;THAP7;MSH6;TAF7;RRP8;MSL3;ING5;PHF19
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.3097815863128545,-0.7906927232104211,0.7699530516431925,0.967354916983082,1.0,5/13,25.85%,DNA2;ENDOV;SLX4;DNASE1L2;EXO1
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.33789699561404607,-0.7883767036121483,0.7370689655172413,0.9670134932581853,1.0,3/10,11.07%,NAA40;NAA60;BRCA2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.3625273547158835,0.7881005521607505,0.7066189624329159,0.9035090658745708,1.0,1/11,1.97%,RPS3
prerank,lysine N-methyltransferase activity (GO:0016278),-0.2777578290254972,-0.7869947574182548,0.7772277227722773,0.9649847596366279,1.0,10/20,36.47%,EHMT2;SETD4;SETD3;EEF2KMT;SETD2;SETD6;SMYD2;EEF1AKMT2;METTL21A;SETD7
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.3510151878693053,0.7864893959907929,0.7232472324723247,0.9033189199972232,1.0,3/12,11.24%,FRS2;SH2B3;SHC1
prerank,SUMO binding (GO:0032183),-0.311115385603142,-0.7787382282261452,0.7361419068736141,0.9742007035665652,1.0,1/13,0.40%,HERC2
prerank,cAMP response element binding (GO:0035497),-0.3359270326619999,-0.7784737141744507,0.7627118644067796,0.9703370391950625,1.0,3/10,11.66%,E4F1;CREB3L2;JUN
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.30373841448524497,-0.7746254270051551,0.7600896860986547,0.9720328591142418,1.0,7/14,25.00%,NFU1;NUBPL;ISCU;SDHB;RSAD2;NDUFS1;ACO2
prerank,tRNA binding (GO:0000049),-0.22886863064751778,-0.7721249941637004,0.8504398826979472,0.9718680123670587,1.0,23/43,36.20%,AARS1;DALRD3;CARS1;PTCD1;TRNT1;SARS1;DARS2;ALKBH8;TRMT9B;PUS1;HSD17B10;AARS2;TRMT10B;SARS2;THG1L;ALKBH1;KARS1;NEMF;SSB;AIMP1;NSUN6;YRDC;EIF2A
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.32685744083983015,-0.7718871940132856,0.7286012526096033,0.96796153586915,1.0,5/10,20.93%,B3GALT1;B3GALT5;B3GALT2;B4GALT7;B3GALT6
prerank,ion gated channel activity (GO:0022839),0.29788422280324584,0.7691060222998928,0.7469670710571924,0.9286397787881467,1.0,3/24,6.15%,ANO6;ANO1;TTYH3
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.297605209839895,-0.7635355270383718,0.8057395143487859,0.9765579781082263,1.0,10/14,47.56%,KCNJ2;KCNJ3;KCNH2;KCNIP2;KCNE4;KCNJ5;KCND3;KCNA5;KCNJ8;KCNE2
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.3329865671097212,0.7625626446393141,0.7429078014184397,0.9360158379948047,1.0,2/14,7.18%,RARRES1;BST2
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.30827017185374433,-0.7622844802622909,0.7922077922077922,0.974094933144091,1.0,6/12,28.24%,STAT1;TBPL1;HDAC1;TAF1;TBP;FOS
prerank,nuclear localization sequence binding (GO:0008139),0.3076216345226895,0.7622178998906746,0.7570422535211268,0.9338938938839944,1.0,8/18,24.22%,KPNA4;KPNA2;NUP153;KPNB1;TNPO1;IPO4;KPNA3;RANBP6
prerank,phosphotyrosine residue binding (GO:0001784),0.26469713550980756,0.7595169746882453,0.7807570977917981,0.9353538750178209,1.0,5/37,11.24%,RASA1;CRK;SYK;ZAP70;SHC1
prerank,ligand-gated calcium channel activity (GO:0099604),0.3005105925155515,0.7574867514521308,0.7723292469352014,0.9357853707517759,1.0,4/19,18.96%,GRIN2D;TRPM2;ITPR3;P2RX4
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.2396321380401548,0.7567625859340928,0.8425655976676385,0.9341686549861105,1.0,15/69,17.82%,MOGAT2;ZDHHC14;ESCO2;ESCO1;ZDHHC3;CERS6;PLAAT1;CREBBP;EP300;KAT6A;PLAAT3;ZDHHC20;ZDHHC2;GTF2B;DGAT1
prerank,nucleotidase activity (GO:0008252),0.3166663376368649,0.7563690624435394,0.7734082397003745,0.9320454982104176,1.0,3/15,14.75%,NT5DC1;NT5C2;ACP3
prerank,Hsp70 protein binding (GO:0030544),0.27835377258914273,0.7555184052680467,0.8109452736318408,0.9307435710361236,1.0,3/31,4.00%,RPS3;ERN1;PRKN
prerank,beta-tubulin binding (GO:0048487),-0.2424646299132987,-0.754562456714918,0.8485576923076923,0.9818017226973529,1.0,7/31,19.69%,TBCD;FGF13;TTLL7;APPL1;GABARAPL1;EMD;BBS4
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.32971586566062516,0.7528522901356103,0.7591240875912408,0.9319820347645842,1.0,4/12,16.61%,CDK12;CDK6;CDK13;BRD4
prerank,sterol binding (GO:0032934),0.2452356501373351,0.746084365723891,0.8425787106446777,0.9393861154748744,1.0,11/56,16.57%,OSBPL9;STARD3NL;ERLIN1;OSBPL11;OSBPL1A;NPC2;GRAMD1B;OSBPL8;OSBPL10;OSBPL5;GPR183
prerank,carboxypeptidase activity (GO:0004180),0.26563239227694574,0.7424672478685529,0.7899686520376176,0.9420200944684679,1.0,1/35,0.62%,PEPD
prerank,leak channel activity (GO:0022840),-0.2706687226873586,-0.7391912082891408,0.8004640371229699,0.9990091315441244,1.0,8/18,28.68%,NALCN;KCNK2;KCNK12;KCNK9;KCNK6;TMEM175;KCNK10;KCNK3
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.29762112204399654,-0.7363619039543527,0.8035714285714286,0.9986677329901721,1.0,2/13,4.67%,PRKAR1A;PRKAR1B
prerank,nuclear export signal receptor activity (GO:0005049),-0.31319988130085463,-0.7358455908103166,0.797979797979798,0.995092974911568,1.0,5/11,36.03%,RANBP17;CSE1L;NUP214;EIF4ENIF1;RAN
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.3153012715833019,-0.7345739505367755,0.8135593220338984,0.9924903065638931,1.0,5/10,29.48%,GABRA2;GABRG2;GABRA4;GABRG3;GABRE
prerank,ADP binding (GO:0043531),0.2767196407173031,0.7337196583391414,0.8309636650868878,0.95120787430631,1.0,2/25,3.17%,PRKAG2;ERN1
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.2581324078760191,-0.7332373917084157,0.8474178403755869,0.990087549095443,1.0,7/20,31.64%,SLC39A11;SLC39A13;SLC39A14;SLC39A6;SLC39A1;SLC30A3;SLC39A7
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.2963939490686185,-0.7301622158137824,0.8318777292576419,0.989858381328735,1.0,8/12,28.84%,ISCU;SDHB;FXN;ISCA1;FDX1;CIAPIN1;CISD3;CISD1
prerank,U6 snRNA binding (GO:0017070),0.3119884263476007,0.7283087302508647,0.8057553956834532,0.9559683058548479,1.0,4/14,16.36%,LARP7;LSM4;LSM2;TUT1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.2743966987622254,0.7239576225865397,0.8068376068376069,0.9589679949908612,1.0,5/24,15.73%,ZDHHC14;ZDHHC3;ZDHHC24;ZDHHC20;ZDHHC2
prerank,phosphatase activity (GO:0016791),0.22610261539658605,0.720375038485277,0.9055007052186178,0.9610367151308816,1.0,11/73,15.12%,PTPRJ;PTPN22;DUSP28;DUSP12;OCRL;HDHD2;LHPP;PPP1CA;ACP3;PTPMT1;DUSP23
prerank,exoribonuclease activity (GO:0004532),-0.2884367169315534,-0.7171365608481385,0.8246013667425968,1.0,1.0,2/12,8.16%,CNOT7;EXOSC9
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.21939608722466264,-0.7149512530467947,0.9353932584269663,1.0,1.0,13/34,31.34%,EHMT2;SETD4;DOT1L;SETD3;SMYD1;EEF2KMT;SETD2;SETD6;EZH2;TTLL12;PRDM9;SMYD2;EEF1AKMT2
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.2813562541464823,-0.710966394861282,0.847682119205298,1.0,1.0,5/13,20.43%,PIK3CB;PIK3C2B;PIP4K2B;PIP4K2C;PIP5K1B
prerank,neuropeptide hormone activity (GO:0005184),-0.2482161789327445,-0.7108126108910431,0.878345498783455,0.9968670506089905,1.0,14/22,50.32%,ADCYAP1;PENK;PNOC;GRP;NPFF;NPY;CRH;GAL;VIP;SPX;CORT;NPPA;GHRH;CALCB
prerank,potassium ion leak channel activity (GO:0022841),-0.2723320362233336,-0.7080001596691611,0.8619153674832962,0.9958100203716397,1.0,7/15,28.68%,KCNK2;KCNK12;KCNK9;KCNK6;TMEM175;KCNK10;KCNK3
prerank,myosin V binding (GO:0031489),-0.27193610810770996,-0.7071806160008648,0.8545034642032333,0.9926650927283224,1.0,2/15,4.41%,RAB6B;RAB3C
prerank,DNA polymerase binding (GO:0070182),0.2791132002709105,0.7033360112556242,0.8461538461538461,0.9797888928477049,1.0,7/18,20.20%,SMG6;POLG2;HSP90AB1;FANCI;LONP1;RTEL1;PCNA
prerank,organic anion transmembrane transporter activity (GO:0008514),0.2034775395293293,0.699311508811899,0.945054945054945,0.9819043004178813,1.0,23/134,17.60%,SLC16A7;CD36;SLC25A17;SLC38A6;SLC25A24;SLC25A2;ABCC4;ABCC1;RTBDN;SLCO5A1;SLC35B3;SLC38A1;SLC2A2;SLC38A2;GJA1;MFSD2A;SLC23A1;SLC23A2;SLC26A7;SLC6A6;SLC5A6;SLCO2A1;SLC36A2
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.22022428347417622,-0.6975871423054064,0.9271356783919598,0.9989396499145967,1.0,11/30,31.64%,SLC40A1;TTYH1;SLC39A11;SLC11A2;SLC39A13;SLC39A14;ATP7B;SLC39A6;SLC39A1;SLC30A3;SLC39A7
prerank,kinase activity (GO:0016301),0.20728868488946822,0.6943023431511001,0.9367588932806324,0.9851733129362866,1.0,11/109,10.04%,POMK;LYN;PGM2L1;IP6K3;GSK3B;PKN2;CHKB;PIK3C2A;PAPSS2;PMVK;DGKH
prerank,MHC class II protein complex binding (GO:0023026),-0.2970361458227475,-0.6925356787239827,0.865979381443299,1.0,1.0,2/11,4.52%,ATP1B1;PKM
prerank,ribonuclease P activity (GO:0004526),-0.28721614471841517,-0.690094264381091,0.8424507658643327,0.9986640976562188,1.0,5/11,24.67%,RPP14;POP1;RPP21;PRORP;POP7
prerank,serine-type endopeptidase activity (GO:0004252),-0.18011082757340624,-0.6893707975418096,0.9927797833935018,0.9953673012840416,1.0,6/80,8.60%,KLK2;MASP1;HTRA2;PLAU;F3;RHBDL3
prerank,aminopeptidase activity (GO:0004177),0.2621975744330871,0.6889224707602511,0.8681135225375626,0.9886421401754175,1.0,4/26,10.23%,XPNPEP3;LNPEP;RNPEP;ENPEP
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.2256044261747725,-0.6883542069891506,0.9215189873417722,0.9922911770653127,1.0,11/28,27.83%,ENDOV;RPP14;POP1;RNASEH1;RPP21;EDC3;PRORP;POP7;EXO1;NUDT16;DBR1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.2919095109172658,0.6880161457374241,0.8516483516483516,0.9869807806986127,1.0,1/15,6.84%,PLA2G2D
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.2667451717467033,-0.6851239465511154,0.8702830188679245,0.9916689037062113,1.0,5/14,24.67%,RPP14;POP1;RPP21;PRORP;POP7
prerank,histone acetyltransferase binding (GO:0035035),0.27089813453018247,0.6822244880101673,0.8453947368421053,0.9905474090092565,1.0,6/21,17.18%,MEF2A;TRIM68;KANSL1;BCAS3;KANSL1L;ZBTB7A
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.21550831943877602,-0.6811963363809656,0.9376693766937669,0.991748770624953,1.0,10/33,28.76%,CNOT7;EXOSC9;DIS3;PAN2;ANGEL2;TOE1;ERI3;PNLDC1;ANGEL1;NOCT
prerank,NF-kappaB binding (GO:0051059),0.2616172814924357,0.6803581076349663,0.8476027397260274,0.9900292764005397,1.0,8/24,22.30%,BCL10;GSK3B;PSMA6;EP300;RELA;BRMS1;FAF1;NPM1
prerank,syntaxin-1 binding (GO:0017075),-0.2357459162265981,-0.67922091666295,0.9101941747572816,0.9896466291802066,1.0,6/22,19.42%,UNC13C;SNAP25;CPLX1;VAMP2;SYT1;CPLX2
prerank,receptor antagonist activity (GO:0048019),-0.24958414091803532,-0.678276824175637,0.8891402714932126,0.986665883552172,1.0,3/17,19.27%,DKK2;IL18BP;DKK3
prerank,four-way junction DNA binding (GO:0000400),-0.24959162857807388,-0.6781723000510388,0.8852459016393442,0.9828857701835143,1.0,7/17,31.89%,BLM;RAD51C;MSH2;HMGB1;HMGB3;MSH6;XRCC2
prerank,fatty acid synthase activity (GO:0004312),-0.2956656257504132,-0.6762181119694549,0.8551307847082495,0.980923626401402,1.0,7/10,36.82%,OXSM;ELOVL1;ELOVL4;ELOVL7;CBR4;ELOVL6;ELOVL2
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.24106036804720768,0.6750089395804038,0.8670886075949367,0.9928442755665339,1.0,8/35,16.92%,FOXP1;NR3C1;KLF10;H3-3A;GTF2A1;MYC;GTF2B;RELA
prerank,NAD+ binding (GO:0070403),-0.2740916920220869,-0.6727437108214845,0.8678414096916299,0.9802032780848852,1.0,4/12,18.38%,SIRT2;UXS1;SIRT5;PARP9
prerank,CoA hydrolase activity (GO:0016289),-0.25119944112475784,-0.6719836101993715,0.9141630901287554,0.9770209352311116,1.0,5/16,25.43%,ACOT9;ACOT7;ACOT11;ACOT8;ACOT1
prerank,cardiolipin binding (GO:1901612),0.31196620893317917,0.6719586961495467,0.8546845124282982,0.9933435486221621,1.0,2/10,16.37%,GSDME;UQCC3
prerank,chloride channel inhibitor activity (GO:0019869),0.3022038983583658,0.6715769875388761,0.8752362948960303,0.9910339838878851,1.0,2/10,8.48%,WNK1;STX7
prerank,signaling receptor complex adaptor activity (GO:0030159),0.23735182677561625,0.6684498260336368,0.9161490683229814,0.9915562434637651,1.0,8/38,15.42%,AXIN1;FRS2;SAV1;SH2B3;NUP62;SHC1;MMS19;RGS14
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.29677680669091855,0.6591749279624483,0.8738229755178908,0.9979621047027648,1.0,1/13,2.60%,BMP2
prerank,Notch binding (GO:0005112),0.25650373579214075,0.6590607624836037,0.8953900709219859,0.995430759787541,1.0,5/22,20.84%,JAG1;CUL3;SNW1;DTX1;ADAM17
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.20892936795094166,-0.6581814445202342,0.9453551912568307,0.9851318951500937,1.0,10/34,28.76%,CNOT7;EXOSC9;DIS3;PAN2;ANGEL2;TOE1;ERI3;PNLDC1;ANGEL1;NOCT
prerank,thioesterase binding (GO:0031996),0.29109746869397213,0.6555714827884905,0.8770343580470162,0.9959682785308186,1.0,1/11,3.32%,CDC42
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.23823901572545603,0.6535013410264842,0.9313099041533547,0.9952123681591026,1.0,6/32,15.49%,PHF8;KDM7A;TET3;HSPBAP1;TET2;KDM2A
prerank,nucleosomal DNA binding (GO:0031492),-0.23030247725392963,-0.6529724925031483,0.9345372460496614,0.985445121729918,1.0,13/21,35.04%,SMARCB1;SMARCC2;SMARCE1;RCC1;HDAC1;CHD4;MBD3;MBD2;SMARCD2;SMARCA4;HDAC2;HMGA2;MTA2
prerank,BMP receptor binding (GO:0070700),0.2967784384294983,0.6520094449667887,0.8735849056603774,0.9940185084979563,1.0,1/12,2.60%,BMP2
prerank,peptide hormone receptor binding (GO:0051428),-0.2719347030065961,-0.6499700032816302,0.9024390243902439,0.9837919043279292,1.0,5/11,39.96%,ADCYAP1;PSMC5;PTHLH;GNRH1;VIP
prerank,methylation-dependent protein binding (GO:0140034),-0.17983585431774526,-0.6487348795951896,0.9845201238390093,0.9811020294548884,1.0,22/57,33.03%,BPTF;ING4;ZCWPW1;WDR5;FMR1;LRWD1;KDM4A;CBX5;PHF2;PHF1;PHF13;MTF2;CXXC1;UHRF1;CBX8;MPHOSPH8;THAP7;MSH6;RRP8;MSL3;ING5;PHF19
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.25638839658132784,0.6464095565682346,0.8917089678510999,0.9965235496380886,1.0,3/22,10.47%,RNF169;MINDY2;ZRANB3
prerank,cytochrome-c oxidase activity (GO:0004129),0.2784646989639101,0.6434626623643592,0.8660550458715597,0.9965618743083677,1.0,5/15,21.39%,COX7A2L;COX10;NDUFA4;CYB5A;COX5A
prerank,exopeptidase activity (GO:0008238),0.21465678793194734,0.6409293657284183,0.9612518628912071,0.9959754418900049,1.0,7/50,10.23%,XPNPEP3;LNPEP;PRCP;ZMPSTE24;RNPEP;DPEP2;ENPEP
prerank,exonuclease activity (GO:0004527),0.21813090511710415,0.6404451126830716,0.9617151607963247,0.9937622538425471,1.0,13/46,22.11%,DCLRE1C;REXO2;CPSF3;ZC3H12A;EXOSC8;EXOSC1;DXO;ENPP1;APEX1;MRE11;REXO5;TRIR;EXOSC3
prerank,lysine-acetylated histone binding (GO:0070577),0.25578332753667626,0.6403941727972617,0.9221854304635762,0.9886644733933315,1.0,3/20,11.15%,KMT2A;TRIM24;PHIP
prerank,acetylation-dependent protein binding (GO:0140033),0.25578332753667626,0.6403941727972617,0.9221854304635762,0.9886644733933315,1.0,3/20,11.15%,KMT2A;TRIM24;PHIP
prerank,phospholipase inhibitor activity (GO:0004859),-0.28279739912971513,-0.6394179426038594,0.9006211180124224,0.9840245066854082,1.0,3/10,18.04%,APOC1;ANXA9;ANGPTL3
prerank,histone methyltransferase activity (GO:0042054),-0.1963547375164725,-0.6376711901973522,0.9553072625698324,0.9815302931582784,1.0,11/32,29.87%,EHMT2;DOT1L;PRMT2;CARM1;SMYD1;SETD2;EZH2;TTLL12;PRDM9;SMYD2;PRMT8
prerank,single-stranded DNA binding (GO:0003697),0.19037884878155978,0.6304326511847707,0.9828722002635046,0.9938794359192119,1.0,18/93,18.46%,RBMS1;RBBP8;FAM111A;MCM9;DDX11;RPA1;RAD52;PURA;RPA3;XPC;POLR2D;RAD51B;SAMHD1;FBH1;MCM8;DMC1;APTX;LONP1
prerank,serine-type peptidase activity (GO:0008236),0.19294989520756542,0.630383600741357,0.9740791268758526,0.991354673305206,1.0,7/96,6.74%,ENDOU;RHBDD1;PARL;RHBDF1;ACR;HTRA3;PREP
prerank,peptidase inhibitor activity (GO:0030414),0.2270443903942498,0.6296356452373234,0.9272151898734177,0.9893473672929075,1.0,7/33,18.51%,PROS1;USP14;CAST;SERPIND1;GPC3;TFPI;RENBP
prerank,steroid hydroxylase activity (GO:0008395),-0.23638718154399352,-0.6194131833617768,0.9282407407407407,0.989467892226164,1.0,8/16,42.75%,CH25H;CYP2A6;CYP39A1;CYP1A1;CYP46A1;CYP1B1;CYP2R1;CYP2S1
prerank,signal sequence binding (GO:0005048),-0.19094854446914736,-0.6193752775112352,0.9785522788203753,0.9857714001240268,1.0,2/35,2.28%,PEX5L;IPO5
prerank,phosphatase inhibitor activity (GO:0019212),-0.21898357801076668,-0.6142608372197461,0.9484777517564403,0.9851721273726318,1.0,3/20,20.22%,MGAT5;SAG;CABIN1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.20429106078597276,0.6132838296375226,0.9717114568599717,0.9983209993098213,1.0,10/55,17.60%,SLC16A7;SLC38A6;ABCC1;SLC38A1;SLC38A2;SLC23A1;SLC23A2;SLC6A11;SLC6A6;SLC36A2
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.25453018049000015,-0.6061450641516005,0.944206008583691,0.9857997862582212,1.0,3/12,14.76%,NDUFS7;CRYZL1;AIFM2
prerank,alpha-tubulin binding (GO:0043014),0.22017049680450426,0.6047974115337889,0.9419795221843004,1.0,1.0,9/31,22.13%,ARL8A;EFHC1;FYN;TBCE;TBCEL;SNCA;EFHC2;RACGAP1;DLEC1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.22094608728044346,0.6037726949811292,0.9430379746835443,0.9992732883103157,1.0,6/32,17.60%,SLC43A2;SLC38A6;SLC38A1;SLC38A2;SLC6A6;SLC36A2
prerank,methyltransferase activity (GO:0008168),-0.17366006532605477,-0.602799068812297,0.9916201117318436,0.9838179004104345,1.0,22/46,41.63%,COMT;AS3MT;FTSJ3;MEPCE;DNMT1;BCDIN3D;MRM2;LCMT1;METTL3;ASMT;RRP8;METTL27;PRMT8;GCSH;EEF1AKMT2;LRTOMT;FTSJ1;PRMT7;GAMT;MGMT;DNMT3B;EEF1AKMT4
prerank,ribosome binding (GO:0043022),0.20342549104274846,0.6019141467549918,0.968421052631579,0.9978898758799398,1.0,9/46,17.88%,RPSA;RACK1;SERBP1;SRP68;ZC3H12A;ETF1;MTIF3;PYM1;EFL1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.265317516132906,0.5964303370423598,0.9329608938547486,0.998686870019928,1.0,1/12,5.11%,RACK1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.23893863523227482,0.5934230457748874,0.9280701754385965,0.9979620522472678,1.0,2/18,9.82%,HSD3B7;HSD17B7
prerank,palmitoyltransferase activity (GO:0016409),0.21976965051575775,0.5902507081826365,0.9585492227979274,0.9972482831655726,1.0,5/28,15.73%,ZDHHC14;ZDHHC3;ZDHHC24;ZDHHC20;ZDHHC2
prerank,solute:anion antiporter activity (GO:0140323),0.25374287077749236,0.5886470982987502,0.9444444444444444,0.9955469048904897,1.0,3/14,21.84%,SLC26A11;SLC26A7;SLC26A8
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.20386046010501943,0.5849373831970933,0.9706336939721792,0.9952451207699207,1.0,8/42,15.79%,CCND3;CCNYL1;CCND2;CCNJ;CDKN2C;CCNQ;CCNY;HEXIM2
prerank,gap junction channel activity (GO:0005243),-0.19898692352528374,-0.5817070108166761,0.9743589743589743,0.9899694027758015,1.0,4/22,19.87%,GJB1;GJC1;GJD3;GJC2
prerank,aspartic-type endopeptidase activity (GO:0004190),0.2566568533453566,0.5757667018266974,0.9314814814814815,0.9975854236152718,1.0,3/12,16.47%,PSEN1;SPPL2B;SPPL2A
prerank,NAD binding (GO:0051287),0.21727850763902157,0.5743344596445739,0.9600665557404326,0.9957909639670501,1.0,4/26,12.94%,SORD;CRYL1;HADH;GLUD1
prerank,active ion transmembrane transporter activity (GO:0022853),0.2050152739027299,0.5715391416778125,0.9794303797468354,0.9946044592697,1.0,9/37,21.39%,SLC16A7;COX7A2L;SLCO5A1;COX10;UQCRFS1;SLCO2A1;NDUFA4;CYB5A;COX5A
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.1817823905259655,-0.5685225163199713,0.9947089947089947,0.9915868418833821,1.0,5/32,13.80%,KCNQ3;KCNQ5;KCNA1;KCNA2;KCNS3
prerank,ribonuclease P RNA binding (GO:0033204),-0.24218318105158368,-0.5622905460407296,0.9472527472527472,0.9902134796267245,1.0,4/10,24.67%,RPP14;POP1;RPP21;POP7
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.24302025381652265,0.5609975609498309,0.9442379182156134,0.9968900657896654,1.0,2/14,11.58%,RACK1;EBAG9
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.2380011060528742,0.5587885063258196,0.9586330935251799,0.9953384159751711,1.0,3/14,19.35%,CMPK1;AK8;AK4
prerank,cation transmembrane transporter activity (GO:0008324),0.18829078802831006,0.5556543910590365,0.9866071428571429,0.9941303961784557,1.0,8/48,17.60%,SLC38A6;SLC25A2;SLC38A1;SLC8B1;SLC38A2;PKD2L1;SLC6A6;SLC36A2
prerank,pseudouridine synthase activity (GO:0009982),0.240051872593746,0.551971901053132,0.9482758620689655,0.9931308578918139,1.0,1/13,5.13%,RPUSD3
prerank,acetylcholine receptor activity (GO:0015464),-0.18982919899091236,-0.551553394257509,0.975669099756691,0.9900313201667984,1.0,10/22,48.95%,CHRM3;ANXA9;CHRFAM7A;CHRNA7;CHRNA5;HRH3;CHRNA3;CHRNB4;CHRM1;CHRNB3
prerank,N-methyltransferase activity (GO:0008170),0.2128132078415127,0.5387932488983969,0.9701230228471002,0.995638137632637,1.0,4/20,15.14%,TRMO;GNMT;PRMT1;HNMT
prerank,voltage-gated sodium channel activity (GO:0005248),-0.18260797889483288,-0.5299368753410704,0.9753086419753086,0.9923323963184351,1.0,3/22,14.30%,SCN1B;SCN8A;SCN1A
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.20937970868910097,-0.5284921413809346,0.9825708061002179,0.9890508763294042,1.0,13/13,79.09%,METTL1;TRMT10B;THUMPD3;FTSJ1;TRMT10C;TRMT5;TRMT11;TRMT1;TRMT10A;THUMPD2;TARBP1;TRMT1L;WDR4
prerank,galactosyltransferase activity (GO:0008378),0.24180926620786447,0.5208750305700148,0.952561669829222,0.998891293082739,1.0,2/11,10.90%,B4GALT6;B4GALT5
prerank,wide pore channel activity (GO:0022829),0.1896595049629352,0.4952124283970314,0.9883527454242929,1.0,1.0,23/23,81.06%,GJB2;GJA1;PANX1;GJB6;GJB5;GJB4;GJC3;GJE1;GJA9;GJA10;GJA8;GJD4;GJA3;PANX3;GJA4;GJA5;PRF1;GJD2;PANX2;GJC2;GJD3;GJC1;GJB1
prerank,amino acid transmembrane transporter activity (GO:0015171),0.16941737468003604,0.4947065961242671,1.0,1.0,1.0,7/47,17.60%,SLC43A2;SLC38A6;SLC38A1;SLC38A2;SLC7A7;SLC6A6;SLC36A2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.2194601381042059,0.48036940508879167,0.9887850467289719,1.0,1.0,11/11,78.07%,SLC25A47;SLC25A20;SLC22A5;SLC22A16;SLC6A20;SLC22A1;SLC25A48;SLC25A45;SLC22A3;SLC25A29;SLC22A4
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.1949459202932156,-0.47801343587453554,0.9851694915254238,0.9940835935803246,1.0,3/11,20.03%,PRMT2;CARM1;PRMT9
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.20721908349026996,0.4546269353540669,0.9907749077490775,1.0,1.0,11/11,79.29%,KCNQ1;KCNE3;KCNE5;KCNE1;KCNE2;KCNJ8;KCND3;KCNJ5;KCNE4;KCNH2;KCNJ3
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.19900492091936145,0.4328456629519256,0.9980879541108987,0.9990673431633611,1.0,1/11,6.84%,BAG3
prerank,adenyl nucleotide binding (GO:0030554),0.19900492091936145,0.4328456629519256,0.9980879541108987,0.9990673431633611,1.0,1/11,6.84%,BAG3
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.17154338817028733,0.40174897620108163,0.9946524064171123,0.9985068853108651,1.0,15/15,82.86%,SLC26A7;SLC26A8;SLC26A2;SLC26A6;SLC26A5;SLC26A1;SLC26A9;SLC39A8;SLC4A8;SLC4A11;SLC26A4;SLC4A1;SLC26A3;SLC4A3;CFTR
